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Abstract
Humans live in association with trillions ofmicrobes and yet we know remarkably liĨle about their
symbiotic relationship. ĉe role thesemicroorganisms have in humans has been characterized only
in the case of few bacteria and much less is understood about the dynamic of this relationship.
Lately, the mass sequencing eﬀorts accompanying the HumanMicrobiome Project have begun to
uncover the composition of these diﬀerent microbial niches, and shed light on some the eﬀects
they have on their host.
ĉe immune system largely determines the composition of bacterial populations living in asso-
ciation with humans. It ėghts oﬀ pathogens while allowing speciėc bacteria to colonize the body.
However, immune system andmicrobiota appear evenmore intimately connected than previously
imagined. Recent evidence shows that interaction with the associated microbiota is necessary for
the proper development of the immune response throughout life. ĉe interface with commensal
microbes is notoriously diﬃcult to probe experimentally, due to the diversity of its composition,
whichmakes diﬀerentiating the individual ramiėcations of each associatedmicrobe amuch harder
task. To understand the complex relationship between the human immune system and micro-
biome, we need methodologies that can simultaneously probe both in a high throughput fashion,
as well as analysis tools to cope with the large amount of resulting data.
Herein I present the development of immunemass screening tools capable of comprehensively
proėling the antibody-mediated and cell-mediated immune response to microbes. I employ mi-
croĚudics techniques to describe the response of single immune cells at high-resolution and in a
physiologically relevant environment. I also present the application of machine learning to gut mi-
crobiome data and demonstrate how it can be used to diﬀerentiate between diseased and healthy
individuals in an IBD patient cohort and to allows to deal with the complexity of microbial com-
munity data.
Moving forward, the goal is to combine these approaches to map how changes in the immune
response aﬀects microbiome composition and vice versa. In turn, characterizing this interplay will
contribute to our understanding of how bacteria shape our homeostasis and health, facilitating the
prediction of which imbalances may lead to disease.
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Part I
Introduction
Ǐ
Humans are colonized by trillions of bacteria, the vast majority of which exist in a mutualis-
tic relationship with their host. Despite their overwhelming presence on the body, we know liĨle
about our associated microbiota. How is the composition of our microbiome determined? How
do bacteria colonize the human body and what determines their ecological success within a spe-
ciėc niche? And perhaps most importantly, what functional roles do they play in health and what
triggers are required to render them pathogenic?
Even though signiėcant technical advances have increased our ability tomap and quantify bac-
teria, these question remain unanswered in large part due to the lack of a systems approach with
which to simultaneously analyze host-derived pressures, microbiome composition and host re-
sponses.
ǉ.ǉ Eﬀects of the immune system on themicrobiome
ĉe number and type of bacteria present at diﬀerent sites on the body are undoubtedly shaped by
the nature and interactions amongst the bacterial species themselves, but their composition is also
heavily inĚuenced by the human immune response.
Innate immunity – mediated by phagocytes, NK cells and neutrophils – aﬀects the number
and species of microorganisms by triggering inĚammation. ĉe innate immune system must tol-
erate associated bacteria while remaining capable of mounting a response to pathogens. ĉis is
largely achieved by reducing the contact between the microbiota and the sensing mechanisms of
the immune system. ĉis separation is aĨained through defensive barriers, such as mucus layers
and anti-microbial factors. When these barriers fail and contact does occur, sensing of microbial
material by toll-like receptors (TLR) present on the surfaces of innate immune cells triggers an
inĚammatory response. ĉe subsequent release of pro-inĚammatory cytokines is responsible for
the activation of adaptive immunity and the initiation of bacterial killing bymacrophages andNK-
cells . ĉesemechanisms, together with the release of lipidmediators of inĚammation and reactive
oxygen species, are responsible for the consequent reduction in microbial load.
Adaptive immunity –mediated by B cells and T cells – is responsible for the antigen-speciėc
killing of pathogens. B cells primarily secrete antibodies, which can have direct anti-microbial ef-
fect (such as IgA in the gut) or otherwise exert an inĚuence on host immune response (such as
anti-neutrophil cytoplasmic antibodies). B cells can be activated by cytokine release or by direct
binding with their antigen in a native form (through the antigen-speciėc B-cell receptor or BCR).
T cells, on the other hand, are activated by pathogen-derived, MHC-associated peptides via their
antigen-speciėc receptors (T-cell receptor or TCR). Cell-mediated killing occurs through cyto-
toxic T cells, which interact with targets directly and release factors capable of disrupting pathogen
integrity.
Regulation of adaptive immunity is intrinsically linked with the composition and function of
the resident microbiota due to its ability to kill speciėc pathogens. ĉroughout the gut, various
types of antigen-speciėc T cells have diﬀerent abundances, which translate into diﬀerences in bac-
terial composition. Two types of T cells are of particular importance in understanding mucosal
immunity: ĉǉǏ cells and regulatory T cells (Treg). ĉǉǏ cells have a role in clearing pathogens
during host defense reactions and in inducing tissue inĚammation in autoimmune disease. Tregs
have opposing eﬀects and are responsible for maintaining a balanced adaptive immune response
and prevent excessive microbial killing.
ǉ.Ǌ Reciprocal inĚuencesof themicrobiomeandthe immunesys-
tem
Despite the large inĚuence the host immune system exerts on the microbiota, the communication
between host and microbiota is far from unidirectional. It is gradually becoming apparent that –
as much as the host inĚuences the composition of the associated microbiota – the presence of mi-
croorganisms is in turn required for the proper development of the immune system and regulation
of the immune response. Substantial evidence supports a role for enteric microbiota both in pro-
tection against disease as well as in its pathogenesis. Imbalances in the equilibrium between host
and microbiota contribute to the development of obesity [ǉ] [Ǌ] [ǋ] [ǌ], autoimmune diseases
[Ǎ] [ǎ] [Ǐ] and allergies [ǐ] [Ǒ]. Similarly, it is postulated that bacteria behave as pathogens to
their host when this equilibrium is perturbed.
However, a complete picture of how this balance is maintained in health and disrupted in dis-
ease remains elusive. Understanding the complex interaction betweenhost andmicrobiotawill not
only help explain the role bacteria play in human biology, but will also contribute new elements to
our grasp of the immune systemand the underlyingmechanismsof the host response. ĉeultimate
goal would be to enable the manipulation of bacteria for therapeutic purposes.
Current molecular biology tools are not powerful enough to decipher these complex interac-
tions. Traditional immunological assays (ELISA or FACS) provide an overall picture of the im-
mune system, but lack the necessary single cell resolution and large throughput data analysis. Sim-
ilarly, available microbiological approaches can only focus on a few of the microbes living in as-
sociation with the human host, largely due to the inherent diﬃculties of growing representative
colonies in culture.
To understand themechanism of the interplay between host immune system andmicrobiota it
is ėrst necessary to describe each comprehensively and in detail. Herein I present the development
of systems biology tools capable of independently characterizing the immune response and the
composition of human microbiota with high resolution and accuracy. ĉese tools can be used
to deėne this delicate interplay, thus enabling the discovery of the mechanism of communication
between the host and symbiotic bacteria.
ǉ.ǋ Outline
I begin by reviewing what is currently known about the relationship between host immune system
and microbiota as well as the reciprocal inĚuence they exert on each other.
In Part II I present the tools developed for the study of the host immune system: ėrst, a tool
to proėle antibody-mediated adaptive immune responses with single cell resolution and second,
a tool capable of observing cell surface receptor dynamics in individual lymphocytes. In Part III,
I present the computational tools developed for the analysis of microbiota composition and its
impact on host health. Lastly, in Part IV I summarize how the tools described further enable the
study of host-microbiome interactions and discuss future directions of this work.
ǉ.ǌ Background
ĉehumanmicrobiome
ĉehumanmicrobiome is established at birth, where maternal bacteria are responsible for the ini-
tial colonization. ĉe composition of these microbiota then evolves based on successive environ-
mental exposures. Despite large individual-to-individual variability, it has been determined that
a core microbiome of approximately ǉǊǈǈ species is shared amongst humans. [ǉǈ] It is estimated
that the total number of genes contained within these bacterial species is ǉǍǈ fold the number of
genes in the human genome. ĉemajority of the microbiota that lives in association with humans
is contained in the gastrointestinal system. It seems therefore plausible that the greater part of the
functionalities provided by these microbes reside here.
Humans andmicrobiome co-evolution
ĉe relationship between the human and the microbiota is mutualistic, therefore the human host
depends on the presence of its associated bacteria to thrive in its environment, while the microbes
dependononeof themicroenvironments in the host for their survival [ǉǉ]. ĉismutualismhas led
to a process of co-evolution which, in turn, has led to the establishment of a balance between the
needs of the host and the survival of the bacteria [ǉǊ]. Bacteria that live in associationwith humans
appear to providemetabolic and digestive functions whichwould otherwise not be available to the
host. ĉey also appear to provide protection frommicrobial pathogens and, importantly, modulate
immune system homeostasis.
Human and microbiota co-evolution is a continuous process and though it may have reached
an equilibrium over time, it is not known how long this state has lasted or how stable it will be over
time. In fact, it has been hypothesized thatmany of the perturbations of this balancewe observe to-
day are the manifestation of this evolutionary competition between host and microbes [ǉǋ] [ǉǌ].
Temporary evolutionary advantages of microbes over their host may manifest as pathogenic pro-
cesses. Similarly, Ěexible mechanisms of immune response may be an evolutionary adaptation of
the host to the rapid pace of genetic change in the microbiota [ǉǍ].
Ecological relationships in themicrobiome
It is thought that microbes living in association with the human host are in a relationship spanning
the continuum from pathogenic to symbiotic [ǉǎ]. In a symbiotic relationship at least one between
microbe or hostwould beneėt from co-existencewith no adverse eﬀect on the survival of the other.
In the gut, for instance,microbes canwork symbioticallywith their host, providing protection from
other microorganisms and aiding in the breakdown of compounds the host would otherwise be
unable to metabolize.
At the other endof the spectrum lie pathogenicmicrobes, which subsist on andpotentially harm
the host while thriving in the niche it provides. Somewhat in the middle of this continuum there
lies a category of microbes termed commensals which inhabits the host without posing either ob-
vious harm or beneėt to it. Lastly, it has been suggested that a new category of bacteria termed
pathobiont should be deėned [ǉǉ] [ǉǏ]. ĉese are normally symbiotic bacteria which, under par-
ticular environmental circumstances, are capable of behaving as a pathogen causing harm to their
host.
One prototypical example of a pathobiont in humans isHelicobacter pylori, which asymptomat-
ically colonizes the gastrointestinal mucosa, without causing any secondary harm [ǉǊ]. In tandem,
H. pylori has been demonstrated to be a major cause of gastritis and gastric cancer in humans. Al-
though the reasons for this incongruence are not completely understood, it is thought that only
particularly aggressive strains of H. pylori can cause disease and do so in the subset of hosts that
have a genetical predisposition. Other bacteria behaving in a similar manner have also been identi-
ėed in mice (Helicobacter hepaticus [ǉǏ] [ǉǐ] and enterotoxigenic B. ěagilis [ǉǑ]) and in humans
(adherent Escherichia Coli strains [Ǌǈ]).
ĉe immune system interface with themicrobiome
Study of the relationship between microbiota and gut immune system are beginning to elucidate
the molecular mechanism by which the immune system is capable of tolerating such an exten-
sive exposure to microbial material and yet remain capable of mounting an immune response to
pathogens. ĉe mechanism through which this tolarance occurs has been termed immune igno-
rance [ǐ]. Rather than developing immune tolerance through sustained exposure to microbial fac-
tors, the mucosal immune system relies on being largely shielded from the commensal bacteria
inhabiting the gut. Immune ignorance to the microbiota is achieved by a combination of anti-
inĚammatory processes, initiated either by the host immune cells or the commensal microbes
themselves, and the physical barriers that limit the majority of bacteria to the lumen of the gut
and away from the mucosal layer [ǉǉ]. ĉe lack of an inĚammatory process prevents antigen-
presenting cells from engulėng commensals and, in combination with physical barriers, minimizes
the contact between immune system and bacteria under normal conditions.
Antigen presenting cells, NK cells and regulatory immune cells are responsible for the release
of anti-inĚammatorymediators, which prevent contact withmicrobes from eliciting a full immune
response. ĉis paradoxical mechanism has most likely evolved to protect the host from the con-
sequences of excessive and prolonged immune responses, including severe epithelial damage and
loss of integrity of the gut mucosa. Resident microbes have also evolved strategies to prevent in-
Ěammatory states in the immune system, since inĚammationwould bring about the indiscriminate
elimination of microbes in the mucus layer as well as in the lumen.
Mucus is the primary physical barrier that prevents microbes to enter in contact with the ep-
ithelial cells of the gut. It is largely composed by the MUCǊ protein and it is divided into two
layers: an outer layer in contact with the microbiota and the lumen, and an inner layer which is
hard to penetrate for bacteria and almost completely devoid of microbial load in vivo [? ].
Despite the existence of these innate defenses, the separation betweenmicrobiota and immune
system is not absolute, since some components of the immune system(egMcells in peyer’s patches
and DC cells in the lamina propria) have been shown to sample commensal bacteria under nor-
mal circumstances [Ǌǉ]. ĉe implications of this immune recognition however still remain un-
clear [ǊǊ].
Microbiome inĚuence on host immune system
Evidence is mounting that microbiota shapes the immune response in fundamental ways. ĉe
study of the inĚuence of microbiota on the host immune response has mainly focused on the gut,
where it has been demonstrated that bacteria are required for the proper development of mucosa-
associated lymphoid tissue. In germ free mice, where the contribution of the microbiota is absent,
the gut-associated lymphoid tissue (GALT) does not fully develop [Ǌǋ].
Furthermore, commensal microbes have been shown to directlymodulate immune homeosta-
sis, both at the level of gut mucosal immunity and systemic immunity [Ǌǌ] [ǊǍ]. ĉere are very
large numbers of species in the microbiota, ecological competition is tight and, therefore, it is not
surprising that microbial species have evolved ways of inĚuencing the host immune system in or-
der to maximize survival. ĉe evolution of such mechanisms is likely an evolutionary strategy on
the part of the microbes in order to preserve mutualism [Ǌǎ] [ǊǏ], however this remains a diﬃcult
hypothesis to test.
ĉe impact of commensals on the balance of the host immune system appears to be subtle
undernormal conditions, but becomes an importantdeterminantof host ėtness in situationswhere
the host and its gut are under the inĚuence of environmental stress [Ǌ]. ĉemicrobial composition
and the shape of the immune response mounted can determine the host’s ėtness during infection
or inĚammation.
Mechanisms
Commensals favor proper functioning of the immune system in the gut by a variety of mecha-
nisms [Ǌǐ]. Mutualistic bacteria may exert their eﬀect either by i) direct penetration of the mu-
cosal membranes and engagement with epithelial cell receptors [ǊǑ] or ii) by secreting speciėc
metabolites [ǋǈ].
When engaging with epithelial cells, mutualistic bacteria contribute to the integrity of the gut
protective barriers, by inĚuencing the rate of proliferation of intestinal epithelial cells and induc-
ing the production of cytoprotective proteins. Resident bacteria in the mucus layer also stim-
ulate the release of anti-microbal compounds capable of signiėcantly reducing bacterial load in
the lumen [ǋǉ]. Microbial-associated molecular paĨerns (MAMPs) are recognized by innate im-
mune receptors which then stimulate the release of anti-microbial peptides (AMPs) and secretory
IgA[ˆiga-note]ã through BAFF and APRIL transcription factors [ǋǊ] [ǋǋ].
Direct interaction between cells of the innate immune system and the bacteria living in the
gut primarily involves toll-like receptor (TLR) signaling. Loss of TLR signalling in MyDǐǐ deė-
cient mice causes greater susceptibility to colonic injuries, suggesting a role of TLR signalling in
the maintenance of epithelial integrity in the gut [ǋǌ].
ĉe secretion of microbial factors ormetabolites is also responsible for changes in themucosal
immune system. For instance, it has been shown that bacterial ATP has an eﬀect on ĉǉǏ cell
diﬀerentiation [ǋǍ]. Similarly, bacterial peptidoglycans have been shown to enhance systemic im-
munity [ǋǎ] and soluble proteins produced from probiotic bacteria have been shown to regulate
the integrity of the intestinal epithelium [ǋǏ].
Lastly, the balance between regulatory T cells andĉǉǏ cells appears to be another important
mechanism by which the microbiota exert their control over mucosa. Tregs are a population of
T cells which is abundant in the gut and present also in the absence of microbiota. It is believed
that their diﬀerentiation is inĚuenced in large part by the gut microbiota, since DNA from speciėc
commensal bacteria has been shown to directly reduce Treg diﬀerentiation [ǋǐ]. Tregs are less
abundant in the small intestine than in the colon. ĉǉǏ on the other hand are less abundant in the
colon than in the small intestine. It is believed that the diﬀerent makeup of the microbial commu-
nities at these two sites inĚuences the balances between these two pools of cells and consequently,
the characteristics of the T cell mediated immune response [ǉǐ].
Eﬀects
It has been demonstrated that diﬀerent bacteria modulate the immune system by independent
mechanisms. ĉe two most important examples are Bacteroides ěagilis and segmented ėlamen-
tous bacteria (SFB). B. ěagilis can induce ĉǉ responses in the gut through polysaccharide-A (a
surface polysaccharide speciėc to B. ěagilis) which in turn stimulates proliferation of regulatory
T cells. ĉus its main eﬀect is to promote an anti-inĚammatory state in the gut [ǉǏ] [ǋǑ]. SFB
arguably acts in the opposite direction, stimulating the proliferation of ĉǉǏ cells in the gut and
thus promoting strong eﬀector immune responses [ǌǈ]. As a result, animals whose microbiota is
devoid of SFB have worse resistance to some pathogenic infections [ǌǉ]. On the other hand, colo-
nization with SFBworsens inĚammation inmicemodels of autoimmunity and can exacerbate dis-
ease [ǉǉ]. Other speciėc bacteria have been postulated to have protective eﬀects in inĚammatory
disease and colitis (F.prauznitsii [ǌǊ] andClostridium bacteria) or colitogenic eﬀect (K.pneumoniae
in SC mice) [Ǌǌ], though more details about the underlying molecular mechanism have yet to be
clariėed.
However, the eﬀective role of each bacterium is oěen not so clear cut. ĉe overall composition
of themicrobial community can change thebehaviourof a singlemicrobe, as shownbyexperiments
where SFB alone was not capable of triggering any intestinal inĚammation in immunodeėcient
mice [ǉǊ]. Similarly, the integrity of the immune system can ultimately determine the eﬀect of
each microbe on the host. Even the prototypical anti-inĚammatory bacterium B. ěagilis has been
shown to cause sepsis in an immunocompromised host [ǌǋ].
Importantly, the observation that distinct microbes have diﬀerent eﬀects on the immune sys-
tem validates the possibility of using individual microorganism tomanipulate the host-microbiota
balance for therapeutic uses. Moreover, it underlines the importance of determining microbiota
composition to fully characterize immune response. If the presence or abundance of speciėc bacte-
ria can result in diﬀerent overall immune responses to pathogens, it will be important to determine
which bacteria live in association with the host in order to predict the success and duration of the
response.
InĚammatory bowel disease
InĚammatory bowel diseases (IBD) - ulcerative colitis (UC) and Crohn’s disease (CD) - are dis-
eases characterized by the inĚammation of the colon and small intestine. ĉe exact cause and etiol-
ogy of IBD is unknown, and diagnosis is made on the basis of symptoms, particularly the presence
of lesions in the lower GI tract. It is considered an autoimmune condition and is usually managed
through immunosuppressive therapies.
ĉere is increasing evidence that host-associatedmicrobiota plays a key role in IBD. An inverse
correlation between incidence of parasitic gut microbiota, such as worms, and the occurrence of
IBD, suggests a protective eﬀect of parasites on host [ǌǌ]. Furthermore, prebiotics and probiotics
also have beneėcial eﬀects in patients with IBD, in some casesmore so that conventional drug regi-
mens [Ǎ] [ǌǍ]. At the same time,microbiota has also been linked to exacerbateddisease pathology,
with ulcerations occurring in stretches of the intestines with the highest concentration of bacteria
[ǌǎ]. In certain cases, treatment with antibiotics, and therefore reduction of gut microbes, can
diminish IBD symptoms.
Dysbiosis in inĚammatory bowel disease
To explain the critical inĚuence of the microbiota in inĚammatory bowel disease, the concept of
dysbiosis has evolved. ĉis is an imbalance in the Ěora associatedwith disease, which can be equally
brought about by environmental factors, colonization by an invasive pathogen, or T-cell mediated
host immune response, as demonstrated in the case of Salmonella Enterica [ǌǏ]. ĉese imbal-
ances have been largely characterized in mouse models as well as humans [Ǐ], but are rarely con-
served across individuals. A few scenarios for bacterial-dependent IBD etiology have been postu-
lated including i) an increased prevalence of pro-inĚammatory bacteria capable of initiating disease
episodes or worsening existing inĚammation, ii) a reduction of those taxa responsible for inhibit-
ing inĚammatory cascades in intestinal epithelial cells, iii) abnormal adherence of the intestinal
microbiota to the epithelial wall, iv) an overall decrease in diversity and v) selection of colitogenic
bacteria by intestinal inĚammation [? ]. It is perhapsmore likely that all these scenarios simultane-
ously play a part in the etiology of IBD, though the extent of each contribution’s changes depends
on the stage of the disease (before or aěer inĚammation), the overall architecture of the commen-
sal microbiota, the presence of other environmental stressors (eg. diet, infections, antibiotics) and
predisposing genetic factors in the host (eg. immune deėciencies, NODǊ variants). Since these
processes are reciprocally connected, pinpointing the actual trigger causing the onset of disease
may be a challenging task. It is indeed probable that the triggering event may be diﬀerent in each
IBD patient and that an integrated ecological approach may be more appropriate in the treatment
of IBD.
Dysbiosis and systemic immunity
Dysbiosis has also been implicated in extra-intestinal disease, particularly in allergy and autoim-
mune diseases.  Hence, there is increasing interest in systematically determining howmicrobiome
correlates with changes in systemic immunity. Despite convincing proof that immune response to
intestinal microbiota is largely conėned to the GALT, there seems to exist a diﬀerent mechanism
by which gut microbes aﬀect the development of systemic immunity in the host. ĉis hypothe-
sis derives from the observation of signiėcant diﬀerences in the immune system of germ-free mice
when compared to control animals. Translocation of microbially-derived factors from the intesti-
nal mucosa to the lymphatic system could account for this inĚuence [ǌǐ] [ǋǎ], but more research
is required to obtain a clear picture.
Regardless of the mechanism by which the microbiota causes these systemic changes in the
immune response, they provide a plausible mechanism for the correlations observed between mi-
crobial dysbiosis and autoimmunediseases. [ǌǑ] Studies inmice have shownhowmicrobiota can
either worsen or ameliorate symptoms of autoimmune disease, though they failed to provide a ca-
suative link. Colonization with microbiota was shown to prevent diabetes in germ-free MyDǐǐ-/-
NODmice, while at the same time increasing the severity of autoimmune encephalomyelitis.
Allergic reactions have also been correlated with microbial imbalances as part of the eﬀort
to demonstrate the hygiene hypothesis[ˆhygienehypothesis]. Administration of probiotics in chil-
dren can reduce IgE reactions, albeit temporarily [Ǎǈ]. Another study in mice models of allergy
demonstrated the role of microbial LPS in preventing anaphylaxis, and showed that TLRǑ stim-
ulation could abolish allergic symptoms [Ǎǉ].   ĉese correlations between microbial imbalances
and systemic immunity have prompted research into the impact of themicrobiome on the eﬃcacy
of vaccinations. On one hand, there is interest in determining if routine vaccinations have an im-
pact on the development ofmicrobiota, though this hypothesis seemsnow largely discredited. [ǍǊ]
On the other hand, given the impact of intestinal microbiota in the development of immune func-
tion, it is likely that the intestinal microbiota will signiėcantly aﬀect how individuals respond to
vaccine antigens. Some studies have indicated a correlation between bacterial overgrowth in the
gut with the eﬃcacy of live-cholera vaccines [Ǎǋ], but it remains diﬃcult to dissect to what extent
these eﬀects are due to the microbial diﬀerences or other unmapped environmental factor. [Ǎǌ]
ĉere is now keen interest in manipulating microbiota to either boost systemic response to vac-
cines or as an adjuvant and delivery vehicle for new vaccines. ĉough experimental studies have
shown promise, no clinical data has yet been reported. [ǍǊ]
Part II
Tools for the study of host-associated
microbiota
Ǌǈ
Until recently, our understanding and study of microbial communities and their diversity have
been severely limited. ĉe majority of naturally occurring microbes are refractory to laboratory
culture, thus biasing the studyof these populations towards thosemembers that canbe individually
propagated.
Novel and less expensive sequencing technologies are now poised to dramatically expand our
understanding of the microbial world. ĉrough genome sequencing and functional classiėcation,
it is now possible to characterize entire populations of microbes, in eﬀect identifying each individ-
ualmember [ǍǍ]. Amplifying and sequencingmicrobialDNA in a complex community, allows for
quantiėcation of the extent of genetic diversity in a speciėc environment, mapping of the underly-
ing structure of the microbial population, and provides clues into the mechanisms responsible for
itsmaintenance [Ǎǎ] [ǍǏ], the communication amongst itsmembers [Ǎǐ] andėnally, its evolution
[ǍǑ].
Following these advances, an increasing number of studies ofmicrobial diversity has been con-
ducted and large amounts of data are beginning to accumulate. However, to infer any biological
insight from the large amount of sequencing data generated it will be necessary to implement su-
perior analytical methods capable of isolating important features in the dataset.
Machine learning algorithms represent a promising approach, as they allow for the automatic
inference of discriminating characteristics and deėning features from large amounts of complex
structured data. ĉe work demonstrated here aims to apply and adapt existing machine learning
techniques to the analysis of microbial diversity.
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Abstract
Pediatric inĚammatory bowel disease (IBD) is challenging to diagnose because of the non-
speciėcity of symptoms; an unequivocal diagnosis can only be accomplished using colonoscopy,
which clinicians are reluctant to recommend for children. Diagnosis of pediatric IBD is therefore
frequently delayed, leading to inappropriate treatment plans and poor outcomes. We investigated
the use of ǉǎS rRNA sequencing of fecal samples and new analytical methods to create a sensitive
and speciėc test for IBD.We applied supervised learning inmicrobial ecology (SLiME) analysis to
ǉǎS sequencing data obtained from i) published surveys ofmicrobiota diversity in IBDand ii) fecal
samples from Ǒǉ children and young adults who were treated in the gastroenterology program of
Children’s Hospital (Boston, USA).ĉe developed method accurately distinguished control sam-
ples from those of patients with IBD; the area under the receiver-operating-characteristic curve
(AUC) value was ǈ.ǐǋ. ĉe accuracy was maintained among data sets collected by diﬀerent sam-
pling and sequencing methods. ĉe method identiėed key taxa associated with disease states and
distinguished patients with Crohn’s disease from those with ulcerative colitis with reasonable ac-
curacy. ĉe ėndings were validated using samples from an additional group of ǏǏ patients; the
validation test identiėed patients with IBD with an AUC value of ǈ.Ǐǎ. Microbiome-based diag-
nostics can distinguish pediatric patients with IBD frompatients with other gastrointestinal condi-
tions. Although this test should not replace endoscopy and histological examination as diagnostic
tools, classiėcation based on microbial diversity is an eﬀective complementary technique for IBD
detection in pediatric patients.__
Ǌ.ǉ Introduction
Crohn’s disease (CD) andulcerative colitis (UC), collectively termed inĚammatory bowel diseases
(IBD), are incurable conditions that cause ulceration of the intestinal mucosa. If leě untreated,
IBD may require repeated surgical intervention to remove aﬀected parts of the gastrointestinal
system [ǎǈ] leading to malabsorption and nutritional complications. [ǎǉ] Despite its importance,
timely diagnosis is diﬃcult because patients oěen present with non-speciėc symptoms, [ǎǊ] and
the presence of CD or UC can only be conėrmed by colonoscopy.
Diagnosis is particularly challenging in children, for whom presenting symptoms may vary
widely and may only consist of subtle extra-intestinal manifestations. [ǎǋ] ĉis in turn leads to
a typical delay in the diagnosis of pediatric IBD, ranging from ǌ weeks in severe colitis [ǎǌ] to ǎ–Ǐ
months in milder disease. [ǎǋ] Reducing this diagnostic delay is important, since a long period of
unmanaged symptoms can signiėcantly impact growth [ǎǌ] and early treatment is essential to pre-
serving long-term quality of life. [ǎǍ] ĉus a sensitive yet non-invasive detection tool, that could
identify patients at high risk for IBD, and therefore warranting endoscopic evaluation, would be a
valuable diagnostic aid.
Non-invasive tests for IBDalreadyexist, including antibodies [ǎǎ], imaging-based screens, [ǎǏ]
[ǎǐ] and fecal biomarkers extbackslashcite [ǎǑ]. Speciėcities for existingmethods range fromǐǑƻ
toǑǍƻ for eitherCDorUC, [Ǐǈ] however,thesemethods are either limited to active disease, poorly
sensitive (ǍǍƻ), or their outcome can be confounded by diseases other than IBD, [Ǐǈ] limiting
their clinical utility. [Ǐǉ] [ǏǊ]
ĉedesignof an accurate test for IBD is challenging, since the precise cause of IBD is unknown.
No single genetic, environmental or epidemiological factor alone is diagnostic of IBD. [Ǐǋ] Instead,
current evidence about the aetiology of IBD points toward a complex interplay between genetic,
environmental, and immunological factors [Ǐǌ] [ǏǍ] [ǌǎ] and the intestinal microbiota. [Ǐǎ] [Ǎ]
[ǏǏ] Arguing in favour of the involvement of gut microbes in the pathogenesis of IBD, it is known
that colonisation with commensal bacteria is required to elicit colitis in mice. [Ǎ] [Ǐǐ] Similarly,
in IBD patients it is known that antibiotics can treat CD colitis in the short term [ǏǑ] and probi-
otics may prevent relapse of UC. [ǐǈ] We hypothesized that changes in the intestinal microbiota,
whether causative of or responsive to disease, may provide a viable diagnostic of disease status.
Previous microbial diversity studies have found characteristic changes in the composition of
the gut Ěora during IBD that could potentially be used to screen patients with non-speciėc symp-
toms. [Ǐǎ] [Ǐ] In one of themost comprehensive studies to date, Frank and colleagues [Ǐ]mapped
microbiota composition in ǉǊǌ IBD and non-IBD patients by biopsy sampling coupled with ǉǎS
rRNA sequencing. ĉeir work showed that patients with a long-standing history of IBD had de-
creased levels of Firmicutes and increased level of Proteobacteria, when compared to control indi-
viduals. While these results ėrmly established the relationship betweenGImicrobiota and disease
status, the overall approach is unsatisfactory as a diagnostic tool because of low sensitivity (ǋǉƻ)
and low overall accuracy (Ǎǉƻ, as determined from Fig. ǋ in [Ǐ]).
More recent studies have been able to accurately distinguish CD and healthy individuals on
the basis of pyrosequencing data, [ǐǉ] but the same model was unable to distinguish UC from
healthy individuals or to diﬀerentiate patients in remission frompatientswith active disease, raising
questions about whether such approaches show clinical potential. Finally, none of these studies
examined pediatric cohorts.
Herewe demonstrate an approach that is capable of routinely diﬀerentiating childrenwith IBD
from controls with other gastrointestinal diseases in a case-control study of ninety-one pediatric
patients. Ourmethodology showshigh sensitivity and speciėcity over a rangeof disease prevalence
and it can be used to i) identify key taxa associated with each disease state, ii) discriminate CD and
UC and iii) diﬀerentiate patients with active disease from those in remission. We conėrmed our
results by blind validation with an independent cohort of seventy-seven pediatric patients. ĉis
method applies next-generation sequencing and robust statistical analysis using machine learning
techniques and, signiėcantly, is a test for IBD based on non-invasive fecal sampling.
Ǌ.Ǌ Results
Supervised classiėcation distinguishes IBD and non-IBD patients in existing
tissue-based studies
ĉecase-control studyofFrankandcolleagues [Ǐ]usedanunsupervisedclustering approach: prin-
cipal components analysis (PCA). When the class labels (healthy vs. diseased) are known for a
training set of samples, then supervised learning methods are preferred (e.g. support vector ma-
chines, random forests, etc.). ĉese algorithms have been widely and successfully applied to many
problems in the biomedical sciences [ǐǊ] and their use in a clinical seĨing is emerging in the anal-
ysis of gene expression data [ǐǋ] and microbiome data. [ǐǌ]
Weėrst investigatedwhether supervised learning could improve theperformanceof amicrobiota-
based IBD detection tool, by applying it to the published IBD data set of Frank et al. [Ǐ] We em-
ployed our Supervised Learning in Microbial Ecology (SLiME) method to classify samples from
the existing data set as IBD or control. SLiME is based on Random Forests (RFs), [ǐǍ] although
we achieved similar results using other supervised learning approaches such as bagging, stacking
and support vector machines (see Figure Ǌ.ǉ).
Applying our classiėcation algorithm to the existing data set yielded amarked improvement in
accuracy when classifying patients into IBD or non-IBD groups, mainly by allowing the model to
be tuned for increased sensitivity. Based on repeated ten-fold cross validation, the area under the
ROC curve (AUC) ã which is a measure of the overall accuracy of the classiėcation algorithm
over the rangeof possible disease incidence [ǐǎ]ãwas ǈ.Ǐǋ (Figure Ǌ.Ǌ). Choosing a cutoﬀon the
curve which gives relatively high sensitivity (ie. ǐǏ.ǎƻ) yields ǌǏ.ǋƻ speciėcity, amply surpassing
the accuracy of the clustering method originally employed. [Ǐ]
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Figure Ǌ.ǉ: Patients are classiėable as IBD and non-IBDwith a variety of supervised learning algo-
rithms. ROC curves for SVM, Bagging, Stacking and RFs are shown
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Figure Ǌ.Ǌ: Accuracy of disease classiėcation. ROC curve for SLiME classiėcation of active IBD
patients vs controls in the pediatric case-control data set.
Supervised classiėcation distinguishes IBD and non-IBD pediatric patients on
the basis of stool
Although the results obtained using the existing Frank et al. data set were encouraging, there are
several reasonswhy theymight not translate to a clinically useful diagnostic test. First, sampleswere
obtained invasively through surgical tissue resection fromadult patientswith advanceddisease, and
maynot reĚect changesobserved in fecal samples frompatientswith less advanceddisease. Second,
the control specimens in theFranket al. studywere largely composedof tissue fromcancerpatients,
and thus were not typical of patients investigated for IBD in the pediatric seĨing. We therefore
designed a new case-control study to evaluate whether fecal samples from children not undergoing
surgery could be utilized to diﬀerentiate between patients with and without IBD.
Weselected a groupofninety-one children andyoungadults receiving care in the gastroenterol-
ogy program of Children’s Hospital (Boston, USA), and obtained fecal samples. Of these children,
Ǌǋ had Crohn’s disease, ǌǋ had ulcerative colitis, one had undeėned IBD (colitis with elements of
CD and UC) and Ǌǌ had non-IBD functional disease (patients with gastrointestinal symptoms
but no intestinal inĚammation). Demographics of the patient populations are given in Table Ǌ.Ǐ
We isolated DNA from the fecal samples and sequenced a portion of the ǉǎS rRNA gene using
high throughput ǌǍǌ pyrosequencing (see Materials & Methods). We then applied SLiME to the
resulting microbial compositional data.
Remarkably, performance of our method improved on this data set despite the substitution
of mucosal samples with stool samples, yielding a ten-fold cross-validated AUC of ǈ.ǐǋ for distin-
guishing IBD patients from controls (Figure Ǌ.ǋ). Sensitivity and speciėcity for the diagnostic test
can be obtained by selecting the desired threshold along the curve. For instance, choosing a cut-
oﬀ on the curve at relatively high sensitivity (Figure Ǌ.ǋ, circle) yields ǐǈ.ǋƻ sensitivity and ǎǑ.Ǐƻ
speciėcity for the test.
ĉe performance of the same classiėcation algorithm was higher when it was applied to dis-
tinguish from controls only those IBD patients with clinically active disease, yielding an AUC of
Pediatric case control
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Figure Ǌ.ǋ: SLiME applied to Frank et al. biopsy data set. ĉe black line indicates performance
obtainedwhen featureswere generatedby taxonomical binningof theoriginal sequencedata (AUC
= ǈ.Ǐǋ); dashed line shows performance when features were selected based on their importance in
the pediatric case-control data set and then applied to the Frank et al. study (AUC = ǈ.Ǐǉ). Two
diﬀerent threshold selections are highlighted: circle, for which SLiME has ǐǈ.ǋƻ sensitivity and
ǎǑ.Ǐƻ speciėcity; triangle, for which SLiME has ǌǍ.ǐƻ sensitivity and ǑǊ.ǌƻ speciėcity.
ǈ.Ǒǉ (Figure ǉB dashed line). Table Ǌ.ǉ and Table Ǌ.Ǌ show how the classiėer performs amongst
the three disease groups (CD,UC and control) at one arbitrary threshold.
Table Ǌ.ǉ: Confusionmatrix for the SLiME classiėcation of the pediatric training cohort. Sensitiv-
ity ǐǏ.ǎƻ. Speciėcity ǌǍ.ǐƻ. Note this is only one possible cutoﬀ value. Diﬀerent sensitivity and
speciėcity can be obtained by appropriately tuning the cutoﬀ
SLiME classiėcation
Diagnosis IBD non-
IBD
CD ǉǏ Ǎ
UC ǌǈ ǋ
Control ǉǋ ǉǉ
Table Ǌ.Ǌ: Confusion matrix for the SLiME classiėcation of the training cohort on the subset of
patient with clinically active disease at the time of sampling. Sensitivity ǐǊ.Ǎƻ. Speciėcity ǏǍƻ.
Note this is only one possible cutoﬀ value. Diﬀerent sensitivity and speciėcity can be obtained by
appropriately tuning the cutoﬀ.
SLiME classiėcation
Diagnosis IBD non-
IBD
CD ǋ Ǎ
UC ǋǈ Ǌ
Control ǎ ǉǐ
To test if the chosen sequencing technology altered the classiėcation of patients into controls
and IBDsamples,we repeated sequencing for ǉǈof the samplesusing theSanger sequencingmethod.
Supervised learning results, however, were independent of the sequencingmethod employed (Fig-
ure Ǌ.ǌ).
We hypothesized that some of the improvement in performance might be due to increased
sampling depth if a subset of discriminatory bacteria are present at low abundance. To test this
hypothesis, we identiėed the bacterial taxa most strongly associated with IBD (either positively or
negatively), and ploĨed their abundance. As shown in Figure Ǌ.Ǎ, many of the most informative
taxa are present at a level of less than ǉƻ per sample – the level at which we would expect to see
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Figure Ǌ.ǌ: Sequencing technology does not signiėcantly inĚuence classiėcation accuracy. ROC
curves for active IBD vs. control classiėcation in ten samples where sequencing was repeated by
Sanger methods and yielded the same area under the curve.
one count or less at the sequencing depth used in Frank et al. [Ǐ] ĉus, sequencing depth is an
important factor in diagnostic accuracy and may account to a large degree for the lower AUC we
obtained in the classiėcation of the Frank et al. data set.
Distinctive taxonomical groups are associatedwith IBD
We identiėed a number of bacterial taxa strongly associated with IBD that both conėrmed and
supplemented previous studies. Figure Ǌ shows taxa that are signiėcantly associated with either
IBD or control patients (q-value< ǈ.ǈǉ, Kruskal-Wallis test, FDR adjusted, [ǐǏ] E(πǈ)=ǈ.ǉǐ, see
Figure Ǌ.ǎ).
Only a few of these taxa show a distribution consistent with an ideal microbial biomarker –
a bacterial group whose presence/absence indicates disease phenotype. For example, the Enter-
obacteriales are indicators of active IBD (ie. patients with clinically active disease and not in re-
mission), while Rikenellaceae and Porphyromonadaceae are generally found within the control
group. By contrast, most of the discriminatory groups in Figure Ǌ.Ǐ are more or less abundant in
IBD patients, but not exclusive to one population (e.g., the Butyricicoccus and Subdoligranum
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Figure Ǌ.ǎ: FDR adjustment of Kruskal-Wallis p-values for those features which best discriminate
between active IBD samples and control samples. (Top-leě) ĉe expected proportion of false
positive samples (pǈ) is estimated by ėĨing. (Top-right) A plot of the calculated q-values versus
the initial p-values. (BoĨom-leě) ĉe number of signiėcant tests for every given q-value cut-oﬀ.
(BoĨom-right)ĉe number of expected false positives for a given number of signiėcant tests con-
sidered.
genera decrease in the IBD patients with clinically active disease, but are still present in some IBD
patients with inactive disease). ĉis highlights the need for quantitative global surveys ofmicrobial
diversity rather than simple indicators of presence/absence.
Microbial alterations are similar in stool and tissue samples
Ourėnding that classiėcationwas similarly accurate in tissue and stool samples ledus to askwhether
the same alterations in the gut proėle were observed in both sample types or whether distinct but
similarly predictive changes occurred in each. To test this, we used the bacterial taxa identiėed in
the pediatric case-control (stool-based) study to re-classify the tissue samples in the study by Frank
et al. [Ǐ] ĉe classiėcation accuracy based on features from the pediatric study was nearly identi-
cal to the model using features picked from the tissue-based study: AUC = ǈ.Ǐǉ (Figure Ǌ.Ǌ), an
increase in estimated measurement error of only ǋƻ.
ĉe relative change (upwards or downwards) of taxa in IBD vs. control groups is remarkably
concordant between the two studies, with the exceptionof Lactobacillales (Figure Ǌ.ǐ). Unsurpris-
ingly, due to the largely diﬀerent sequencing depthmany of the low-abundance taxa detected in the
pediatric case-control (e.g., Alistipes) are of liĨle importance in the classiėcation, when applied to
the Frank et al. data (Figure Ǌ.Ǒ).
On the other hand, the Subdoligranulum genus and the Proteobacteria phylum remain two
consistently important features across data sets (Figure Ǌ.ǐ). ĉese results are encouraging because
they suggest stool samples canbeused to study changes in other compartments such as themucosa.
Microbiota diversity decreases as disease severity increases
An important clinical question is to establishwhether amarkerof disease activity exists, and towhat
extent it can be used to stratify patients according to disease severity. To address this question, we
measured disease activity bymeans of standard clinical indices (PUCAI, [ǐǐ] PCDAI [ǐǑ]), based
on symptoms and blood test results, [Ǒǈ] and compared to SLiME predictions. While SLiME
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Figure Ǌ.Ǐ: Taxa signiėcantly associated with IBD. Center panel is a compositional heatmap of the
selected taxa for each of the samples in the pediatric case-control study. Leě panel indicates the
signiėcance of the association of each taxa with disease state, as measured by the q-value. Right
panel shows a measure of eﬀect size (Cohen’s delta), highlighting in red those taxa which are sig-
niėcantly more prevalent in IBD samples. BoĨom panels show relevant metadata for each sample,
including disease activity as measured by PUCAI [ǐǐ] and PCDAI indices [ǐǑ].
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Figure Ǌ.ǐ: Taxa in the pediatric data set (stool-based) and the Frank et al. data set (tissue-based)
agree in their relative abundance. Mean diﬀerence in normalized abundance between IBD sam-
ples and control samples is ploĨed for each taxa. Positive values (x-axis) mean the taxa is more
prevalent in IBD samples, while negative values are associated with taxa more abundant in control
samples. Stool-based and tissue-based data set are diﬀerentially colored (dark blue and light blue
respectively).
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Figure Ǌ.Ǒ: Taxa in the pediatric data set (stool-based) and the Frank et al. data set (tissue-based)
vary in their importance as features. Best features - as determined by the RandomForest algorithm
- applied to the pediatric data set are used to classify the Frank et al. data set. ĉe importance of
each feature - calculated as the decrease in accuracy of the algorithm when the feature is not used
- is ploĨed for both studies. Noticeably, feature at the genus level are far more important in the
pediatric data set than when used on the Frank et al. data set. ĉis may reĚect the greater depth of
sequencing (see supplementary ėgure Ǌ).
couldnot reliably classify on thebasis of activity due to the small number of patients in eachdistinct
level of disease severity, we nevertheless observed that overall microbiota diversity was strongly as-
sociated with disease activity. As disease severity increased, independently of the type of disease
(CDorUC), overall bacterial diversity decreased asmeasured by the Shannondiversity index (Fig-
ure Ǌ.ǉǈ).
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Figure Ǌ.ǉǈ: Stratiėcation of patients by activity levels. (A)Overallmicrobial diversity asmeasured
by the Shannon Diversity Index. Activity was assessed on the basis of patient symptoms using
PCDAI and PUCAI clinical indices.
ĉese results further support the view that IBD reĚects an overall GI tract dysbiosis rather than
the eﬀect of a small number of pathogenic taxa. [ǏǏ] [Ǐ] [Ǒǉ]Moreover, a number ofmicrobial taxa
showed signiėcant associationwith disease activity levels. Among themost discriminative taxawas
the Proteobacteria phylum (Figure Ǌ.ǉǊ and Figure Ǌ.ǉǉ).
Speciėcally, the Gammaproteobacteria class was prevalent in all active forms of the disease.
Severe disease in particular was associatedwith the Serratia andEscherichia-Shigella genera as well
as the Coryneobacteriacea family.
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Figure Ǌ.ǉǉ: FDR adjustment of Kruskal-Wallis p-values for those features which best discriminate
between levels of IBD activity. (Top-leě)ĉe expected proportion of false positive samples (pǈ) is
estimated by curve ėĨing. (Top-right) A plot of the calculated q-values versus the initial p-values.
(BoĨom-leě)ĉe number of signiėcant tests for every given q-value cut-oﬀ. (BoĨom-right) ĉe
number of expected false positives for a given number of signiėcant tests considered.
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Figure Ǌ.ǉǊ: Best features to discriminate by activity levels. Activity levels are considered simulta-
neously, employing the Kruskal-Wallis test. Grey bar indicate the q-value and thus the strength of
the association between the features and the disease state. Color bars indicate the average percent-
age of reads for each disease activity level.
Gutmicrobiota shows characteristic changes from active disease to remission
ĉe factors responsible for triggering episodes of active disease are largely unknown. To identify
microbial groups potentially associated with the establishment of active disease, we compared the
composition of bacteria in fecal samples taken during active disease and remission periods. Clas-
siėcation with SLiME yielded signiėcant diﬀerences between active and remission, with an AUC
of ǈ.ǏǊ. Amongst the taxa which were signiėcantly associated with active disease (Figure Ǌ.ǉǋ)
we found Proteobacteria (q-value< ǈ.ǈǍ, Kruskal-Wallis test, FDR adjusted, [ǐǏ] E(πǈ)=ǈ.ǋǍ, see
Figure Ǌ.ǉǌ) which was in agreement with previous observations. [ǑǊ]
ĉis ėnding appears to conėrm the hypothesis that before or during active disease Proteobac-
teria rapidly expand and potentially displace other bacterial groups, such as Actinobacteria. On
the other hand, members of the Eubacteriaceae, Incertae Sedis XIV and Biėdobacteriaceae fam-
ilies were associated with remission, which to our knowledge has not been reported previously.
ĉe Lachnospiraceae family, Subdoligranulum and Butyricicoccus, a butyrate-producing organ-
ism that can ferment dietary polysaccharides, were also associated with remission.
We hypothesized that individual-to-individual variation might obscure some of the signals of
disease activity. To test this, we compared ėve patients at diﬀerent stages of their disease. Consis-
tent with our previous observations, we found an increase in Proteobacteria from samples taken
during active phases of the disease in all ėve patients (see Figure Ǌ.ǉǍ).
In additionwe found thatFirmicutes andActinobacteria phylaweredistinctively prevalent dur-
ing periods of remission for these patients. Also associated with remission were the genera Leu-
conostoc (heterofermentative bacteria capable of synthesizing dextran from sucrose), Roseburia
(saccharolytic, butyrate-producingbacteria) andEggerthella (anaerobic gram-positivebacilli).ĉese
results suggest that some disease-taxon associations may only be apparent when sampled are com-
pared against an appropriate individual-speciėc baseline, highlighting the need for longitudinal
studies of disease progression.
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Figure Ǌ.ǉǋ: Features that show the greatest diﬀerence between active and inactive state in the pe-
diatric case-control study. All features with signiėcant association (q-value< ǈ.ǈǍ, see supplemen-
tary ėgure ǉǊ) [ǐǏ] to either active disease or remission are shown. Grey bars indicate the q-value
of each taxon, heat maps describe the median normalized abundance in each sample. ĉe right
panel indicates the eﬀect size and highlights in red the taxa which are prevalent in active samples.
0.0 0.2 0.4 0.6 0.8
0.
4
0.
6
0.
8
1.
0
λ
pi
0(λ
)
p^i0 = 0.349
0.00 0.02 0.04 0.06
0.
02
0.
04
0.
06
0.
08
0.
10
p−value
q−
va
lu
e
0.02 0.04 0.06 0.08 0.10
0
10
20
30
40
q−value cut−off
si
gn
ific
an
t t
es
ts
0 10 20 30 40
0
1
2
3
4
significant tests
ex
pe
ct
ed
 fa
ls
e 
po
sit
ive
s
Figure Ǌ.ǉǌ: FDR adjustment of Kruskal-Wallis p-values for those features which best discriminate
between active IBD samples and inactive IBD samples. (Top-leě)ĉeexpected proportion of false
positive samples (pǈ) is estimated by curve ėĨing. (Top-right) A plot of the calculated q-values
versus the initial p-values. (BoĨom-leě) ĉe number of signiėcant tests for every given q-value
cut-oﬀ. (BoĨom-right) ĉe number of expected false positives for a given number of signiėcant
tests considered.
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Figure Ǌ.ǉǍ: Antibiotic therapy reduces overall microbial diversity. Box plot showing the distribu-
tion of Shannon diversity indices for all patients undergoing antibiotic therapy, compared to the
patients with IBD and without antibiotics, as well as controls.
Diversity is correlated with antibiotic therapy
We found that overall microbial diversity, as measured by the Shannon diversity index, was the
single most important feature for discriminating between patients undergoing antibiotic therapy
or not. Although we could not classify whether samples were obtained from antibiotic-treated
patientswithhighaccuracy (AUC<ǈ.ǎ),wedidėnd that Shannondiversity indexwas signiėcantly
and negatively associated with antibiotic therapy in the IBD samples (p-value = ǈ.ǈǈǎǏ, Wilcoxon
test, see Figure Ǌ.ǉǎ).
ĉis observation is consistent with a simple model of antibiotic eﬀect on the gut microbiota:
most taxa and bacterial groups are killed by antibiotics, while the few bacterial strains which have
resistance survive and increase in relative abundance.
Diﬀerential diagnosis of ulcerative colitis and crohn’s disease is possible
Ulcerative colitis is generally limited to the colon, while intestinal inĚammation in Crohn’s disease
may occur in any region of the gastrointestinal tract. Classiėcation of pediatric IBD patients into
UCorCDat the timeof fecal testing is desirable, given the diﬀerent clinicalmanagement of the two
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Figure Ǌ.ǉǎ: FDR adjustment of Kruskal-Wallis p-values for those features which best discriminate
between CD samples and UC samples. (Top-leě)ĉe expected proportion of false positive sam-
ples (pǈ) is estimatedby curve ėĨing. (Top-right)Aplot of the calculatedq-values versus the initial
p-values. (BoĨom-leě) ĉe number of signiėcant tests for every given q-value cut-oﬀ. (BoĨom-
right)ĉe number of expected false positives for a given number of signiėcant tests considered.
diseases. Even though distinguishing UC from CD was not the primary aim of our study design,
we found that SLiME applied to the case-control data set could separate UC patients and control
patients accurately (Figure Ǌ.ǉǏ, cross-validated AUC=ǈ.ǐǊ and ǈ.ǐǋ respectively), but was less
accurate in distinguishingCrohn’s disease patients (AUC=ǈ.ǎǐ). Whenwe excluded controls from
the data and aĨempted to distinguish between CD and UC in all IBD patients, we were able to
do so with accuracies (AUC=ǈ.Ǐǎ,ie. a speciėcity of ǌǑƻ at ǑǍƻ sensitivity) superior to current
noninvasive clinical methods [ǏǊ].
ĉe most informative bacterial families in discriminating UC, CD and Control samples as de-
termined by Kruskal-Wallis test were the Eubacteriaceae, Bacteroidaceae, and Verrucomicrobi-
aceae (Figure Ǌ.ǉǑ and Figure Ǌ.ǉǐ).
Verrucomicrobia were consistently employed in the classiėer because bacteria of this group
were completely absent from UC patients, which tended to be characterized by Lactobacillales or
Bacilli and Gammaproteobacteria.
Steroid treatment could potentially aﬀect the composition of the microbiota and in turn the
accuracy of the classiėcation between CD and UC. To assess this eﬀect, we limited our analysis
to those patients undergoing steroid therapy. However, we found no substantial diﬀerence in the
accuracy of the classiėcation (AUC=ǈ.Ǐǋ, ǌǈƻ speciėcity at ǑǍƻ sensitivity) betweenCDandUC
patients in the steroid subgroup with respect to the totality of all IBD patients.
Classiėcation in CDorUC performed diﬀerently depending onwhether the patient was expe-
riencing active disease or remission, and surprisingly was more accurate at distinguishing CD and
UC patients in remission (AUC=ǈ.Ǐǋ) than for patients with active disease (AUC=ǈ.ǎǏ). ĉis
ėnding suggests that changes in microbiota composition during acute inĚammation may be simi-
lar in both UC and CD, rendering distinction by microbial diversity more challenging.
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Figure Ǌ.ǉǏ: Discrimination of CD and UC. Above, ROC curve for the classiėcation of CD vs UC
in samples where diagnosis of IBD is already established. Below, ROC curve for the classiėcation
of each disease class against all other classes.
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Figure Ǌ.ǉǐ: ROC curve for the CD vs UC classiėcation in the steroid-treated subgroup. ĉe per-
formance in this subset of the cohort is comparable to the totality of IBD patients.
Blind validation with an independent patient sample conėrms the accuracy of
supervised classiėcation
To conėrm the general validity of our results, we selected an independent patient sample of ǏǏ
children and young adults. Following fecal sampling andǉǎS rRNAsequencing, we applied SLiME
– trainedonour initial pediatric cohort – to thenewdataset. Encouragingly, SLiMEmaintains good
performance in distinguishing IBD patients from controls (AUC = ǈ.Ǐǌ, Figure Ǌ.Ǌǈ).
Table Ǌ.ǋ illustrates the classiėcation performance of SLiMEon the validation cohort when the
model is tuned for high sensitivity (Ǒǉ.ǎƻ) and low speciėcity (ǉǏ.ǎƻ).
Classiėcation by SLiME is comparable to testing by fecal calprotectin
We compared the accuracy of SLiME with the outcome of the fecal calprotectin test on a portion
of our samples from both the pediatric cohort and the validation cohort, to determine how our
method compared to the most clinically accepted non-invasive test for IBD. A summary of the re-
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Figure Ǌ.ǉǑ: Strength of association for the best features (q-value < ǈ.ǈǍ) [ǐǏ] which allow dis-
crimination between CD and UC.
Table Ǌ.ǋ: Confusion matrix for the blind validation of the SLiME classiėer on an independent
validation cohort. Sensitivity for IBD vs controls is Ǒǌ.Ǎƻ while speciėcity is ǌǎ.ǉƻ. Note this is
only onepossible cutoﬀ value. Diﬀerent sensitivity and speciėcity canbeobtainedby appropriately
tuning the cutoﬀ.
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Figure Ǌ.Ǌǈ: Blind validation of a SLiME model ã previously trained on our pediatric cohort ã
applied to an independent set of fecal samples from ǏǏ patients. ROC curve shows that high sen-
sitivity and high speciėcity are maintained across a range of disease prevalences.
sults is contained in Table Ǌ.ǌ and Table Ǌ.Ǎ. On those samples where we could obtain calprotectin
measurements retrospectively, we found that SLiMEcould classify the samples as IBDwith compa-
rable accuracy to calprotectin (AUC= ǈ.ǏǑ compared to calprotectin’s AUCof ǈ.ǐǉ). Superposing
the two ROC curves (Figure Ǌ.Ǌǉ and Figure Ǌ.ǊǊ) shows that calprotectin was only slighly more
sensitive than SLiME.
Table Ǌ.ǌ: Summary of calprotectin assay results per disease condition; Assay range: ǉǈ mcg/g -
ǎǈǈ mcg/g
Diagnosis n Mean St.dev
CD ǋǎ ǌǌǌ.ǎ Ǌǌǉ.Ǌ
UC Ǎǌ ǌǎǏ.ǎ ǊǊǋ.ǎ
Control ǊǑ ǉǑǎ.ǌ Ǌǈǐ.Ǌ
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Figure Ǌ.Ǌǉ: Comparison of SLiME and fecal calprotectin assay. ĉe two assays have comparable
eﬃcacy in distinguishing IBD patients from control when applied to all samples in the training and
validation cohorts for which calprotectin could be measured (n=ǉǊǈ)
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Figure Ǌ.ǊǊ: Comparison of SLiME and fecal calprotectin assay. SLiME is slightly superior in dis-
tinguishing CD fromUC samples, when applied to all CD and UC samples (n=Ǒǈ) in the training
and validation cohorts for which calprotectin could be measured
Table Ǌ.Ǎ: Summary of calprotectin assay results per activity level; Assay range: ǉǈ mcg/g - ǎǈǈ
mcg/g
Activity n Mean St.dev
Active ǌǐ Ǎǈǉ.ǉ ǊǈǍ.ǎ
Inactive ǌǋ ǌǈǉ.ǋ ǊǍǉ.ǊǑ
Control ǊǑ ǉǑǎ.ǌ Ǌǈǐ.Ǌ
Ǌ.ǋ Discussion
Delay in the diagnosis of pediatric IBD is likely due to the non-speciėc presentation of the dis-
ease. An inexpensive and sensitive diagnostic tool could reduce this delay by rapidly identifying
patients at high risk for IBD and, therefore, warranting endoscopic evaluation. In this study, we
demonstrated the feasibility of a new approach to detecting pediatric IBD based on analysis of fe-
calmicrobiota. ĉe sensitivity and speciėcity of our approach, asmeasured byROCcurve analysis,
matches or surpasses that of alternative methods proposed for clinical use.
Twokeymethodological advances are responsible for improvedperformance compared topre-
vious studies. ĉese include the SLiME soěware package, which is freely available for public use,
and increased sampling depth, which allows low abundance but highly informative groups to be
sampled. ĉe advantages of employing machine learning methods to analyze microbiome data
have already been discussed. [ǐǌ] Compared to clustering methods, machine learning excels in
classifying unlabelled data and extracting pivotal features from large and complexmicrobiomedata
sets.
Previous surveys of microbial diversity in IBD relied on clustering analyses to diﬀerentiate be-
tween IBD and non-IBD samples. [Ǐ] [ǑǊ] [Ǐǎ] As a result, these studies suﬀered from poor sen-
sitivity and, more importantly, did not generate predictive models that could be employed to dis-
tinguish new unlabelled samples. In this study, we employed SLiME to achieve high sensitivity as
well as high speciėcity in diﬀerentiating active IBD samples from controls. Models generated by
SLiMEwere capable of classifying unlabelled samples with accuracy, as demonstrated by the large
AUC obtained both aěer cross-validation and aěer blind validation with an independent cohort.
Importantly, our approachwas eﬀective across disparate data sets using diﬀerent sample types, and
processing and sequencing technologies. Finally, SLiME generates a list of taxa speciėcally asso-
ciated with each disease state (active IBD, remission samples, CD and UC) facilitating biological
interpretation.
Although we succesfully employed speciėc taxa as predictive biomarkers, our results indicate
that IBD reĚects an overall GI tract dysbiosis rather than the eﬀect of a small number of pathogenic
taxa. ĉis result is in agreementwith previous observations [ǏǏ] [Ǐ] [Ǒǉ] and suggests that a global
community survey rather than a test for bacterial presence/absence is beĨer suited to identifying
IBD.
Departing from the traditional clustering analysis, a recent and promising study [ǐǉ] showed
the use of a predictivemodel in classifying samples as IBDon the basis ofmicrobial diversity. How-
ever, the same study arised concerns regarding a) the ability to distinguish UC patients from con-
trols and b) the ability to discriminate between samples frompatients with active disease and those
in remission. Our study answers these questions, and importantly we report only cross-validated
results that should more closely reĚect accuracy in a clinical seĨing.
Some potential limitations in our study stem from its relatively small scale. For instance, while
we are able to succesfully distinguish both UC andCD patients, SLiME appears to classify UC pa-
tientsmore succesfully thanCDpatients. However, we ėnd that this diﬀerence in performance dis-
appears aěer downsampling, conėrming that it is due to the uneven split between CD and UC pa-
tients in our training cohort. We also aĨempted to ėnd correlations between therapeutic regimens
(antibiotics, salicylates, anti-TNF, methotrexate, etc.) and microbial composition. Unfortunately
SLiME was not capable to diﬀerentiate between subgroups with diﬀerent therapeutic regimens,
most likely due to the broad range of treatments employed in our cohort and the small number of
patients in each subgroup. While these results indicate that SLiME may not be inĚuenced by dif-
ferent therapeutic interventions while diﬀerentiating patients with IBD from controls, recruiting
a larger number of patients following similar therapeutic regimens would have allowed to identify
key microbial changes brought about by the therapy.
It is arguable that both these potential limitations will be addressed by studies with larger pa-
tient samples, beĨer suited to compare alternatives in disease behaviour and therapeutic manage-
ment of IBD. In addition, a cross-sectional study design on fecal samples taken at the time of diag-
nosis and before the start of any therapy, rather than the case-control study we employed, would
allow to estimate more precisely the sensitivity of SLiME when employed in the general popula-
tion.
Even thoughour results demonstrate the potential of the gastrointestinalmicrobiome as a diag-
nostic tool in IBD, further validationwill be necessary before this tool is accepted into clinical prac-
tice. Our comparison between SLiME and calprotectin is encouraging, insofar as it shows that the
two methods have comparable accuracies on this data set. Further comparison of SLiME against
other IBD biomarkers, including C-reactive protein, fecal lactoferrin, and fecal calprotectin [ǎǑ]
in larger patient samples will allow clinicians to gauge the relative beneėts of each method.
Despite these limitations, our results demonstrate the considerable potential of microbiome-
based diagnostics in the clinic, particularly in the case of pediatric patients where diagnosis is oěen
challenging. Similar approaches could evaluate the eﬃcacy of novel therapies (e.g. probiotics, an-
tibodies), predict the outcome of disease and forecast the timings of Ěare-ups. While not replacing
endoscopy andhistological examination as diagnostic tools, wepropose that classiėcationbasedon
microbial diversity can be included as an eﬀective complementary technique to aid in the diagnosis
of IBD, particularly in pediatric patients.
ĉe aim of eﬀorts to improve diagnostics for IBD revolve around the central tenet of avoid-
ing invasive techniques such as endoscopy, particularly in pediatric patients for whom these pro-
cedures can be particularly disagreeable. SLiME, in its current form, is not sensitive enough to
unequivocally distinguish IBD; neither are currently used serological tests. However, with certain
additional improvements to thesemethodologies, they canpotentially be combined to signiėcantly
improve sensitivity.
According to the internationally mandated guidelines on IBD, suspected cases should be sub-
jected to a full blood count, an erythrocyte sedimentation rate, liver function tests and a measure
ofC reactive protein. In addition, a test of calprotectin is oěen includedwhich can quantify inĚam-
mation and is somewhat speciėc to the gut. ĉese values do not usually result in an unambiguous
diagnosis, and even when the indications of IBD are strong, they are still unable to diﬀerentiate
between CD and UC. Perinuclear antineutrophil cytoplasmic antibody and anti-saccharomyces
cerevisiae antibody are positively associated withUC andCD respectively, but with low sensitivity
and with liĨle clinical utility. In addition, many other conditions can confound diagnosis of IBD
andmust be excluded in suspected cases. ĉese include diarrheal diseases and certain gut parasitic
infections. With the plummeting costs of sequencing, one can imagine including microbial pro-
ėling to the panel of stool tests. SLiME classiėcation will then be able to yield a likelihood of the
stool sample being result of IBD and thus suggest earlier the need for a colonoscopy.
ĉe main strengths of SLiME as applied to IBD patient cohorts are its non-invasiveness and
its ability to not only identify IBD but to also distinguish between CD and UC. Further training
of the algorithm on additional datasets, as they become available, stands to improve the sensitivity
of its predictive power and may ultimately replace the need for colonoscopy, at least in children.
Although with the current training data it cannot be used as a stand-alone test, it can easily be
combined with the currently accepted serology, particularly as cost of microbial shotgun sequenc-
ing will decrease. Even if each test on its own is not categorical, the diagnostic capability of them
combined stands to be much superior. Moving forward, it will be important to test SLiME as a
component of a multi-pronged non-invasive diagnostic approach for this disease.
Ǌ.ǌ Methods
Patient population and recruitment
Fecal samples were obtained from  Ǒǉ children and young adults with Crohn’s disease, ulcerative
colitis, and non-inĚammatory conditions of the gastrointestinal tract. ĉe control population was
composed of patients with symptomatology suggestive of IBD: constipation (n=Ǒ), abdominal
pain (n=ǐ), gastroesophageal reĚux (n=Ǌ), poor weight gain (n=ǉ), diarrhea (n=ǉ), blood in stool
(n=Ǌ) and oropharyngeal dysphagia (n=ǉ) (see Table Ǌ.ǎ). Table Ǌ.Ǐ shows the patient demo-
graphics. Recruitment was conducted in the clinic or inpatient hospital wards under a protocol
approved by the Children’s Hospital CommiĨee on Clinical Investigation. 
Table Ǌ.ǎ: Control patients’ diagnoses
Training Cohort (n = Ǌǌ) Validation Cohort (n = ǉǋ)
Functional Abdominal Pain ǐ (ǋǋƻ) ǌ (ǋǈƻ)
Constipation ǉǈ (ǌǊƻ) ǉ (ǐƻ)
Irritable Bowel Syndrome ǈ ǋ (Ǌǋƻ)
Vomiting ǈ ǋ (Ǌǋƻ)
Rectal Bleeding with Normal EGD/Colon ǉ (ǌƻ) ǉ (ǐƻ)
Diarrhea Ǌ (ǐƻ) ǈ
ReĚux ǉ (ǌƻ) ǈ
Poor Growth ǉ (ǌƻ) ǈ
Feeding Diﬃculty ǉ (ǌƻ) ǈ
History of Food Allergies ǈ ǉ (ǐƻ)
Fecal samples were generally obtained within ǌ hours of the bowel movement, and stool was
frozen at –Ǐǈ degrees C on the receipt of the sample from the patient.  Clinical data and possible
confounding variables were recorded at the time of sample acquisition including: disease type,
disease location, disease duration, disease activity (as determined by the Pediatric Crohn’s disease
activity index for CD, and the pediatric ulcerative colitis activity index for UC) [ǐǑ] [ǐǐ], and
current prescribed medications.  An additional independent patient sample of ǎǐ children and
young adults was selected for blind validation. Table Ǌ.ǐ shows the patient demographics of this
additional sample set.
Histological evidence and data on disease duration for both sample sets are contained in Ta-
ble Ǌ.ǉǉ, Table Ǌ.ǉǊ, Table Ǌ.Ǒ and ??.
Table Ǌ.Ǐ: demographics of paediatric (training) cohort
Crohn
(n=Ǌǋ)
UC
(n=ǌǋ)
Control
(n=Ǌǌ)
IBDU
(n=ǉ)
Gender
Male ǉǋ(Ǎǎƻ) Ǌǉ(ǌǑƻ) ǉǈ(ǌǊ.ƻ) ǉ
Female ǉǈ(ǌǌƻ) ǊǊ(Ǎǉƻ) ǉǌ(Ǎǐƻ) ǈ
Age (Median +/-) ǉǌ.ǉǋ ± ǋ.ǐǌ ǉǋ.Ǐ ± ǌ.ǊǍ Ǒ.ǈǐ ± ǌ.ǋ ǉǌ
Range ǋ–Ǌǈ ǌ–Ǌǌ ǋ–ǉǏ
Montreal Classiėcation
Lǉ ǉ(ǌƻ)
LǊ ǉ(ǌƻ)
Lǋ ǉǍ(ǎǍƻ)
Lǌ ǎ(Ǌǎƻ)
Bǉ ǉǐ(Ǐǐƻ)
BǊ ǌ(ǉǏƻ)
Bǋ ǉ(ǌƻ)
Eǉ Ǌ(Ǎƻ)
EǊ ǎ(ǉǌƻ)
Eǋ ǋǍ(ǐǉƻ)
Disease
Activity
Control ǈ ǈ Ǌǌ ǈ
Inactive ǉǌ ǉǉ
Mild Ǎ ǉǍ ǉ
Moderate ǋ Ǒ
Severe ǉ ǐ
Medications
Salicylates only ǉ (ǌƻ) ǎ(ǉǌƻ)
ǎmp/AZA/MTX ǉǉ (ǌǐƻ) ǉǊ(Ǌǐƻ)
Anti-TNF Ǐ (ǋǈƻ) ǌ(Ǒƻ)
Calcineurin
inhibitor
ǈ Ǌǋ(Ǎǋƻ)
Antibiotics ǎ (Ǌǎƻ) ǉǌ(ǋǋƻ) ǉ
(Steroids) ǉǋ (ǍǏƻ) ǊǍ(Ǎǐƻ) ǉ
Table Ǌ.ǐ: Patient demographics for the validation set
Crohn’s (n=ǊǍ) Control (n=ǉǋ) UC (n=ǋǈ)
Gender
Male ǉǎ (ǎǌƻ) ǎ (ǌǎƻ) ǉǐ (ǎǈƻ)
Female Ǒ (ǋǎƻ) Ǐ (Ǎǌƻ) ǉǉ (ǎǈƻ)
Age
Median +/- ǉǍ +/- ǌ.Ǐ ǉǋ +/- ǎ.ǐ ǉǋ +/- ǌ.ǈ
Range Ǎ–Ǌǋ ǋ–Ǌǉ Ǎ–Ǌǉ
Montreal Classiėcation
Lǉ ǋ (ǉǊƻ)
LǊ ǈ
Lǋ Ǐ (Ǌǐƻ)
Lǌ ǉ (ǌƻ)
Bǉ ǉǎ (ǎǌƻ)
BǊ ǉ (ǌƻ)
Bǉp ǎ (Ǌǌƻ)
BǊp ǉ (ǌƻ)
Bǋp ǉ (ǌƻ)
Lǉ + Lǌ ǉ (ǌƻ)
LǊ + Lǌ ǌ (ǉǎƻ)
Lǋ + Lǌ Ǒ (ǋǎƻ)
Eǉ Ǌǋ ǏǏƻ)
EǊ ǎ (Ǌǈƻ)
Eǋ ǉ (ǋƻ)
Disease Activity
Control ǈ ǉǋ ǈ
Inactive ǉǍ (ǎǈƻ) ǉǍ (Ǎǈƻ)
Mild ǎ (Ǌǌƻ) Ǐ (Ǌǋƻ)
Moderate Ǌ (ǐƻ) ǎ (Ǌǈƻ)
Severe Ǌ (ǐƻ) Ǌ (Ǐƻ)
Medications
Salicylates only ǉ (ǌƻ) ǈ ǉǉ (ǋǏƻ)
ǎmp/AZA/MTX ǉǉ (ǌǌƻ) ǈ ǉǊ (ǌǈƻ)
Anti-TNF Ǎ (Ǌǈƻ) ǈ Ǌ (Ǐƻ)
Calcineurin inhibitor ǈ ǈ ǎ (Ǌǈƻ)
Antibiotics ǌ (ǉǎƻ) ǈ ǉǋ (ǌǋƻ)
Steroids Ǒ (ǋǎƻ) ǈ ǉǉ (ǌǈƻ)
Table Ǌ.Ǒ: Disease Duration at Time of Sample Acquisition. Initial (Training) Cohort (n = Ǒǉ)
Median Disease Duration
(months)
Mean Disease Duration
(months)
Interquartile Range
(months)
All IBD (n = ǎǏ) Ǌǉ ǋǌ.ǐ Ǎǐ.ǈ (ǌ.ǈ - ǎǊ.ǈ)
Crohn’s Disease (n
= Ǌǋ)
Ǌǐ ǋǐ.ǌ ǎǏ.ǈ (Ǌ.ǈ - ǎǑ.ǈ)
Active Disease (n =
Ǒ)
Ǎ ǊǑ.ǎ ǎǑ.ǈ (ǈ.ǋ - ǎǑ.ǋ)
Steroids (n = Ǎ) ǈ.Ǎ Ǌ.ǊǍ ǎ.ǈ (ǈ.ǋ - ǎ.ǋ)
Antibiotics (n = ǈ) - - -
Steroids & Abx (n =
Ǌ)
Ǎǈ.Ǎ Ǎǈ.Ǎ ǌǐ (Ǌǎ.ǊǍ - Ǐǌ.ǏǍ)
Inactive Disease (n
= ǉǌ)
ǋǉ.Ǎ ǌǌ Ǐǈ.ǐ (Ǎ.ǈ - ǏǍ.ǐ)
Steroids (n = ǌ) Ǌǋ.Ǎ ǋǍ.ǐ ǐǊ.ǐ (ǈ.Ǎ - ǐǋ.ǋ)
Antibiotics (n = ǉ) ǉǉǊ ǉǉǊ ǈ
Steroids & Abx (n =
Ǌ)
ǎǍ ǎǍ.ǈ ǎǋ.ǈ (ǋǋ.Ǎ - Ǒǎ.Ǎ)
Ulcerative Colitis
(n = ǌǋ)
Ǌǉ ǋǋ.ǎ ǍǍ.ǈ (Ǎ.ǈ - ǎǈ.ǈ)
Active Disease (n =
ǋǊ)
ǉǑ.Ǎ ǋǍ.ǎ ǍǑ.Ǎ (ǌ.ǋ - ǎǋ.ǐ)
Steroids (n = ǉǊ) ǎ Ǌǈ.ǐ Ǌǐ.ǋ (ǈ.Ǎ - Ǌǐ.ǐ)
Antibiotics (n = Ǌ) ǎǑ.Ǎ ǎǑ.Ǎ ǌ.Ǎ (ǎǏ.ǋ - Ǐǉ.ǐ)
Steroids & Abx (n =
ǉǉ)
ǉǈ.Ǎ ǋǍ.ǌ Ǎǈ.Ǌ (ǈ.ǐ - Ǎǉ.ǈ)
Inactive Disease (n
= ǉǉ)
Ǌǎ ǋǊ.ǌ ǌǌ.ǈ (Ǒ.ǈ - Ǎǋ.ǈ)
Steroids (n = Ǌ) Ǎ Ǎ.ǈ ǌ.ǈ (ǋ.ǈ - Ǐ.ǈ)
Antibiotics (n = ǉ) ǐǈ ǐǈ.ǈ ǈ
Steroids & Abx (n =
ǈ)
- - -
IBDU (n = ǉ) ǌ ǌ.ǈ ǈ
Table Ǌ.ǉǈ: Disease Duration at Time of Sample Acquisition. Validation Cohort (n = ǎǐ)
Median Disease Duration
(months)
Mean Disease Duration
(months)
Interquartile Range
(months)
All IBD (n = ǍǍ) ǊǊ ǋǋ.ǈ ǌǐ.ǈ (ǌ.ǈ - ǍǊ.ǈ)
Crohn’s Disease (n
= ǊǍ)
Ǌǌ ǌǉ.ǈ ǎǑ.ǈ (ǌ.ǈ - Ǐǋ.ǈ)
Active Disease (n =
ǉǈ)
ǎǋ ǍǑ.ǉ Ǐǉ.ǐ (ǉǊ.ǈ - ǐǋ.ǐ)
Steroids (n = ǋ) Ǎǋ ǍǏ.Ǌ Ǎǐ.Ǐ (Ǌǎ.ǐ - ǐǍ.Ǎ)
Antibiotics (n = Ǌ) Ǐǐ Ǐǐ.ǈ Ǎ.ǈ (ǏǍ.Ǎ - ǐǈ.Ǎ)
Steroids & Abx (n =
Ǌ)
ǌ ǌ ǈ
Inactive Disease (n
= ǉǍ)
ǉǐ Ǌǐ.Ǒ ǋǊ.Ǎ (Ǌ.ǈ - ǋǌ.Ǎ)
Steroids (n = ǌ) ǈ.ǐ ǈ.Ǒ ǈ.Ǒ (ǈ.ǌ - ǉ.ǊǍ)
Antibiotics (n = ǈ) - - -
Steroids & Abx (n =
ǈ)
- - -
Ulcerative Colitis
(n = ǋǈ)
Ǌǈ Ǌǎ.ǋ ǋǑ.ǈ (Ǎ.ǈ - ǌǌ.ǈ)
Active Disease (n =
ǉǍ)
Ǌǈ ǊǊ.ǎ ǋǍ.Ǒ (ǈ.ǎ - ǋǎ.Ǎ)
Steroids (n = ǉ) ǈ.Ǎ ǈ.Ǎ ǈ
Antibiotics (n = ǋ) ǌǎ Ǎǋ.ǈ ǊǏ.Ǎ (ǋǏ.Ǎ - ǎǍ)
Steroids & Abx (n =
ǐ)
Ǎ ǉǌ.ǉ Ǌǉ.ǉ (ǈ.Ǐ - Ǌǉ.ǐ)
Inactive Disease (n
= ǉǍ)
Ǌǈ ǋǈ.ǈ ǋǏ.Ǎ (Ǒ.Ǎ - ǌǏ.ǈ)
Steroids (n = Ǌ) ǉǈ.Ǎ ǉǈ.Ǎ Ǒ.Ǎ (Ǎ.ǏǍ - ǉǍ.ǊǍ)
Antibiotics (n = Ǌ) ǍǍ ǍǍ.ǈ ǉǊ.ǈ (ǌǑ.ǈ - ǎǉ.ǈ)
Steroids & Abx (n =
ǈ)
- - -
Table Ǌ.ǉǉ: Histological evidence of disease at diagnostic colonoscopy. Initial (Training) Cohort
(n = Ǒǉ)
Crohn’s (n=Ǌǋ) UC (n=ǌǋ) IBDU (n=ǉ)
Ileal Disease
Active Ileitis ǉǎ (Ǐǈƻ) ǋ (Ǐƻ) ǉ (ǉǈǈƻ)
Ileal Ulceration Ǐ (ǋǈƻ) ǈ ǈ
Ileal Granulomas ǌ (ǉǏƻ) ǈ ǈ
Colonic Disease
Chronic Active Colitis ǉǑ (ǐǋƻ) ǌǋ (ǉǈǈƻ) ǉ (ǉǈǈƻ)
Chronic Inactive Colitis ǈ Ǌ (Ǎƻ) ǈ
Continuous Colitis Ǎ (ǊǊƻ) ǌǊ (Ǒǐƻ) ǉ (ǉǈǈƻ)
Patchy Colitis ǉǌ (ǎǉƻ) ǉ (Ǌƻ) ǈ
Colonic Granulomas ǉǉ (ǌǐƻ) ǈ ǈ
Table Ǌ.ǉǊ: Histological evidence of disease at diagnostic colonoscopy. ValidationCohort (n = ǎǐ)
Crohn’s (n= ǊǍ) UC (n= ǋǈ) IBDU (n=ǈ)
Ileal Disease
Active Ileitis ǉǑ (Ǐǎƻ) Ǌ (Ǐƻ) ǈ
Ileal Ulceration Ǒ (ǋǎƻ) ǈ ǈ
Ileal Granulomas Ǐ (Ǌǐƻ) ǈ ǈ
Colonic Disease
Chronic Active Colitis ǉǏ (ǎǐƻ) ǋǈ (ǉǈǈƻ) ǈ
Chronic Inactive Colitis Ǌ (ǐƻ) ǎ (Ǌǈƻ) ǈ
Continuous Colitis ǐ (ǋǊƻ) Ǌǎ (ǐǏƻ) ǈ
Patchy Colitis ǉǈ (ǌǈƻ) ǌ (ǉǋƻ) ǈ
Colonic Granulomas ǉǊ (ǌǐƻ) ǈ ǈ
DNA extraction and pyrosequencing
DNA from stool samples was extracted using the QIAamp DNA Stool Mini Kit (Qiagen, Inc., Va-
lencia, CA) according to manufacturer’s instructions. ĉe manufacturer protocol was altered to
accommodate larger volumes of stool and to improve homogenization using bead-beating tech-
niques at several steps: a) a minimum of ǊmL of Buﬀer ASL and ǋǈǈmg of stool was used in the
protocol; b) a ratio of ǏǈǈuL of Buﬀer ASL per ǉǈǈmg of stool weight was used for larger volumes
using nomore than ǉǍǈǈmg of stool and ǉǈ.ǍmL of Buﬀer ASL; c) following the addition of Buﬀer
ASL to each sample (step ƺǊ), ǈ.ǏǈmmGarnet Beads (MOBIOLaboratories, Inc., Carlsbad, CA)
were added to the suspension and vortexed for ǉǈ seconds; d) a second bead-beating was done
following the heating of the suspension (step ƺǋ) in ǈ.ǉ mmGlass Bead Tubes (MO BIO Labora-
tories, Inc., Carlsbad, CA), and vortexed for ǉǈ minutes.
ExtractedDNAwas employed for ǌǍǌ FLXTitaninumpyrosequencing of PCR-ampliėedwin-
dows of the ǉǎS gene. Variable region Vǋ-VǍ ampliėcation primers were designed with FLX Ti-
tanium adaptors (A adaptor sequence: Ǎ’ CCATCTCATCCCTGCGTGTCTCCGACTCAG ǋ’;
B adaptor sequence: Ǎ’ CCTATCCCCTGTGTGCCĈGGCAGTCTCAGǋ’) on the Ǎ’ end of the
ǉǎSprimer sequence: ǌǍǌB_ǋǍǏF(Ǎ’CCTACGGGAGGCAGCAGǋ’) andǌǍǌA_barcode_ǑǊǎR
(Ǎ’ CCGTCAAĈCMĈTĆGT ǋ’). See Table Ǌ.ǉǋ. Polymerase chain reaction (PCR)mixtures
(ǊǍμl) contained ǉǈng of template, ǉx Easy A reaction buﬀer (Stratagene, La Jolla, CA), ǊǈǈmM
of each dNTP (Stratagene), ǊǈǈnM of each primer, and ǉ.ǊǍU Easy A cloning enzyme (Strata-
gene). ĉe cycling conditions for the Vǋ-VǍ consisted of an initial denaturation of ǑǍ°C for Ǌmin,
followed by ǊǍ cycles of denaturation at ǑǍ°C for ǌǈ sec, annealing at Ǎǈ°C for ǋǈ sec, extension
at ǏǊ°C for Ǎ min and a ėnal extension at ǏǊ°C for Ǐ min.  Amplicons were conėrmed on ǉ.Ǌƻ
Flash Gels (Lonza, Rockland, ME) and puriėed with AMPure XPDNA puriėcation beads (Beck-
manCoulter, Danvers,MA) according to themanufacturer and eluted in ǊǍ μL of ǉX lowTEbuﬀer
(pHǐ.ǈ). Ampliconswere quantiėedonAgilentBioanalyzer ǊǉǈǈDNAǉǈǈǈ chips (AgilentTech-
nologies, SantaClara, CA) andpooled in equimolar concentration. EmulsionPCRand sequencing
were performed according to the manufacturer’s speciėcations. Sequencing was performed with a
target of Ǎǈǈǈ raw reads per sample.
Sanger sequencing
Polymerase chain reaction (PCR)mixtures (ǊǍμl) contained ǉǈng of template, ǉx Easy A reaction
buﬀer (Stratagene, La Jolla, CA), ǊǈǈmMof each dNTP (Stratagene), ǊǈǈnMof each primer (ǎǋf:
Ǎ’ GCCTAACACATGCAAGTC ǋ’; UǉǍǊǍR: Ǎ’ AAGGAGGTGWTCCARCC ǋ’), and ǉ.ǊǍU
Easy A cloning enzyme (Stratagene).  ĉe cycling conditions consisted of an initial denaturation
of ǑǍ°C for Ǌ min, followed by ǋǈ cycles of denaturation at ǑǍ°C for ǌǈ sec, annealing at Ǎǈ°C for
ǋǈ sec, extension at ǏǊ°C for Ǌ min and a ėnal extension at ǏǊ°C for Ǐ min.  PCR products were
puriėed with QIAquick PCR puriėcation kit (QIAGEN, Inc, Valencia, CA) according to the man-
ufacturer, and size selected on a ǉƻ agarose gel. ĉe gel bands were puriėed with QIAquick gel
extraction kit (QIAGEN) according to themanufacturer’s instructions with onemodiėcation: the
gel bands were dissolved at room temperature on a Dynal Bioteck Rotator (Model RKDYNAL,
seĨing ǋǈ, Invitrogen, Life Technologies, Carlsbad, CA) for ǉǍ minutes.  Cleaned amplicons were
cloned (pCRǊ.ǉ-TOPO vector, TOPO-TACloning kit and electrocompetent cells TOP ǉǈ; Invit-
rogen, Carlsbad, CA) and sequenced.
Processing sequencing samples
Sequences were processed using a data curation pipeline implemented in MOTHUR [Ǒǋ], which
removed sequences from the analysis if they were less than Ǌǈǈnt or greater than ǎǈǈnt, had a low
read quality score (< ǊǍ), contained ambiguous characters, had a non-exact barcode match, or
had more than ǌ mismatches to the reverse primer sequences (ǑǊǎR). Remaining sequences were
assigned to samples based on barcode matches, aěer which barcode and primer sequences were
trimmed. Chimeric sequences were identiėed using the ChimeraSlayer algorithm [Ǒǌ], and reads
were classiėedwith theMSURDPclassiėer vǊ.ǊǍusing the taxonomymaintainedat theRibosomal
Table Ǌ.ǉǋ: ǌǍǌ barcodes and primers
barcode seq “A” barcoded adapter for XLR system + barcode +
Vǋ–Ǎ ǑǊǎR primer
CACGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCACGCCCGTCAAĈCMĈ-
TĆGT
CGCAAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCGCAACCCGTCAAĈCMĈ-
TĆGT
TGAAGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGTGAAGCCCGTCAAĈCMĈ-
TĆGT
ACĈGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGACĈGCCCGTCAAĈCMĈ-
TĆGT
TCACAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGTCACACCCGTCAAĈCMĈ-
TĆGT
CGTGAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCGTGACCCGTCAAĈCMĈ-
TĆGT
ACGCGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGACGCGCCCGTCAAĈCMĈ-
TĆGT
CCTCTC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCCTCTCCCGTCAAĈCMĈ-
TĆGT
ACTCAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGACTCACCCGTCAAĈCMĈ-
TĆGT
AGACAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAGACACCCGTCAAĈCMĈ-
TĆGT
CGACTC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCGACTCCCGTCAAĈCMĈ-
TĆGT
AGCĈC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAGCĈCCCGTCAAĈCMĈ-
TĆGT
AAGCCGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAAGCCGCCCGTCAAĈCMĈ-
TĆGT
CAAGAAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCAAGAACCCGTCAAĈCMĈ-
TĆGT
AGĈGGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAGĈGGCCCGTCAAĈCMĈ-
TĆGT
TATCAAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGTATCAACCCGTCAAĈCMĈ-
TĆGT
AGGCGGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAGGCGGCCCGTCAAĈCMĈ-
TĆGT
CGGTATC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGCGGTATCCCGTCAAĈCMĈ-
TĆGT
TGACGAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGTGACGACCCGTCAAĈCMĈ-
TĆGT
ACAAGGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGACAAGGCCCGTCAAĈCMĈ-
TĆGT
AGACCTC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGAGACCTCCCGTCAAĈCMĈ-
TĆGT
ATACCAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGATACCACCCGTCAAĈCMĈ-
TĆGT
TCGCGGC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGTCGCGGCCCGTCAAĈCMĈ-
TĆGT
ATCĈAC Ǎ’ CCATCTCATCCCTGCGTGTCTCC-
GACTCAGATCĈACCCGTCAAĈCMĈ-
TĆGT
Database Project (RDP ǉǈ database, version ǎ) [ǑǍ]. Aěer processing, the resulting sequencing
depth was ǊǎǑǈ ± ǐǑǐ (median ± median abs. deviation) reads per sample.
Supervised Learning inMicrobial Ecology (SLiME) 
Using a set of training data, supervised learning algorithms can be trained to classify each micro-
biota sample into distinct classes (eg. IBD/non-IBD) based on a deėned set of features (eg. the
relative abundance of each OTU). We ėrst assigned each sequence in the data set to a taxonom-
ical group using the RDP Naive Bayesan classiėer. [Ǒǎ] For each sample we then calculated the
relative abundance of each taxa with respect to the total number of sequences in each sample. We
then trained a random forest (RF) classiėer (R-project implementation [ǑǏ] [ǐǍ]) to assign the
class (IBD or non-IBD) based on the relative sequence abundances in every t extbackslashaxa. We
used ten-fold cross-validation to compute accuracy of the classiėer, where training of the classiė-
cation algorithm employs a random Ǒǈƻ of the available patients and the performance of the gen-
erated model is tested on the remaining ǉǈƻ of patients. Performance of the resulting model can
be described by using a receiver-operating-characteristic (ROC) curve. All plots were generated
in R. [Ǒǐ]
Fecal calprotectin test
Calprotectin was assayed using the calprotectin ELISA kit (ALPCO, Salem, NH) and followed the
manufacter testing protocol. Samples were shaken on an orbital shaker at ǎǈǈ rpm. ELISA plates
were read with the Varioskan (ĉermo Scientiėc). SkanIT soěware (ĉermo Scientiėc) was used
to ėt the standard curve using four parameter curve ėĨing.
Statistical analyses
Several approaches can be used to identify the features most important to the classiėcation: a)
a priori statistical tests, b) statistics intrinsic to the supervised learning algorithm or c) iterative
measuresof the importanceof eachvariable. [ǑǑ]Tominimize computational complexitywechose
to employ an apriori statistical test. Taxawere tested for signiėcant associationwithdisease state by
means of non-parametric Kruskal-Wallis test, which does not include an assumption of normality.
Multiple p-values were then converted to q-values, by FDR adjustment [ǐǏ] and a signiėcance
threshold was chosen between q-value < ǈ.ǈǉ or q-value < ǈ.ǈǍ by estimating the πǈ parameter
as well as the number of false positives vs. cutoﬀ (see [ǐǏ, Storey] for details). In the case of
IBD/control, CD/UC and activity classiėcation, features individuated by Kruskal-Wallis test were
largely overlapping with the list of most discriminative features obtained by iterative measures and
intrinsic measures (data not shown).
Receiver operating characteristic analysis was used to evaluate the classiėcation algorithms
across a range of possible disease prevalences. Reported AUC values are median AUC values re-
sulting from ǋ repetitions of ǉǈ-fold cross validations. All calculations and plots were performed in
R. [ǑǏ] [Ǒǐ]
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Abstract
Complex microbial communities have recently begun to be characterized by means of high-
throughput sequencing and proteomics. As a result, the burgeoning ėeld of metagenomics and
microbial ecology is generating a large number of complex high-dimensional datasets, which pose
a considerable analytical challenge. In order to gain insight from these systematic eﬀorts in the
near future, it will be necessary to correlate compositional and functional data and mine it for the
presence of biologically relevant paĨerns. Most analytical strategies which have been proposed
thus far tend to be descriptive, oěen resulting in long lists of genetic and functional components
ascribed to each community. Few strategies have been capable of highlighting important biological
paĨern between communities and infer the underlying molecular mechanism, largely due to the
sheer size and complexity of the data involved. It is only recently that more advanced data mining
algorithms have begun to be applied to the study of these complex biological datasets. Machine
(or synthetic) learning algorithms, in particular, are designed to rapidly infer the discriminating
characteristics and deėning features of large amounts of complex structured data. ĉe increasing
abundance of large complex datasets in a number of disciplines have made machine learning the
subject of intense research eﬀorts and have rapidly advanced the capabilities of these algorithms.
We and others [ǐǌ] have recently demonstrated the succesful application of these algorithms to
microbiota data. In order to favour further applications of these analytical techniques, we have
developed a soěware tool, SLiME(synthetic learning inmicrobial ecology) and a publicly available
web interface. Here we characterize its performance on benchmark datasets, illustrate potential
uses and outline some of the architectural choices made. Lastly, we discuss planned features and
outstanding issues in the application of machine learning to microbiota data.
ǋ.ǉ Introduction
ĉe advent of faster and more aﬀordable sequencing technologies has allowed many innovative
studies in the ėeld of microbial ecology. Community studies of microbial diversity have been con-
ducted for a variety of natural environments, including saltwater [ǉǈǈ] [ǉǈǉ] [ǉǈǊ] [ǉǈǋ], salt
marshes [ǉǈǌ] and lakes [ǉǈǍ]. ĉese studies have allowed the inference of information about
community structure, number and type of ecological niches, mechanisms of bacterial communi-
cation and population-wide metabolic networks [ǉǈǎ] [ǉǈǏ]. It has also been possible to observe
cooperativity and group behaviors in reaction to external stimuli and evolutionary pressures [Ǌ].
Eﬀorts are nowwell underway to describe themicrobial diversity of the human-associatedmi-
crobial Ěora, or human microbiome [ǉǈǐ], and its relation to human disease. [ǉǈǑ] ĉe Human
Microbiome Project (HMP) aims to provide a map of the bacterial diversity found in association
with humans. ĉrough the use of metagenomics and whole genome sequencing of microbial Ěora
samples fromthe skin, vagina,mouth, gut andnasal passagesof hundredsof individuals, this project
aims to establish associations between themake-up ofmicrobial populations and health or disease.
[ǉǈǑ] [ǉǈǐ]
ĉeaccumulation of these large datasets, hasmade increasingly clear that gathering insight into
the microbial ecology of microbial communities will chieĚy depend on the ability to analyze the
data in a scalable and meaningful way. However, the sheer size of microbial sequencing data being
accumulated poses a signiėcant logistical and computational challenge to this goal. In addition,
the inference of biological mechanisms or disease association is currently hindered by the lack of
appropriately sophisticated analytical tools. ĉe large number of species which can be found in an
humanmicrobiome sample,makes assembly and annotation considerablymore challenging. [ǉǉǈ]
Few of the tools classically employed in bioinformatics for comparison, prediction or detection of
evolutionary signatures can be directly applied to data simultaneously originated from multiple
species. [ǉǉǉ]
ĉeapplicationofmachine learning algorithmrepresents anoptimal solution to this dilemma[ǐǌ].
Machine learning algorithms (or supervised learning algorithms) allow for the automatic inference
of discriminating characteristics and deėning features from large amounts of complex structured
data. Due to the increasing abundance of large complex datasets in a number of discipline rang-
ing from computer science to economics, machine learning techniques have been the subject of
intense research in recent years.
Employing training data, supervised learning algorithms build a predictive model (classiėer),
which can be seen as a set of rules aĨempting to discriminate and assign unknown samples to their
appropriate class. In principle, the precisionof the classiėer increaseswith thenumber of input data
points, thusmakingmachine learning an ideal approach in those situations where data is abundant
and the underlyingmodel and structure of the data is too complex to be known in detail at the start
of the analysis.
We decided to create a tool that would allow such kind of analysis on a routine basis, by people
that may lack the required bioinformatic and computational training. Our soěware SLiME can be
freely accessed through aweb application, is simple to use, gives high-quality graphic output which
can be easily exported and use in publications, require minimal input from the user and minimal
pre-processing of the sequencing data. We demonstrate the use of SLiME in both benchmark clas-
siėcation tasks and a regression task, showing that it’s well suited to the diﬀerent type of metadata
usually part of a microbial ecology analysis. In addition, we show that SLiME is eﬀective on a vari-
ety of benchmark data sets and metagenomic simulated data.
Sequencing technologies and targets
ĉetypeof analysis used formicrobial sequencingdatadirectlydependson the sequencingmethod
employed to sample the bacterial community. Traditionally, sample preparation begins with DNA
extraction. DNA is commonly extracted from the environment or fromanhuman sample bymeans
of joint solvent extraction, mechanical disruption, and treatment with buﬀers of varying chemi-
cal compositions depending on the exact protocol being followed [ǉǉǊ]. Once DNA has been
extracted and puriėed, ampliėcation can proceed by means of polymerase chain reaction (PCR)
with a set of desired primers. Historically, bacteria have been taxonomically classiėed based on
PCR ampliėcation and sequence analysis of the ǉǎS ribosomal RNA gene [ǉǉǋ]. ĉis gene’s sec-
ondary genetic structure is characteristic and highly conserved ( likely due to its central role in
protein translation), encompassing both conserved and hypervariable regions [ǉǉǌ]. Single gene
analysis of this sort is obviously less precise than Multi Locus Sequence Analysis [ǉǉǍ] [ǉǉǎ] or
whole genome analysis, techniques that taxonomically classify bacteria based on the sequence of a
set of housekeeping genes or their entire genetic material, respectively. Yet, the importance of the
ǉǎS rRNAmethod cannot be ignored as, in many instances, it has proven suﬃcient in understand-
ingwhole population structures andmetabolic networks [ǉǈǊ]. Focusing on a single gene also has
the advantage of requiring relatively less expensive sequencing schemes ad thus enabling large scale
and/or longitudinal studies of microbial diversity. ĉe preparation of ǉǎS rRNA gene libraries is
arguably the most delicate step in microbiome studies and it is important to consider some of the
biases it introduces in the data obtained downstream. Even though ǉǎs rRNA has shown to be
quite precise in determining the presence or absence of diﬀerent microbes in given environments,
it is uncertain whether observed abundance of a particular DNA sequence in the sample can be
taken as ameasure of the original abundance of a particular microbe. Primer selection and binding
characteristics, secondary structure of genomic DNA, presence of sequence repeats and the num-
ber of hypervariable regions considered, can all strongly inĚuence the quality and sensitivity of
taxonomic reconstruction and thus the precision of subsequent bioinformatic analysis to interpret
these datasets.
ĉe choice of sequencing technology that ultimately yields the sequence of interest, be it the
ǉǎS rRNA gene or a larger genetic stretch, can also signiėcantly bias data output . Currently the
mostwidelyused systems include the traditional Sangermethod, andnext-generationhigh-throughput
methods such as the Solexa GA platform (developed by Illumina) and ǌǍǌ GSǊǈ pyrosequencing
platform (developed by Roche). ĉese next-generation technologies are actively being developed
with the aim of improving upon cost, output volume, read length and speed. Choice of technology
needs to be considered on the basis of the ultimate experimental goal, since each system present
with its own unique set of strengths and limitations [ǍǍ]. ĉe ėrst generation ǌǍǌ GSǊǈ platform
provided an average read length of ǉǈǈ nucleotides as compared to the ǋǎ nucleotides of the Solexa
GA, however due to the speciėcs of its underlying biochemistry these longer reads were also prone
to containing unresolved hypervariable regions [ǉǉǏ]. ĉe traditional, and more costly, Sanger
method produces high quality reads of ǐǈǈ bases but relies on a round of cloning and suﬀers of
low throughput [ǉǉǐ]. Subsequent generation of ǌǍǌ and Solexa platforms, as well as the ongoing
development of single-molecule sequencing by Helicos and Paciėc Biosciences, should provide
substantial improvements to the resolution and quality of microbiome sequencing. Eﬀorts to uni-
form the sampling methods are already an integral part of the HMP [ǉǈǑ] [ǉǈǐ].
Traditionalmicrobiome analysismethods
Genomic analysis ofmicrobial communities poses diﬀerent challenges than the assembly of a refer-
ence genome sequence [ǉǉǈ]. Community structure or composition has to be inferred from phy-
logenetic and taxonomic analysis [ǉǉǌ]. Current approaches that employmicrobiome ormetage-
nomic data to understand structure and diﬀerences between communities rely on the arbitrary
deėnition of operational taxonomic units (OTUs) [ǍǏ]. Sequences corresponding to each sam-
pled microbial strain are grouped into a manageable number of units on the basis of their genetic
similarities. ĉis grouping allows for the statistical comparison of related groups from twodiﬀerent
communities, since it becomes necessary to consider only fewer operational units rather than the
entire spectra of single sequences. ĉe threshold of similarity under which diﬀerent sequences are
grouped together is usually selected to obtain species-level grouping, but does not take into con-
sideration information about the underlying ecology, phenotype or evolutionary history of the
microbial community.
Many diﬀerent methods exist to compare two diﬀerent communities subdivided in OTUs.
Metrics such as P-test, Fst, Libshuﬀ orMANOVAcan estimate the statistical signiėcance of the dif-
ference inOTUcomposition between two diﬀerent communities [ǉǉǑ]. P-test, Fst andUniFrac in
particular tend to be the preferred choices, as they do take phylogenetic information into account
[ǉǊǈ]. ĉe presence or absence of certain OTUs, or their estimated abundance in the sample,
is used in various ways to produce a global measure of similarity or, more ėĨingly, dissimilarity.
Methods such as principal component analysis (PCA) can be used in a similar manner or in con-
junctionwith thesemethods to visualize andquantify diﬀerences between communities. However,
there exists several disadvantages to these analytical methods. Summarizing in a single value the
diﬀerence between two extremely complex bacterial communities is bound to have negative eﬀects
on the ability to distinguish closely related groups. By losing resolution on the ėner architecture
of the bacterial groups, it becomes diﬃcult to deconvolve the actual diﬀerences observed between
communities. Measures such as P-test orUnifrac are only capable of producing a single value quan-
tifying the relatedness between twomicrobial communities, but fail to produce a list of taxonomic
groups (or thresholds in the abundance of certain microbial groups) capable of discriminating be-
tween samples. Although PCA determines how diﬀerent two or more communities are, it does
not permit identiėcation of whichmicrobial groups can be used to distinguish between communi-
ties. Perhapsmost importantly, when employed for diagnostic purposes on human samples, global
metrics have not proven suﬃcient to discriminate between diseased and control patients with rea-
sonable accuracy. A singlemeasuremaynot distinguish between individual to individual variations
and truly meaningful biological diﬀerences between diseased and healthy patients. In one of the
few clinical studies to date, clustering by PCA was shown to be relatively precise (ie. high positive
predictive value) in identifyingpatientswith inĚammatory gut disease, but suﬀered fromextremely
low sensitivity (ie. low recall or a high number of false negatives) [Ǐ].
Approaches based on classiėcation
Some of the limitations of the current analytical techniques can be overcome by implementing
approaches based on learning and classiėcation. Instead of measuring microbial diversity in com-
munities based on their global composition and our current hypotheses about the underlying mi-
crobiology, the data itself can be used to infer the key elements which diﬀerentiate multiple micro-
biomes. Inferring paĨerns from complex data in an automated fashion should elucidate an increas-
ing number of associations thatwould otherwise be overlookedby clustering and visual inspection.
Machine learning is a discipline at the intersection of artiėcial intelligence and statistics that is
concernedwith this exact problem [ǉǊǉ]. Manymachine learning techniqueshavebeendeveloped
for the automated classiėcation of unknown samples based on the recognition and learning of com-
plex paĨern in a training dataset. In its application tomicrobiome data, knowledge associated with
the individual microbiomes (whether the individual is diseased or healthy, for instance) is used
to train a classiėer capable of placing the elements of the training data set into the correct classes.
When applied to new samples (a patient for which the diagnosis is uncertain, for instance) the clas-
siėer predicts with a certain accuracy which class the sampled microbiome is part of (eg. healthy
or diseased). ĉe features or underlying structure of the data individuated by machine learning
algorithms provides a local high-resolution measure of diversity (in contrast with the global values
produced by P-test, UniFrac, etc.) and should prove signiėcantly more robust in accounting for
individual to individual variation.
Synthetic learning algorithms require minimal user input oěen allowing to reduce computa-
tionally expensive pre-processing steps. Importantly, machine learning does not explicitly require
knowledge of the speciėc domain being classiėed, hence its wide applicability to diverse problems.
Oěen this translates into insights that would otherwise being overlooked, if domain speciėc the-
ory was applied to the analysis of the data. Developments in other ėelds can be carried over to the
speciėc domain of interest and speciėc classiėcation problems can easily be shared with a wider
community. However, the lack of domain speciėc structure can also mean that deducing mech-
anistic details from these techniques may be challenging. As a result of their widely applicability,
many synthetic learning algorithms exist in literature and a large portion has already been applied
in the biological ėeld.
One important implication of learning algorithms is that accumulation of larger training data
set should in principle improve classiėcation accuracy and, as a consequence, knowledge of the sys-
tem. Diagnostic and analysis tools based on these algorithmswould therefore become increasingly
precise and accurate when employed on larger datasets. ĉus, by identifying the key features in the
data that distinguish diseased and healthy patient, or diﬀerent ecological habitats, machine learn-
ing will permit the development of cheaper and more eﬀective diagnostic tools, guide biological
discovery and inform future sequencing eﬀorts.
ǋ.Ǌ Results
Classiėcation can accurately distinguish body sites
To test the performance of classiėcation algorithms applied tomicrobiota we selected the Costello
body sites dataset [ǉǊǊ], which contains sequence data for ǎǈǊ samples taken from a collection
of individuals and body sites. Our algorithm of choice is the widely used randomForest algo-
rithm [ǐǍ], which has already been demonstrated to work with high accuracy across a series of
microbial datasets [ǐǌ]. To build a training dataset we employ the RDP naive bayes classiėcation
and avoid binning the data into OTUs, to reduce the computational complexity of the pipeline.
We then count the occurence of each sample at each taxonomical level individuated by the naive
bayes classiėer. RandomForest is then run in weigthedmode with ǉǈ-fold cross validation and the
resulting measures of variable importance as well as sample classiėcation probability are recorded.
When applied to the classiėcation of body habitat, SLiMEwas capable of classiėng samples on the
basis of their origin from the skin very succesfully (Figure ǋ.ǉ is a sensitivity-speciėcity curve for
the classiėer), resulting in an almost perfect classiėer.
SLiME regression can predict nitrate levels in bioremediation pools
ĉeapproachpackaged inSLiMEcanalsobe appliedwith success todatawith continuous labels, as
oěen found whenmicrobiome data is sampled along physical variables in an environmental gradi-
ent. To illustrate the capabilities of SLiME in this regressionmode, we selected a dataset describing
the microbial composition of communities found in uranium bioremediation pools [ǉǊǋ]. Com-
munity composition as determined by sequencing was compared with various physico-chemical
Figure ǋ.ǉ: Sensitivity-speciėcity curve for SLiME applied to the Costello body habitat dataset.
SLiME can classify whether the sample was taken from the skin of each individual with high accu-
racy. A perfect classiėer would lie on the top right corner with ǉǈǈƻ sensitivity and ǉǈǈƻ speci-
ėcity. A random classiėer would consist of a diagonal line from top leě to boĨom right.
parameters to individuate potential correlation. Aěer training, and on the basis of microbial com-
position alone, SLiME was able to accurately predict both nitrate NO3 levels (Figure ǋ.ǋ) and
chemical oxygen demand (COD) (Figure ǋ.Ǌ), an indirect measure of the amount of organic com-
pounds found in water. SLiMEwas precise in predicting nitrate, with the exception of two samples
for which the predicted value is a gross underestimate. ĉe predicted values for CODwere also an
underestimate, however the shape of the correlation is obviously linear and would allow for sys-
tematic adjustments if SLiME was routinely applied to this type of datasets.
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Figure ǋ.Ǌ: Chemical oxygen demand predictions by SVM regression. Support vector regression
was employed to predict the COD value on the basis of microbial composition. ĉe prediction
measure is an underestimate of the real value, but is consistent throughout microbial samples and
can therefore be systemically adjusted.
Naive assignment to taxonomic groups is suﬃcient for accurate classiėcation
Considering the capability of SLiME to classify microbiota on the basis of continuous and dis-
crete labels, we wanted to understand if the classiėcation accuracy could be improved by diﬀerent
data pre-processing steps. Classically, all analysis of microbial community composition rely on the
construction of tables quantifying the occurrence of each OTU in the samples. Nevertheless, the
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Figure ǋ.ǋ: Nitrate prediction by SVM regression. Support vector regression was employed to
predict the logarithm of the nitrate value on the basis of microbial composition. Notice the almost
perfect correlation betweenpredicted and actual values, with the exception of two speciėc samples.
construction of OTU tables can be a computationally intensive task, especially with larger dataset
size. Moreover, diﬀerent approaches can be used to build OTUs: selecting an identity threshold
percentage or aligning the sequence to a reference phylogeny. How these two OTU deducation
methods aﬀect the ėnal result is not known. An alternative approach to building an OTU table
is to rely on the rapid approximation of taxonomical lineage, such as the one oﬀered by the RDP
naive bayes classiėer. ĉis is a quick but redundant approach, since no eﬀort is taken to limit the
occurrence of the diﬀerent samples multiple times over taxonomical levels. Whether redundancy
negatively or positively aﬀects classiėcation accuracy is poorly understood. To address some of
these questions we performed a SLiME classiėcation task at a range of OTU identity thresholds,
as well as on the naive RDP classiėcation.
While tables derived from the naive RDP classiėcation yielded lower classiėcation accuracy
than non-redundant OTU table, the computational complexity required to compute OTU tables
makes naive RDP binning a valid approach (Figure ǋ.ǌ). Its validity in classiėcation of microbiota
will however depend on the speciėc machine learning algorithm used. RandomForest and other
ensemble algorithm may be particularly robust (and indeed beneėt) from the accumulation of
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Figure ǋ.ǌ: Classiėcation error as a function of OTU identity threshold employed in the dataset
construction. De novo clustering of sequences inOTUbased on identity thresholdmay be done at
any arbitrary threshold, generating a diﬀerentOTU table depending on the value of this parameter.
SLiMEwas applied to eachof the resultingOTUtables anda linearėtwasused todescribe the trend
observed. Ribbon indicates the variability of the test error (standard deviation) as estimated by ǉǈ-
fold cross validation. ĉe dashed lines indicates the performance of SLiME on tables generated by
the much faster RDP binning method.
semi-redundant data and will automatically avoid problems of overėĪing (A model which is over-
ėĨing may be really accurate on the training/test data sets, but may be harder to generalize to less
similar datasets). Other algorithms which do not rely on ensemble methods may be negatively
aﬀected by the presence of multiple correlated data and indeed suﬀer from overėĨing.
Computational complexity increases considerablywith thenumberofOTUan-
alyzed
We analyzed the computational complexity (and time taken) for each step in the computational
pipeline employed by SLiME.While the speciėc implementation found in SLiMEmay diﬀer from
other soěware, similar steps are found in any machine learning pipeline deployed thus far. Speciė-
cally, we focussed our aĨention on those steps that occur aěer a compositional table is submiĨed
by the user. Diﬀerent possibilities exist: random forest can be run directly on the unėltered table,
or rarefaction and ėltering can reduce the size of the table before random forest is run.
Filtering, in particular, addresses the problem that ǉǎ rRNA sampling of a particular environ-
ment at a speciėc timemay include spurious OTUs. High transfer from a productive environment
(source) to a poorly productive environment (sink) may mean that the majority of the bacteria
sampled in the later environment are only transient members of the microbiota. In the gut, lumen
bacteriamay be heavily inĚuenced by the ingested bacteria and samplingmay not represent the res-
ident population of the gut. Filterint OTUswhich occur only in a small fraction of samples is a one
potential way to reduce the impact of this sampling bias. Rarefaction, on the other hand, addresses
the diﬀerences in sequencing reads between samples that are oěen the result of shotgun sequenc-
ingmethods. By downsampling the dataset to aminimumnumber ofOTUspresent in each sample
considered, these diﬀerences are reduced. ĉe downside of this approach is the potential loss of
information caused by ignoring a large portion of sequencing data.
Figure ǋ.Ǎ shows that the time taken by each classiėcation step increases almost exponentially
with the number of OTUs considered. Even though randomForest is a fast algorithm, any table
containingmore thanǍǈǈOTUs would involve a noticeable amount of time (from above ǉǈmin
to ǉ hour on a typical scientiėc computer cluster at the time of writing) for processing. If however,
rarefaction and ėltering are performed before classiėcation, the time required for classiėcation is
substantially reduced.
A tradeoﬀ thus exist between preprocessing steps (rarefaction and ėltering) and the time taken
on the classiėcation step (Figure ǋ.ǎ). Rarefaction and ėltering of the compositional table is also
computationally burdensome and the cumulative time involved in preprocessing and classiėcation
needs to be weighed against the time taken by the classiėcation step on the raw unėltered dataset.
In the implementation chosen for SLiME both non-redundant OTU tables and RDP binning
methods are allowed. However we opted to rely on RDP binning for the default output, as the
computational costs it incurs are minimal.
Sample rarefaction and ėltering does not aﬀect classiėcation accuracy
Since ėltering and rarefaction steps may signiėcantly reduce the size of the data, we wanted to as-
sess if any decrease in classiėcation accuracy could occur as a result of the ėltering and rarefaction
step. Promisingly, no noticeable diﬀerence exist (Figure ǋ.Ǐ) between SLiME classiėcation as per-
formed on ėltered compositional tables or raw count tables. ĉis applies when classifying diﬀerent
variables, across a range of OTU threshold, and also when employing RDP naive bayes binning.
Normalization does not reduce classiėcation error
If the rarefaction step is bypassed, the diﬀerence in the number of sequences between samples can
be a source of bias for the classiėcation algorithm. To investigatewhether the randomForest imple-
mentation contained in SLiME was sensitive to this bias we compared classiėcation performance
(ǉǈ repeats of ǉǈ-fold cross validations) of SLiME when fed normalized taxon abundance data or
raw counts. No diﬀerence was noticed in the classiėcation output of the two types of input data,
even across diﬀerent variables.
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Figure ǋ.Ǎ: Computational timemeasured as a functionofOTU identity threshold. Timewasmea-
sured by the UNIX command time on the computational server beagle.darwinproject.mit.edu.
Dashed line in each panel represent the time takenwhen fed the RDPnaive binning compositional
table, which involved the least computational complexity.
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Figure ǋ.ǎ: Trade-oﬀ between rarefaction, ėltering and classiėcation. Above ǑǊƻ identity thresh-
old, the preprocessing steps become themain driver of overall computational time. When the clas-
siėcation step is performed on raw data, the performance is substantially worse than with ėltered
data.
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Figure ǋ.Ǐ: Error as a function of OTU identity threshold and its dependence on ėltering. OOB
error for SLiME across a variety of OTU identity threshold was performed on the habitat bench-
mark and the host benchmark. No substantial diﬀerence appears between ėltered abundance data
and raw read counts. Dashed line show the performance obtained by the RDP-binned table.
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Figure ǋ.ǐ: Normalization does not aﬀect performance. Normalizing the compositional table with
respect to the total number of reads per each sample does not alter the outcome in any signiėcant
manner.
Classiėcation accuracy improves with the number of samples
One aĨractive property of machine learning algorithms is that in principle their accuracy will im-
prove asmore training cases are added to the datasets. ĉe study of this correlation betweenmodel
accuracy and sample size remains largely empirical, but this trend has nonetheless been demon-
strated with many algorithms, both in balanced and unbalanced data sets [ǉǊǌ]. To test this prop-
erty we formed a series of random subsets from the IBDChildren’s dataset and fed them to SLiME,
measuring the area under the resulting ROC curve. ĉe data was then ėĨedwith a local regression
(LOESS) and ploĨed in Figure ǋ.Ǒ. Conėrming expectations, a non-linear trend upwards was ob-
servable and, at least for the number of samples available, it was not possible to determine at which
level would it reach an asymptote.
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Figure ǋ.Ǒ: Area under the ROC curve increases as more training samples are added. ĉe area
under the ROC curve for the classiėcation of patients in IBD or healthy was measured while rar-
efaction of the number of samples included was performed.
Simple heuristics for phylogenetic data incorporation do not improve classiė-
cation accuracy
It is well established that microorganism distribution across habitats is correlated with their phy-
logeny, such that diﬀerent habitats can be distinguished on the basis of beta diversity. [ǉǊǍ] Com-
paring ǉǎs rRNA surveys and other phylogenetically informativemarker genes [ǉǊǎ] showed that
this correlation is relatively stable and that habitat preferences do not change signiėcantly in evo-
lutionary time. However, this is not to say that phylogeny can completely describe the distribution
of microorganisms in their habitat and that other phenomenon (such as horizontal gene transfer)
take place. A detailed prediction of the microbe in each environmental niche need to take into
account other elements beside phylogenetic composition, although this serves as a good ėrst ap-
proximation.
Considering the reliability of phylogenetic information in predicting microbial distribution,
it is reasonable to assume that including phylogenetic structure in the data analyzed by machine
learning would improve the performance of the prediction. Measures such as unifrac have been
shown to clustermicrobial compositional databeĨer thannon-phylogeneticmeasures such asbray-
curtis [ǉǊǏ]. On the other hand, because diﬀerent datasets would require building separate phylo-
genies, employing phylogenetic information in the classiėcation task will prevent simple compar-
ison of datasets, unless a common reference phylogeny is agreed upon and employed. To test the
validity of phylogenetic information in aiding classiėcation tasks we aĨempted to build training ta-
bles employing on a simple phylogenetic heuristic (see Figure ǋ.ǉǈ) and performed classiėcation
tasks on the Children’s Hospital IBD dataset previously described.
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Figure ǋ.ǉǈ: Phylogenetic information heuristic. Training tables which incorporated phylogenetic
information were constructed by assembling a tree from the submiĨed sequences and traversing
the tree from leaf to root. At each node, the number of leafs present in each sample was counted,
weighted by either distance to ancestors or node depth, and further propagated recursively.
We used both SLiME and other algorithms such as hierarchical decision trees ( [? ]) and
measured the classiėcation accuracy as the diagonal of the resulting confusion matrix. Average
accuracy across a variety of condition was ǐǈƻ, which was lower than observed with SLiME.
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Tree branches are colored based on diagnosis. Bacterial groups in a normal patient are colored green; 
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Figure ǋ.ǉǉ: Hierarchical decision tree outlining the classiėcation of a patient as normal, crohn’s
or colitis, depending onwhether sequences are present at the given nodes in the phylogenetic tree.
Average accuracy is ǐǈƻ. Decision treenodes are coloredwith respect to thehierarchical level. Tree
branches are colored based on diagnosis. Bacterial groups in a normal patient are colored green;
magenta for Crohn’s samples and cyan for colitis samples.
To address whether the observed decrease in performance was due to the classiėcation algo-
rithm, we also tested the same heuristic with support vector machines (SVM). We found (Fig-
ure ǋ.ǉǊ) an improvement in average overall accuracy to ǐǍƻwhich was also reĚected inmulticlass
classiėcation, yielding an average of ǏǊƻ accuracy.
ĉus, while in principle phylogenetic information should augment the data available to ma-
chine learning algorithm and thus allow an improvement in performance, when we include phy-
logenetic distance by means of a simple heuristic, we found minimal change in performance. ĉe
improvement was not signiėcant enough to justify the increase in computational complexity and
the inability to compare diﬀerent data sets quickly. Obviously more work is necessary to individ-
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Phylogenetic feature selection for SVM classification. Nodes in the 
phylogenetic tree with a disproportionate (p < 0.05) number
of disease-associated or health-associated sequences are chosen
as features for SVM. Cross-validated classification leads to 85%
average accuracy in distinguishing healthy and diseased patients.
Distinction in the three classes (control, colitis, Crohn’s) is 72%
accurate. At each node the proportion of sequences for each patient
in the subtree is indicated.
Branches are colored based on the corresponding patient diagnosis
(green for control, blu for colitis, yellow for remission and red for Crohn’s).
Figure ǋ.ǉǊ: Phylogenetic feature selection for SVM classiėcation. Nodes in the phylogenetic tree
with a disproportionate (p< ǈ.ǈǍ) number of disease-associated or health-associated sequences
are chosen as features for SVM. Cross-validated classiėcation leads to ǐǍƻ average accuracy in dis-
tinguishing healthy anddiseased patients. Distinction in the three classes (control, colitis, Crohn’s)
is ǏǊƻ accurate. At each node the proportion of sequences for each patient in the subtree is indi-
cated. Branches are colored based on the corresponding patient diagnosis (green for control, blu
for colitis, yellow for remission and red for Crohn’s)
uate other means of including phylogenetic information.
One of the main disadvantage of incorporating phylogenetic information is that comparing
multiple data sets requires the construction of a common tree. Another approach, of which the
RDP naive bayesian classiėer is a basic example, is the assignment of reads onto a reference phy-
logeny. Given an existing phylogeny, it is computationally far more tractable to assign reads by
similarity to the diﬀerent phylogenetic levels, without recomputing the base phylogeny. Soěware
tools such as RaXML have been adapted and used for this purpose [ǉǊǐ]. However, this requires
the reference phylogeny to be of high standard and completeness, enough to be agreed upon by
researchers in diﬀerent ėelds and who plan to align very disparate data sets. ĉis remains largely
unachievable at present, given the varying quality of sequencing data across theTree of Life. More-
over, a reference phylogeny that does not incorporate the data at hand in its construction may be
signiėcantly less precise, particularly at the taxonomical levels included in the analysis.
SLiME is a web appwhich oﬀers interactive visualizations
While the functionalities provided by the SLiME package can be accessed from the command line
under anymajor UNIX operative system, to further encourage adoption of machine learning anal-
ysis in the ėeld of metagenomics, I have developed a web interface to SLiME’s functionality. ĉe
application is built on a python stack, and at its basis lies a queueing system to which the web
process passes commands and data ėles to be processed. ĉe user interfaces with the web process
through a user interface designed with the aid of Bootstrap. ĉe worker process performs the
classiėcation and relies on the scikit.learnmachine learning library and matplotlib library
to output the data. Further interactive visualizations via the D3.js library is planned in future ver-
sions. Other planned features include the ability to choose diﬀerent machine learning algorithms
for classiėcation and the online optimization of learning parameters for the random forest algo-
rithm.
ĉe web interface allows any user to submit either sequence data or tabular data (default) and
obtain a job id upon submission. ĉe job id is then used to poll the worker queue on the computa-
tional server and retrieve the output of the classiėer. ĉe user can then explore the importance of
each variable and the probability the model assign to each label directly through a web browser.
ǋ.ǋ Discussion
We demonstrate the use of SLiME in both benchmark classiėcation tasks and a regression task,
showing that it’s well suited to diﬀerent type of metadata which could be part of a microbial ecol-
ogy analysis. To date, there are few similar applications ofmachine learning tomicrobiota. Knights
et al [ǐǌ] have advocated for the use of machine learning techniques applied to microbiome data
andpreparedbenchmarkdata [ǐǌ] to test newalgorithms against. ĉeyhave also showed the appli-
cation of these techniques to detect sequence samplesmislabelings [ǉǊǑ] and to track the source of
microbial contamination [ǉǋǈ]. Another package (MetaDistance) recently developed addresses
the sparcity typical of otu vs. samples dataset and implements distance-based learning to classify
multiple labels [ǉǋǉ]. ĉe R package pensim was developed to facilitate the application of penal-
ized regression techniques to metagenomic data, providing facilities to scale data and obviate to
overėĨing artefacts. Exclusively generative models have also been adapted to work with micro-
bial composition data andmetagenomics data. A variation onDirichlet’s mixture namedDirichlet
Multinomial Mixtures was shown as it applies to metagenomic data from the obese/lean bench-
mark dataset.
ĉese positive results demonstrate the applicability of machine learning tomicrobial sequenc-
ing data which I believe will have a pivotal role in the discovery of mechanisms and functions of
the commensalmicrobiota. A potential approach to foster the power and applicability of predictive
models tomicrobiome analysis is the launch ofmachine learning competitionswithmetagenomics
data [ǉǋǊ]. Crowd-sourcing has recently shown great potential in improving the accuracy of mod-
els for a variety of predictive task andmay confer SLiMEor other equivalentmethods the precision
necessary to be employed in the clinical and research seĨing.
Application of a machine learning approach to the analysis of microbial sequencing data will
also help shape future study design and data collection. Since the HMP is a communal eﬀort
amongst numerous institutes and labs all over the world, sample preparations, ampliėcations and
sequencing approaches being used vary signiėcantly across participants. Any tool employed to
analyze the resulting data should not only correct for these potential biases, but should deliver
quantitative information to aidmethod development. Classiėcation - instead of the classical global
quantiėcation of diversity - can produce such information, allowing for the evaluation of the im-
pact of the various technological parameters (sequencing platform, read length, variation between
centres,etc.) and advising on the best possible strategy for any future HMP study.
Given that the potential yield of the HMP is immense, new approaches for output standard-
ization and analysis are absolutely essential to extracting the full signiėcance of what these data can
teach us about health, disease and microbial evolution. Machine learning and the development
of sophisticated learning algorithms represent a powerful and promising approach to tackle these
challenges.
ǋ.ǌ Methods
Machine learning algorithms
Support vectormachines (SVM) is an algorithm capable of dealing with high-dimensional in-
put data [ǉǋǋ] [ǉǋǌ]. Input is mapped onto a multi-dimensional space and SVM will aĨempts to
ėnd the separating hyperplane which leaves the largest possible margins between the two set of
points in this multidimensional space. Multi-way classiėcation using SVM can be done by parti-
tioning the dataset and running the algorithm for each one-against-all combination of classiėca-
tion variable. All input variables are taken into consideration and the performance is determined
by those samples closest to the generated hyperplane (support vectors). Albeit extremely powerful
and rapid, this algorithm does not allow for rapid translation of the classiėer in terms of discrimi-
nating microbial populations and can thus be less intuitive.
Ensemble methods To further improve classiėcation accuracy and robustness, machine learn-
ing algorithms oěen combinemultiple diﬀerentmodels [ǉǋǍ]. Suchmethods are called ensemble
methods because they aggregate the performance of many classiėers to boost the overall classiė-
cation accuracy. Boosting and bagging [ǉǋǎ] for instance, sum the performance of many weak
classiėers to obtain a strong classiėer. Random forests [ǐǍ] [ǉǋǏ] aggregate classiėcation trees
inferred on randombootstraps of the entire sample population, take into account the result of each
tree and determine the ėnal result by combining (usually by a majority vote) these individual re-
sults. ĉe resulting predictive model generally performs comparably to regression trees, but is less
prone to overėĨing. Speciėcweighting schemes canbe employed to account for highly unbalanced
datasets (data in which one class of sample constitutes a minor portion of the entire dataset, as in
the detection of rare disease) [ǉǊǌ]. ĉe algorithm also estimates error, by applying the regression
tree obtained at each bootstrap iteration to the data excluded from the bootstrap. ĉe resulting
out-of-bag error estimate can be used to quickly compare classiėcation performance on the training
data set and does not require additional computational steps. Lastly, random forests generate a
measure of variable importance. ĉe diﬀerence in out-of-bag classiėcation error is measured itera-
tively excluding each variable from the training set, and the variables are ranked according to their
impact on the ėnal error across all bootstrapped trees.
Part III
Tools for the study of the immune system
Ǒǌ
ĉe immune system is a highly complex network of cells that interact with each other dynam-
ically across time and space. Traditional immunological assays are simply not capable of fully and
comprehensively characterize the immune response due to their inherent limitations. Biochemi-
cal assays cannot provide the required level of resolution and high throughput necessary to form
a complete picture of the immune network at any given point of time. In addition, these assays
oěen rely on isolating immune cells from their microenvironment and exposing them to stimuli
very diﬀerent from the ones which they would be exposed to under physiological conditions.
Recently, insight into the etiology of complex autoimmune diseases has underscored the need
of a more integrative approach (or systems approach) to immunity. Autoimmune diseases (IBD,
diabetes, etc.) have been shown to be multifactorial, in that no single trigger is responsible for
the observed phenotype. Abnormalities in the communication between immune cells, as well as
a variety of noxious stimuli, all contribute to disease manifestations. Only an overall ã and phys-
iologically relevant ã view of the immune response to a particular condition will allow for the
characterization and prediction of the course of a disease will take.
To obtain a systems view of immunity, novel immunological assays are necessary. Tools ca-
pable of generating multivariate data with high-throughput and high resolution would allow for
the generation of highly detailed snapshot of the immune system. ĉese snapshot, in turn, could
be used to construct predictive models of immunity. Assays capable of mimicking physiological
stimuli andmicroenvironments would ensure the physiological relevance of any predictive model.
Chapter ǌ
Mapping rapid surface dynamics in naïve B
cells exposed to subsaturating doses of ligand
Eliseo Papa, J. Christopher Love, YouMe Kim, Annemarthe G. van der Veen, Hidde L. Ploegh
ĉis chapter is presented as prepared for submission to [ISME?]
Ǒǎ
Abstract
ĉecapture of antigen on surface-disposed receptors of B cells is critical to inducing a humoral
immune response. ĉe binding events cause ǉ) rearrangement of receptors into chlosterol-rich
microdomains, Ǌ) initiation of phosphorylation-mediated signaling pathways, and ǋ) internaliza-
tion of bound antigen for proteolysis and loading onto major histocompatibility (MHC) class II
complexes. ĉese processes have been studied by biochemical and imagingmethods, but these are
insuﬃcient to describe early dynamics in a quantitative manner. Here we show how amicroĚuidic
device was used to apply sequential doses of cross-linking ligands to primary naïve B cells from
mice, allowing to track the early dynamic of the labeled B cell receptors by live cell confocal mi-
croscopy. We ėnd that upon stimulation with ligand, B cell receptors (BCRs) redistribute slowly
(ǏǍ.ǋ s), but a second exposure induces a more rapid rearrangement (ǋǍ.ǋ s) of a distinct set of
receptors. We also show that the rearrangement of surface-disposed class II MHC requires BCR
ligation but not BCR microcluster formation. ĉese results suggest that B cell respond to antigen
in a manner proportional to the total amount of antigen acquired at the surface of the cell. ĉe
approach described should allow further studies on the distinct roles played by surface-bound re-
ceptors in early signaling and subsequent internalization events.
ǌ.ǉ Introduction
Ligation of B cell receptors (BCRs), present on the surface of naïve B cells, triggers at least two sig-
niėcant events. First, initiation of a signaling cascade prepares the B cell for proliferation and diﬀer-
entiation into immunoglobulin (Ig)-secreting plasma cells [ǉǋǐ] [ǉǋǑ]. Second, internalization
of the bound antigen allows its proteolysis within lysosomal compartments, and the immunogenic
peptides generated associatewith class IImajor histocompatibilitymolecules (MHC)[ǉǌǈ] [ǉǌǉ].
Presentation of internalized antigen via the class II MHC pathway allows engagement of antigen-
speciėc CDǌ+ helper T cells, which then license the B cell to diﬀerentiate into memory cells or
antibody-secreting plasma cells.
ĉe aﬃnity and the valency of the interaction between a ligand and a BCR determine how the
cognate pairs are reorganized on the surface as well as internalized. Observations of both primary
B cells (and immortalized lines of B cells) have shown that continuous exposure of cells tomultiva-
lent antigens leads to cross-linking of two ormore BCRs at the surface of the B cell [ǉǌǊ]. ĉis pro-
cess induces the translocation of BCRs into cholesterol-rich, detergent-insoluble microdomains
(so-called lipid raěs) [ǉǌǋ] where the BCRs have been thought to act as the primary sites for sig-
nal transduction via tyrosine phosphorylation [ǉǌǌ] [ǉǌǍ]. BCRs located in these microdomains
recruit kinases, including Lyn, Syk, Btk, involved in the signaling cascade, and gain additional sta-
bilization by aĨachment to the cytoskeleton and possibly by recruitment of other adaptor proteins
[ǉǋǐ] [ǉǌǎ]. Monovalent antigen can also initiate both signal transductionvia tyrosinephosphory-
lation and internalization of the BCR-antigen complex, but does so with delayed kinetics relative
to multivalent antigens [ǉǌǊ]. B cells exposed to monovalent antigen are also poor at soliciting
help from appropriate CDǌ+ T cells.
Previous studies that have used biochemical and imaging methods to describe the dynamic
translocationofBCRson theplasmamembranehave reliedonapplying cross-linking ligandsunder
conditions that favor the equilibrationof the ligand-receptor reaction (e.g., low temperatures at ǌ°C
forǊǈ–ǎǈmin), or that expose cells to a continuous sourceof ligandat ǋǏ°C [ǉǌǊ] [ǉǌǏ] [ǉǌǐ] [ǉǌǑ] [ǉǍǈ].
Physiologically, however, it is likely that B cells in secondary lymphoid tissues only experience sol-
uble antigen transiently, and in limited amounts, as it is delivered via aﬀerent lymphatics.
Here we present new observations of the early reorganization and aggregation of both BCRs
and major histocompatibility complex (MHC) class II molecules on individual primary naïve B
cells that were exposed to sequential, subsaturating dosages of a cross-linking anti-Ig. To apply
metered quantities of the ligand to live cells, we designed a microĚuidic device for directing short
“pulses” (Ǌǈ–ǋǈ s) of ligands or other molecules to the cells immobilized inside the device. ĉis
system made it possible to apply two diﬀerent stimuli sequentially in time while monitoring the
naïve cells by live cell imaging. We examined the eﬀects of a single, subsaturating pulse of anti-
IgM on the redistribution of both BCRs and class II MHC at the surface of naïve B cells, and the
subsequent redistribution of a second, temporally-distinct population of BCRs. Quantitative im-
age analysis of individual cells subjected to these “pulse-chase” experiments indicated naïve cells
respond slowly to form aggregated patches of membrane-bound BCRs upon initial cross-linking,
but subsequent exposure to cross-linking ligand induces rapid aggregation. Furthermore, the char-
acteristic time for aggregationofMHCclass II on the surface is faster than that forBCRs, suggesting
that formation of BCRs microcluster aěer ligation is not necessary for inducing the events leading
to internalization of class II MHC.
ǌ.Ǌ Results
MicroĚuidic delivery ofmetered quantities of ligand
We designed and fabricated a microĚuidic device by soě lithography that used changes in hydro-
dynamic pressure to deliver deėned amounts of ligands (cross-linking antibodies) to immobilized
B cells. ĉe poly(dimethylsiloxane) device comprised three parallel channels with widths of ǉǍǈ,
ǉǈǈ, and ǉǍǈ µm connected by a single perpendicular channel (Figure ǌ.ǉ). Each channel had an
independent input, but all three shared a common reservoir for waste. ĉe relative hydrodynamic
pressure applied to eachof the three input streamsdetermined thepartitioningof the streams inside
the system. For routine observation of the cells, culture media was delivered through the central
channel of the device; the solutions of ligands (e.g., anti-mouse IgM) were kept at rates of Ěow
such that they remained in the two outer channels, separate from the central channel. A “pulse” of
ligand to the cells was applied by adjusting the pressures at the three inlets so that one or the other
stream of ligands replaced the stream of media in the central channel (Figure ǌ.Ǌ).
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Figure ǌ.ǉ: “Pulse-chase” labeling of B cells bymicroĚuidics. Opticalmicrographs of the Ěuid Ěows
through an example of the microĚuidic device. Here, the independent Ěows, moving from leě to
right, containPBS and two coloreddyes for clarity and visualization of the design used. Varying the
hydrodynamic pressure applied at the inlets enabled three possible states of the system as shown.
A pulse of ligand was achieved by switching between two of the states for a deėned duration. ĉe
black box indicates the location where immobilized cells were observed.
ĉe simple design of this microĚuidic system allowed control over the duration of the pulses,
the amount of ligand to which the cells are exposed, and the time between two sequential pulses
without the need of actuated valves. We characterized the shape of the actual pulses empirically
to determine the optimal parameters for applying subsaturating dosages of cross-linking ligands to
immobilized cells. To measure how the shape and duration of the pulse varied from the applied
pulse (square pulse), wemeasured the Ěuorescent intensity of transferrin (Tfn, labeled with either
Alexa–Ǎǎǐ or Alexa–ǎǌǏ) over the duration of an applied pulse (Figure ǌ.ǋ). ĉe shape of the ap-
plied pulse was somewhat diﬀerent than that for an ideal applied pulse. ĉis observation indicated
that the total amount of ligand delivered through the central channel was, therefore, less than the
theoretical amount of ligand that could be delivered. ĉe observed diﬀerence was most likely due
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Figure ǌ.Ǌ: Schematic illustration of the experimental design inside amicrochannel. B cells immo-
bilizedon theboĨomof amicrochannel experience two temporally-separate pulses of cross-linking
ligands (green and red).
to the delayedmechanical response of the pumps used, and ėnite time required to stabilize the Ěow
in thedevice. For extremely lowconcentrations of the Ěuorescent ligand, the non-linearity intrinsic
in Ěuorescence measurements may also contribute to the delayed response time observed.
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Figure ǌ.ǋ: Characterization of single pulses and sequential pulses. Graphs of the expected and
measured shapes of a pulse in a microchannel when a square pulse of ǋǈ s is imposed. ĉe quasi-
periodic Ěuctuations observed reĚect the mechanical noise of the syringe pump.
ĉe width of a measured pulse was most similar to that of an applied pulse when its duration
was less than ǉǈ s (¹). ĉe eﬀective concentration of the ligand at the surface of the cell, however,
only approached that of the bulk solution for pulses lasting more than Ǌǈ s (Figure ǌ.Ǎ). For this
reason, we chose to use pulses of ǋǈ s in duration for the experiments described below to ensure
consistent and reproducible application of ligand. It was possible to apply these pulses sequentially
ǉ s apart without signiėcant overlap (Figure ǌ.ǎ).
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Figure ǌ.ǌ: A graphof the theoretical andmeasuredwidths of single pulses as a function of duration
of the imposed pulse.
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Figure ǌ.Ǎ: A graph of the normalized eﬀective concentration of ligand at the surface of the channel
as a function of the duration of the applied pulse. ĉe grey shading indicates the optimal range of
times required for the concentration of applied ligand to approximate that of the bulk reservoir.
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Figure ǌ.ǎ: Aplot of consecutive pulses of twodiﬀerent ligands (Tfn-Alexa Ǎǎǐ andTfn-AlexaǎǌǏ).
ĉe imposed pulses were ǋǈ s in length, separated by ǉ s.
Limited stimulation of B cells with cross-linking ligand induces microcluster-
ing of BCRs
To examine the dynamics of BCRs on splenic B cells exposed to subsaturating quantities of a cross-
linking ligand, we deposited naïve B cells puriėed from a transgenic mouse expressing class II
MHC-eGFP into a microchannel coated with poly-L-lysine, and applied a ǋǈ s pulse of anti-IgM-
Alexa Ǎǎǐ (ǉǈ μg/mL) to the cells. We estimated that approximately ǉ–ǉǈƻ of the surface-bound
receptors were labeled by a single pulse, by assuming a highly transient reversible receptor-ligand
reaction at the channel surface (see section ǌ.ǌ). Rather than employing classic equilibrium solu-
tions, we estimatedmaximum receptor occupancy by evaluating the transient solution at the point
in which it reaches its maximum value (here at the end of the pulse; see supplementary materi-
als). Such low receptor occupancy suggests a regime in which unoccupied receptors are largely
abundant with respect to occupied labeled receptors, thus implying that any subsequent pulse will
preferentially ligate to unlabelled receptors and thus label distinct surface populations.
ĉe population and history of cells puriėed from the mouse are heterogeneous by nature. We,
therefore, limited our observations to cells in which the class II MHC-eGFP signal was primarily
located at the plasma membraneãa phenotype consistent with naïve B cells. To maximize the
time for observing the signal from the limited quantity of bound ligand, we imaged the cells at
three roughly equatorial sections by confocal microscopy at intervals of Ǌǈ–ǋǈs. Images of entire
cells takenby confocalmicroscopy indicated that therewas noparticular spatial bias to the distribu-
tion of receptors on the surface, and that imaging an equatorial plane was suﬃcient for measuring
the characteristic time required for reorganization of BCRs into aggregated patches on the plasma
membrane (data not shown).
ĉe population of labeled BCRs was uniformly distributed at the membrane immediately fol-
lowing an applied pulse of anti-IgMãthat is, the measured Ěuorescent intensity observed on the
surface of the cell was highly uniform (Figure ǌ.Ǐ). With time, the labeled receptors formed mi-
croclusters on the surface that were both larger andmore intense than those observed immediately
aěer the pulse. ĉese patches likely represent growing aggregates of BCR-containing lipid raěs
(also called “microclusters”) because the postulated size of individual raěs (ǉǈ–ǉǈǈ nm) is smaller
than the optical resolution aﬀorded by our microscope (ǉǊǈ–ǉǍǈ nm). Punctate structures con-
taining ligand also appeared inside the cell Ǌ–ǌ min aěer the applied pulse. ĉis result is similar
to the average timeframe for internalization of labeled BCRs determined by Ěow cytometry and
other microscopy experiments. [ǉǌǊ] [ǉǌǏ] [ǉǌǐ]
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Figure ǌ.Ǐ: Dynamic rearrangement and internalization of labeled BCRs. Series of Ěuorescence
micrographs of a naïve B cell before, during, and aěer exposure to a pulse of αIgM-Alexa Ǎǎǐ (ǉǈ
μg/mL) for ǋǈ s. ĉe time elapsed aěer the pulse is indicated. Note the punctate structures inside
the plasma membrane at ǉǊǈ s. ĉe scale bar is Ǎ μm.
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Figure ǌ.ǐ: Outline of method for conversion of Ěuorescent intensity around the cell membrane
from a single confocal micrograph to a linear density plot. ĉe scale bar is Ǎ μm.
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Figure ǌ.Ǒ: Kymograph depicting the behavior of labeled BCRs as a function of time and position
on the cell membrane. ĉe green bar indicates the time and duration of the applied pulse of αIgM-
Alexa Ǎǎǐ. Scale bar is ǈ.ǌ radians.
To further analyze the dynamic redistribution of receptors, we mapped the surface distribu-
tion of the Ěuorescent intensity observed for a cell as a function of time (Figure ǌ.Ǒ). Assuming
circular symmetry in the two-dimensional optical slices, we ploĨed the measured Ěuorescence in-
tensity in intervals of ǈ.ǈǌ radians (for a typical B cell, arcs of ǉǍǈ nm in length) around the
circumference of the cell within a ring of ėnite thickness [ǉǍǉ]. ĉe thickness of the ring was set
to exclude punctate structures clearly separated from the plasma membrane. Visualizing the data
for individual cells as a function of time showed that the number, sizes, and spatial distribution of
the microclusters of BCR changed dynamically following a pulse of anti-IgM. Although some of
the variationsmay have resulted frompatchesmoving in and out of the selected confocal plane and
internalization of some of the ligated BCRs occurred within a few minutes, the data suggest that,
on the whole, aggregated domains containing cross-linked BCRs remain present and mobile on
the surface for longer than ǉǈ min.
When pulses of ligand were applied to cells, surface-disposed BCRs organized into intensely
Ěuorescent structures of various sizes at the plasma membrane over time, but we rarely observed
stable polarized, cap-like structures of BCR, even aěer ǋǈ min of observation. Continuous expo-
sure to ligand for Ǌǈ min or more in the microchannels was required to induce cap-like structures
that did not change dynamically inǎǈƻ of cells observed (data not shown). ĉese data conėrm
that the size of aggregated patches of BCR, and the resulting polarization of the cell, depends to
a large extent on the total number of cross-linked receptors, and suggest that considerable cross-
linking of surface-disposed BCRs is required to induce cap-like structures.
Rate for reorganization of BCR increases with additional ligation
ĉe ability to label a temporally distinct population of BCRs with a second pulse anti-IgM made
it possible to probe how unperturbed BCRs redistributed on the surface of the cell following the
initial ligation. We applied two sequential pulses of diﬀerentially labeled cross-linking ligands sep-
arated in time by ǋǈǈ s to naïve B cells expressingMHCclass II-eGFP (Figure ǌ.ǉǈ). ĉis temporal
separation between pulses was suﬃcient to allow the BCRs cross-linked by the ėrst pulse to cluster
on the surface, and to internalize partially. ĉe populations of BCRs that were observed imme-
diately aěer the second pulse typically were spatially distinct from the aggregated populations of
BCRs labeled in the ėrst pulse (Figure ǌ.ǉǉ). Correlating the distribution of both populations of
BCRs as a function of time aěer the second pulse (ǉǐ cells) indicated that less than half of the two
populations of ligated BCRs overlapped immediately aěer the pulse (ǌǍƻ colocalization) (Fig-
ure ǌ.ǉǊ). ĉe degree of colocalization increased steadily over time; complete colocalization of the
two populations requiredmore than Ǎmin. ĉese observations suggest that, although somedegree
of co-staining of BCRs may have occurred with the second pulse, a distinct population of BCRs
remained separate from the gross clusters of BCRs formed aěer the ėrst pulse.
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Figure ǌ.ǉǈ: Colocalization of temporally-distinct populations of BCRs. Fluorescence micro-
graphs of a B cell labeled with αIgM-Alexa Ǎǎǐ (green, pulse = ǋǈ s) and then aěer an interval
of ǋǈǈ s, with αIgM-Alexa ǎǌǏ (red, pulse = ǋǈ s).
ĉe average size of lipid raěs (ǉǈ–ǉǈǈ nm)makes it diﬃcult to resolve the timing for transloca-
tion of cross-linked BCR into raěs by conventional optical microscopy. We chose instead to deėne
a characteristic time (t) representing the ėrst appearance of stabilized patches of BCRs on the sur-
face of the cell larger than ǌǍǈ nm in size. ĉe median values of t varied as a function of the pulse
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Figure ǌ.ǉǉ: Kymographs for the cell shown in (a) for both αIgM-Alexa Ǎǎǐ and αIgM-Alexa ǎǌǏ.
ĉe green and pink boxes indicate the position and duration of the applied pulses.
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Figure ǌ.ǉǊ: Plot of the colocalization of the two populations of labeled BCRs as a function of the
time following the second pulse (ǉǐ cells).
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Figure ǌ.ǉǋ: Histograms showing the characteristic time (t) at which intense aggregates of BCRs
were observed on the surface of the cell following each applied pulse (ǉǐ cells).
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Figure ǌ.ǉǌ: Histogram of the diﬀerence between the characteristic times for the two populations
of labeled BCRs for a given single cell (ǉǐ cells).
applied. Aěer the ėrst pulse, labeled BCRs aggregated into microclusters larger than ǋǈǈ nm in
size over a median time of ǏǍ.ǋ s (log-normal ėt, geometric std. dev. ±Ǌ.ǋ s, ǉǐ cells) (Fig. ǌd).
In contrast, the median time for aggregation of BCRs labeled by the second pulse was consistently
faster with less variation (median: ǋǍ.ǋ s, geometric std. dev. ±ǉ.Ǌ s, ǉǐ cells). For a given individ-
ual cell, the diﬀerence between themeasured times for aggregation aěer the ėrst and second pulses
showed that the second population of labeled BCRs consistently organized into clusters as fast or
faster than the ėrst population (ǉǐ cells, ²).
Class IIMHC reorganizes rapidly and independently fromBCR
Upon ligation of BCRs, class II MHC molecules at the plasma membrane of naïve B cells also
rearrange and internalize into intracellular compartments, which ultimately intersect endocytic
compartments containing internalized, ligated BCRs [ǉǋǐ] [ǉǌǊ]. ĉis process is essential for
presentation of the acquired antigen to T cells. To examine the relationship between these two
surface-disposed glycoproteins immediately aěer ligation, we followed the distribution of class II
MHC-eGFP on the surface of naïve cells aěer exposure to a pulse of cross-linking anti-IgM (Fig-
²uch-ėgǌe
ure ǌ.ǉǍ). Following ligation, the labeled BCRs and class II MHC appeared to organize on the
surface independent of one another: the clusters that formed for one exhibited a low degree of
colocalization with the other over time (Figure ǌ.ǉǎ). Colocalization of these two populations
appeared to increase gradually over time (Ǌǈ–ǌǍƻ), but never approached that observed for the
two distinct populations of labeled BCRs. ĉis observation suggests that the two receptors are
not closely associated in the plasma membrane of a naïve B cell, and that following ligation and
activation, the receptors partition largely into distinct microclusters for internalization.
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Figure ǌ.ǉǍ: Colocalization of class II MHCwith labeled BCRs. Fluorescence micrographs of a B
cell labeled with αIgM-Alexa Ǎǎǐ (green) and expressing class II MHC-eGFP (yellow). ĉe pulse
of αIgM-Alexa Ǎǎǐ was applied for ǋǈ s at the time indicated.
Following a pulse of anti-IgM, surface-disposedMHCclass II reorganized into distinguishable
aggregates in a characteristic time (tMHC) that was shorter, and less variable, than that observed
for the ligated BCRs (Figure ǌ.ǉǏ). ĉemedian time was ǋǎ.Ǐs (lognormal ėt, geometric std. dev:
ǉ.Ǌ, ǉǐ cells). Examination of the diﬀerence between tBCR and tMHC on the same cell further
indicated that the time for aggregation of BCRs was consistently slower than that for MHC class
II (Figure ǌ.ǉǐ, ǉǐ cells). ĉese observations suggest that cross-linking ligation of the BCR (and
not subsequent BCR microcluster formation) is suﬃcient to trigger signaling events that lead to
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Figure ǌ.ǉǎ: Plot of the colocalization of the population of labeled BCRs with the class II MHC-
eGFP as a function of the time following the pulse. ĉe average value was calculated from ǉǐ cells.
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Figure ǌ.ǉǏ: Histograms showing the characteristic time (t) at which intense aggregates of BCRs
or class II MHC-eGFP were observed on the surface of the cell following the applied pulse (ǉǐ
cells).
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Figure ǌ.ǉǐ: Histogram of the diﬀerence between the characteristic times for the populations of
labeled BCRs and class II MHC-eGFP for a given single cell (ǉǐ cells).
the reorganization, and eventually internalization, of both class II MHC and BCRs.
Dynamic rearrangement of BCR andMHCII requires cholesterol
Studies of the BCR by both biochemistry and optical microscopy have indicated that cross-linked
BCRs translocate into lipid raěs,whichare liquid-orderedmicrodomains rich in cholesterol [ǉǋǐ] [ǉǌǊ] [ǉǍǊ].
To test whether depletion of cholesterol from the plasma membrane aﬀected the mobility and
dynamic rearrangement of BCRs on the surface of naïve B cells, we ėrst exposed cells immobi-
lized in themicrochannels tomethyl-b-cyclodextrin (MBCD)ãacyclic oligosaccharide that binds
cholesterol to deplete it from the plasma membrane and disrupt lipid raěs, and then applied two
pulses of cross-linking anti-IgM separated in time by Ǎ min. Treatment of cells with MBCD im-
mediately disrupted the distribution of MHC class II-eGFP in the plasma membrane, and large
clusters were present on the surface of the cells when ėrst observed. ĉe populations of BCRs,
labeled by the pulses of anti-IgM, were highly colocalized (Ǐǈƻ, Ǎ cells) with the MHC class II
(Figure ǌ.ǉǑ and Figure ǌ.Ǌǈ).
ĉe population of BCRs labeled by a second pulse also highly colocalized with the ėrst popu-
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Figure ǌ.ǉǑ: MBCD treatment of naïve B cells. Kymographs for a representative cell for MHCII-
eGFP, αIgM-Alexa Ǎǎǐ and αIgM-Alexa ǎǌǏ. ĉe cells were treated for Ǎ min. prior to imaging
with ǉǈ mMMBCD at ǋǏ°C. ĉe green and pink boxes indicate the position and duration of the
applied pulses.
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Figure ǌ.Ǌǈ: Plot of the colocalization of the two populations of labeled BCRs (αIgM-Alexa Ǎǎǐ
and αIgM-Alexa ǎǌǏ) as a function of the time following the second pulse. ĉe average value was
calculated from Ǐ cells.
lation. All together, the populations of BCRs andMHCII showed liĨle or no dynamic variation in
timewith liĨle or no change in thedegree of colocalization. ĉesedata starkly contrast the distribu-
tion and mobility of both BCRs andMHC class II observed on untreated naïve cells, and indicate
that, as expected, depletion of cholesterol substantially alters the Ěuidity of the plasma membrane
as well as the distribution of both BCR andMHC class II.
ǌ.ǋ Discussion
ĉemicroĚuidic system engineered for these experiments made it possible to examine for the ėrst
time thebehavior of theBCRsonprimarynaïveB cells aěer sequential stimulationwith subsaturat-
ing quantities of cross-linking ligands or non-speciėc drug treatments. ĉese experiments provide
insight to the early dynamics of the reorganization of both BCRs and MHC class II at the plasma
membrane upon limited exposure to cross-linking ligands, and also, on the role of BCR signaling
inMHC class II-mediated antigen presentation.
ĉeobserved timingof the aggregationofBCRs is consistentwith reports onother early events
in activation of the signaling cascade. Phosphorylation of Igα and Igβ, a heterodimer compo-
nent of the BCR complex [ǉǍǋ], by the Src-family kinase Lyn in cholesterol-dependent, detergent-
insoluble membrane domains is thought to stabilize the partitioning of the BCR into those mi-
crodomains [ǉǋǐ]. In B cell lines, quantitative FRET imaging has shown that Igα and Lyn closely
associate Ǌǈ–ǋǈ s aěer exposure to a cross-linking ligand [ǉǌǐ]. Recruitment of a second kinase,
Syk, to the phosphorylated Igα and Igβ happens, on average, ǌǈ s aěer ligation of the BCR [ǉǍǈ].
For naïve B cells exposed to a pulse of ligand, the average time for ligated BCRs to aggregate into
intensely Ěuorescent clusters on the plasma membrane of a cell was ǉǉǍ s.
Our results suggest that B cells exposed to activating ligand are poised for a more rapid or
sustained response upon additional engagement of unligated BCRs than exhibited in the ėrst en-
counter. ĉe initiation of signaling cascades mediated by the phosphorylation of Igα and Igβ is
thought to promote the assembly of raěs containing ligated BCRs into clusters, which also asso-
ciate with the cytoskeleton. ĉe wide distribution of times observed for the gross aggregation of
BCRs on individual cells aěer an initial exposure to ligand (ǋǈ s – ǋǐǈ s) indicates that the process
of clustering is a stochastic one, and that the formation of stable aggregates depends on the grad-
ual accumulation of requisite kinases, adaptor proteins, and cytoskeletal elements at the plasma
membrane.
In contrast, the narrow distribution of times observed for the rearrangement of ligated BCRs
aěer a second pulse (ǋǈ–ǎǈ s) suggest two possible mechanisms: ǉ) the components involved in
the activation of the signaling cascade may remain at the plasma membrane to allow rapid forma-
tion of new signaling complexes upon additional cross-linking of unligated BCRs, or Ǌ) the rate
for lateral diﬀusion of BCRs in the membrane may increase as ligated BCRs are sequestered into
cholesterol-richmicrodomains. ĉe ėrst suggests a rheostat-like mechanism that would permit in-
cremental increases in signaling that are proportional to the amount of antigen accumulated by a B
cell.
Although the scarcity of cytoplasmic space in naïve B cells made it diﬃcult to score internal-
ization of BCR quantitatively, it is worth noting that visual inspection of the data for several cells
suggested that the rate of internalization of the population of BCRs labeled by a second pulse of
cross-linking ligand was slower than that for the ėrst labeled population. ĉis qualitative obser-
vation, in conjunction with the observation by others that phosphorylation of the ligated BCR
hinders its internalization [ǉǌǏ] [ǉǌǐ], further supports the hypothesis that the auxiliary compo-
nents necessary for stabilizing cross-linked complexes are retained near the surface following their
initial recruitment.
ĉe relationship between the signaling cascade activated upon ligation of the BCR and the
internalizationof aggregatedBCRcomplexes for subsequent antigenpresentation via class IIMHC
has been poorly deėned. Biochemical and optical analysis of these two processes have suggested
that they are predominantly independent events [ǉǌǏ] [ǉǌǐ]. B cells expressing class II MHC-
eGFP and exposed to a single pulse of cross-linking ligand showed that class II-eGFP reorganized
rapidly at the surface aěer ligationof theBCR, and that thedistributionof times for this processwas
narrow. ĉe fast response suggests that ligatedBCRsdonot need to form large, stablemicroclusters
on the surface of the cell to induce the internalization of class II MHC.
In conclusion, the experiments presented here demonstrate the utility of simple microĚuidic
devices for manipulating the microenvironment around living primary B cells in real time in order
to explore the dynamics of their surface-bound receptors. ĉe ability to resolve diﬀerent popula-
tions of identical receptors on the surface by this method has made it possible to distinguish the
initial events following ligation of a limited number of BCRs from the events that follow upon ad-
ditional accumulation of cross-linking ligands. Further exploration of the early dynamics of the
activation of B cells with this technology should improve the understanding of the ordering and
timing of the initial signaling events, and the relationship between signaling and internalization of
BCRs.
ǌ.ǌ Methods
Soě lithography
Soě lithography comprises a set of techniques for microfabrication based on the use of biocom-
patible elastomeric materials [ǉǍǌ]. PaĨerns of interest are printed and molded in bas-relief us-
ing elastomeric stamps. ĉis approach oﬀers the ability to control the structure of surfaces and to
paĨern them with proteins and other moieties, to fabricate channel structures appropriate for mi-
croĚuidics, and to paĨern and manipulate cells in three-dimension. For the relatively large feature
sizes used in biology (> 50m), production of prototype paĨerns and structures is convenient,
inexpensive, and rapid.
Generally, microĚuidic systems are fabricated using an elastomeric material, poly (dimethyl-
siloxane) or PDMS, starting from a paĨerned silicon wafer employed as a mold. Features of the
chip (eg. a network of microĚuidic channels) are modeled with computer aided design (CAD).
ĉis design is converted into a transparency by a high-resolution printer which, in turn, is used
as a photolitographic mask to create a master in positive relief. PDMS cast against the resulting
mold yields a polymeric replica containing all the designed features in bas-relief. ĉe chips are
then oxidized in an oxygen plasma, in order to allow the surface of the chip to seal tightly and ir-
reversibly when brought into conformal contact. For instance, oxidized PDMS seals irreversibly
to other materials used in microĚuidic systems, such as glass or silicon. Oxidation of the PDMS
has the additional advantage that it yields channels whose walls are negatively charged when in
contact with neutral and basic aqueous solutions, thereby rendering the chip hydrophilic and thus
biocompatible, ideally suited for a range of biomedical applications [ǉǍǍ].
Fabrication ofmicrochannels
ĉe microchannels were fabricated in poly(dimethylsiloxane) (PDMS, Sylgard ǉǐǌ, Dow Corn-
ing)usingphotolithographyand replicamolding. One layerof photoresist (SU–ǐ–ǉǈǈ,Microchem,
Newton, MA) was paĨerned on a ǋ” silicon wafer using a transparency photomask (CAD/Art
Services, Bandon, OR) to produce a master with a positive relief paĨern of the microchannels.
To facilitate removal of PDMS in subsequent steps, the masters were silanized by treatment with
(tridecaĚuoro–ǉ,ǉ,Ǌ,Ǌ-tetrahydrooctyl)–ǉ-trichlorosilane (UCT, Bristol, PA) in a vacuum desic-
cator for ǉ h. PDMS was cast onto the master, cured for Ǌ h at ǎǈ°C, and peeled away. Inlets and
outlets were punched into the device using a homemade bore (ǉǎG) or a cork borer (Ǎ mm). ĉe
microchannels were then treated with an oxygen plasma (PDC–ǋǊG, Harrick, Ithaca, NY) for ǋǈ
seconds and sealed to a coverglass (Ǌǌ mm x Ǎǈ mm, Corning, Corning,NY); this process also
sterilizes the device. ĉe sealed device was ėlled immediately by capillarity with sterile phosphate
buﬀered saline (PBS, Gibco, Grand Island, NY).
Reagents, Cell Culture, andMice
Naïve splenic B cells from BǎMHCClass II-GFP+/+mice orMDǌMHCClass II-GFP+/+mice
werepuriėedbydepleting the splenocytesofCDǌǋ-orCDǉǉc-positive cells using antibody-conjugated
microbeads (Miltenyi Biotec). Alexa Ǎǎǐ-Tfn and Alexa ǎǌǏ-Tfn (Invitrogen) were used for char-
acterization of the pulses administered in the device. Alexa ǎǌǏ-anti-IgM and Alexa Ǎǎǐ-anti-IgM
(Invitrogen) were employed in pulse-chase experiments with B lymphocytes. Mice employed in
these experiments received human care in accordance with the guidelines speciėed by the Depart-
ment of Comparative Medicine at MIT under protocol ƺǉǈǈǍ–ǈǏǈ–ǈǐ.
Confocal ĚuorescenceMicroscopy
Live cell imagingwasperformedonacustomized invertedmicroscope(NikonTEǊǈǈǈE)equipped
with a spinning disk confocal head (CSU–ǉǈ, McBain Instruments) and a ǉǈǈx TIRF objective. A
switchable laser source (Coherent, SantaClara, CA)was used to excite the Ěuorophores at Ǎǎǐ and
ǎǌǏ nm excitation wavelengths. Images were acquired with a CCD camera (Hamamatsu, ORCA
AG) using Metamorph soěware (Molecular Devices, Downingtown, PA) for automation of the
stage position, z position and time of acquisition. Temperature was maintained at ǋǏ°C within a
plexiglass chamber surrounding the microscope.
Quantitative analysis of pulses inmicrochannels
To characterize the concentration proėle at the surface of the microchannels during the applica-
tion of a pulse of soluble ligand, ėnite element (FEM) simulation results were compared to actual
values of Ěuorescence intensity sampled at an optical plane close to the glass surface. Solution of
the partial diﬀerential equations (PDEs) by FEM in the ǊD and full ǋD geometry were obtained in
MATLAB (ĉe MathWorks, Natick, MA) and custom code. Models were ėrst created in COM-
SOL (Comsol, Burlington, MA). Simulations were performed using the MATLAB PDE toolbox.
Fluorescence was measured by confocal microscopy in a plane close to the glass surface. Meta-
morph soěware was employed to extract the average at every time point. ĉe eﬀect of shear stress
on B lymphocytes was quantiėed employing standard approximation and FEM simulations, over
the range of Ěows (ǉ–ǌ μL/min) and geometries employed. Applied shear stress peaked at the
time of switching between pulses, reaching values in the order of ǉ.ǉ dyneǊ/cmǊ. ĉese are values
comparable or belowmeasured physiological shear stresses (in the order of ǉ–ǉǈdyne2/cm2) and
below values found to inĚuence activation in vitro [ǉǍǎ] [ǉǍǏ].
Pulse-Chase Experiments
MicroĚuidic devices were coated with poly-l-lysine for ǉ h at room temperature and then rinsed in
PBS.Naïve B lymphocytes or plasmablasts were transferred into phenol-red freemodiėedDMEM
(ǍƻICS, beta-mercaptoethanol,NEAA,L-Glutamine) and seeded in thedevice for Ǌǈmin at ǋǏ°C.
Electrostatic aĨachment to the glass surface did not aﬀect the three dimensional distribution of
BCR (data not shown). ĉe microĚuidic device was then transferred to the microscope stage,
equilibrated at ǋǏ°C and connected via plastic tubing (PE–ǎǈ, BD Biosciences) to syringes con-
taining solutions of ligands and media. To control the Ěow of media and ligands into the device,
we employed syringe pumps (GeniePlus, Kent Scientiėc), in turn controlled by LABVIEW (Na-
tional instruments, USA) soěware equipped with custom routines. Once the Ěow proėle stabi-
lized, multi-dimensional acquisition was started in Metamorph soěware and synchronized to the
program of pulses controlled by LABVIEW.
Image Processing andAnalysis
Raw Ěuorescent data collected with Metamorph (Molecular Devices, USA) was imported into
MATLAB and organized into time series. A single exponential was ėt to the photobleaching curve
previously determined (data not shown) and used to determine the correct multiplicative factor
to adjust total Ěuorescence at every time point. An annular mask encompassing the entirety of
each cell membrane was created individuating circular structures by a Hough transform-based al-
gorithm. Fluorescent intensity across the annulus was sampled as a function of angle, averaging
over the ėnite thickness of the annulus itself. Kymographs were generated by normalizing the Ěu-
orescence to the maximum value recorded in each experiment and arranging Ěuorescent data as a
function of angle and time. ĉe same time series was employed to determine the ėrst occurrence
of signiėcant levels of clustering, deėned as the ėrst time point where Ěuorescent peaks of width>
ǌǍǈnm (linear circumference) are observable and accompanied by monotonic increases in overall
signal strength (in order to discriminate signiėcant labeling from simple variations in noise levels).
ĉe time was recorded for each cell and in each channel. Lag was calculated by subtracting the
characteristic time in each channel for each cell. Time data was ėĨed by a lognormal distribution
(two parameters, μ and σ), for which geometric mean (exp[μ]) and geometric standard deviation
(exp[σ]) were reported. Colocalization was measured by Pearson’s correlation coeﬃcients, em-
ploying normalized raw Ěuorescent data. Similar analysis was applied to a ǋD reconstruction to
conėrm the lack of apparent bias in the three-dimensional distribution of ligand binding at the
surface. Full z stacks of a lymphocyte subjected to a pulse of ligand concentration were collected
over time. A set of diﬀerentially oriented two-dimensional slices were obtained by reslicing the
reconstructed volume (Volocity, Improvision). ĉere was minimal variance in the distribution of
intensity amongst all slices compared (data not shown).
Equations describing themicrochannel Ěow
ĉeĚow in themicroĚuidic device can be fully described by a systemof coupled partial diﬀerential
equations:
L(x; z; t)
t
+ ~vrL(x; z; t) = DrL(x; z; t)
r  ~v = 0

D~v
Dt
= g  rP + r2~v
where L is concentration of ligand, v is the velocity proėle in the channel, D is the diﬀusive
constant,  is viscosity. ĉe coordinate x-axis is oriented along the length of the channel, the y-axis
is oriented across the width and the z direction describes the height from the boĨom glass surface
(where cells are plated).
Important nondimensional numbers that describe the Ěow include Re and Pe:
Re =
vavgh

Pe =
vavgh
D
For Ěow in microchannels Re is order ǉ or less and Ěow is laminar. We designed our system to
have high Pe number, in the order of ǉǈǍ, the transport process is dominated by convenction with
diﬀusion eﬀects playing a role exclusively in a thin region near the boundary.
We limit analysis to the two dimensional (ǊD) case, solving exclusively the x-z components of
the above PDEs. For two dimensional Ěow, the velocity proėle is given by
~v(z) =
1
2

  p
x

z(z   h)
where h is the height of the channel and p is pressure. Shear stress for Ěow in a ǊD rectangular
cross section channel is then given by
x = 
v
z
jz=0 = 12~v
h
Boundary conditions
We employed the following set of standard boundary conditions
L(x; z; 0) = 0
L(0; 0; t) = L0 (u(t  t0)  u(t  t1))
D
dL
dz
jz=0;h = 0
where u(t) is the step function, Lǈ is the concentration in the segregated stream of ligand and
tǈ, tǉ are the beginning and end time of the pulse respectively. Here we assumed that the pulse has
uniform concentration at the inlet, an assumption that was corroborated by full ǋD simulation of
the concentration proėle.
Following our design, for the range of Peclet number (Pe) employed in our device (ǉǈˆǍ),
the solutiondoes not depend signiėcantly on the axial position in the channel or the imposed initial
concentration.
Reaction at the cell-populated surface
ĉe boundary conditions at the boĨom of the channel merits further discussion. We decided to
solve numerically the given set of PDE maintaining zero Ěux at the surface, although in reality a
reaction is occurring at this surface, due to the presence of cells. ĉe boundary condition is given
by
D
dL
dz
jz=0;h = kfRTL(x; z; t)
from which we can observe how reactions of diﬀerent magnitudes at the surface, with diﬀer-
ent reaction rates k, will aﬀect the concentration distribution of the ligand in the channel quite
dramatically.
In fact, for fast enough reaction rates, the eﬀective concentration at the surface approaches zero.
ĉe extent of this eﬀect can be gauged by calculating the Dahmkohler number for the system of
interest, which gives the relative contribution of themass transfer process to the surface, compared
to the reaction occurring at the surface
Da =
diffusion
reaction
=
h2kf
DRT
Yet, as long as the eﬀective ligand concentration remains at levels below receptor saturation, our
solution remains a good estimate of the eﬀective ligand concentration. ĉat is, to a ėrst approxi-
mation, the value in which we are interested - themagnitude of the overall reaction term - does not
change signiėcantly when calculated directly from the boundary condition or when extracted from
the concentration proėle at the surface in the zero-Ěux case.
Importantly, by employing the zero-Ěux approach, we obtain a concentration proėlewhich we
can apply in the analysis of a variety of diﬀerent kinetic reactions and hence diﬀerent cell systems,
thereby increasing the applicability of the numerical solution.
Cells are exposed to pulses at sub-saturating concentrations of ligand
To beĨer understand the eﬀects of a transient concentration pulse on cell labeling, it is necessary
to quantify the extent of the labeling reaction occurring on the cell surface. In particular, it’s nec-
essary to determine the operating regimes for which the labeling concentration does not saturate
cell surface receptors.
ĉe absorbed concentration depends on the concentration of the ligand, the binding constant,
and the type of reaction. A reasonable estimate of the receptor occupancy can be obtained assum-
ing a reversible reaction at the channel surface, where ligand binds receptors to form complexes at
the cell surface.
In our system the reaction normally under consideration is between the bivalent ligand anti-
IgM and BCR receptors on the surface of B lymphocytes. However, rather than solving the highly
nonlinear problem of bivalent ligand, we employed amuch simplermonovalent ligand description
to obtain a ėrst indication about the operating regime of the device. In the case under considera-
tion the approximation is a particularly good one, due to the high binding constant of these two lig-
ands; we can safely exclude serial engagement and assume in our analysis that ligand is sequestered
rapidly from the freely diﬀusing fraction upon crosslinking and internalization.
ĉe binding process in the presence of ligand is highly transient (ǉǈ–Ǌǈ seconds) and classic
equilibrium solutions donot apply (for the given ligands equilibrium is only reached for time scales
in the order ofminutes). We canobtain an estimate ofmaximumreceptor occupancy, by evaluating
the transient solution at the point in which it reaches its maximum value, which correspond in this
case to the end of the pulse. For a simple monovalent reversible reaction R + LC , with initial
receptor occupancy equal to zero, the equation is given by:
C(t)
RT
=
L0/KD
1 + L0/KD

1  exp

 

1 +
L0
KD

krt

where L0 is the ligand concentration associated with the pulse (which we assume constant),
KD is the dissociation constant,RT is the total number of receptors and kr is the reverse binding
constant.
We decided to treat the concentration of ligand as constant for the time course of the pulse,
given the rapid transient, the relatively uniform concentration proėle over the length of the pulse
and the negligible depletion eﬀects. We also assume ligand depletion eﬀects are negligible given
the small number of total receptors, when compared to the number of ligand molecules in a pulse.

n
Nav
[Complex]

 [L0]
where n is the cell density and L0 is the imposed ligand concentration. We also select to ig-
nore diﬀusional eﬀects at the receptor surface, in order to obtain a more conservative estimate.
Maximum receptor occupancy is therefore given by:
Roccupancy =
C(t = t)
RT
where Δt is the eﬀective duration of the imposed pulse.
It is important to notice how for the time scales of interest (below ǉ min), few combination
of parameters will give a receptor occupancy larger than Ǎǈƻ. For the antiIgM –BCR interaction,
where the polyclonal antibody is a nanomolar binder, we have kf = 104Ms , kr = 10
 51
/
s,KD =
10 9 M and RT = 105. For the range of concentrations we employed, L0 = ǎǈ–ǉǊǈ nM, the
maximum receptor occupancy is in the range ǉ–ǉǉƻ, well below the saturation regime.
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Abstract
Determining the eﬃcacy of a vaccine generally relies on measuring neutralizing antibodies in
sera. ĉis measure cannot elucidate themechanisms responsible for the development of immuno-
logical memory at the cellular level. Quantitative proėles that detail the cellular origin, extent and
diversity of the humoral (antibody-based) immune responsewould improve the assessment of vac-
cines, and thus the development of new vaccines. Here we describe a novel approach to collect
multiparametric datasets that describe the speciėcity, isotype, and apparent aﬃnity of the anti-
bodies secreted from large numbers of individual primary B cells ( 103   104). ĉe antibody/
antigen binding curves obtained by this approach can be used to classify closely related popula-
tions of cells using algorithms for data clustering, and the relationships among populations can be
visualized graphically using aﬃnity heatmaps (AﬃMaps). ĉe technique described was employed
to evaluate the diversity and cellular origins of the antibodies generated during an in vivo humoral
response to a series of immunizations designed to mimic a multipart vaccination. Proėles cor-
relating primary antibody-producing cells with the characteristics and diversity of their secreted
antibodies should facilitate both the evaluation of candidate vaccines, and broadly, studies on the
repertoire of antibodies generated in response to infectious or autoimmune diseases.
Ǎ.ǉ Introduction
Antibodies generated by a natural immune response or by a vaccine are important for limiting the
ability of a pathogen to infect the host [ǉǍǐ] [ǉǍǑ]. In many instances, the concentration of those
antibodies circulating in the blood provides a surrogate measure for the eﬃcacy of a vaccine. In
vitro immunoassays, such as the enzyme-linked immunosorbant assay (ELISA) or opsonophago-
cytic assay (OPA), can determine the ability of antibodies from sera to neutralize the appropriate
virus or toxin, to induce anti-microbial activity, or to simply bind a speciėc component in the vac-
cine. ĉese measures provide some insight into the degree of immunity aﬀorded, but obscure the
relative contributions from individual antibodies. Furthermore, analysis of the sera does not reveal
anything about the B cells and plasma cells responsible for producing the antibodies. Such detailed
knowledge of the molecular characteristics and cellular origins of unique antibodies raised during
a humoral response would beneėt the design and evaluation of new vaccines [WackǊǈǈǍ][]. ĉe
aĨributes of an antibody, including its isotype and aﬃnity for an antigen, can distinguish it from
others with similar speciėcities. It is challenging, if not impossible, however, to separate individual
antibodies present in polyclonal sera in suﬃcient quantity to produce a complete assessment of
their molecular characteristics. Instead, a number of techniques have been developed to examine
the antigen-speciėc B cells that produce these antibodies. Methods formeasuring the frequency of
antigen-reactive B cells include the Jerne plaque assay [ǉǎǈ], the splenic focus assay [ǉǎǉ], a vari-
ant of the plaque assay that uses colonies of cells immobilized on discs of ėlter paper [ǉǎǊ] [ǉǎǋ],
the enzyme-linked immunospot (ELISpot) assay [ǉǎǌ], and Ěuorescence-activated cell sorting
(FACS) [ǉǎǍ] [ǉǎǎ]. None of thesemethods, however, can by itself deėne a comprehensive set of
correlated characteristics suitable to describe the diversity of antibody-producing B cells respond-
ing to a vaccine or other immunological challenge.
One important characteristic of an antibody that remains diﬃcult to assess in a rapid and high-
throughput manner is its apparent aﬃnity for a given antigen. Presently, assessing the aﬃnity of a
monoclonal antibody involves the preparation of antibody-secreting cell lines, the production and
puriėcation of suﬃcient quantities of the antibody, and ėnally characterization by ELISA or sur-
face plasmon resonance (SPR).ĉe transformation of primary cells into antibody-secreting clonal
lines requires either immortalization of cells by fusion or viral transduction, or molecular cloning.
Both processes are relatively ineﬃcient at capturing the entire repertoire of clones present from
the primary cells, and as a result, the frequencies measured may vary from the distribution found
ex vivo. ĉese processes also are time-consuming, and thus further impose a practical limit on the
total number of clones evaluated. Here, we report amethod to estimate an apparent aﬃnity/avidity
for the antibodies produced by individual primary cells that does not require immortalization of
the cells. ĉe approach uses a soě lithographic technique, called microengraving, to produce a set
of replicate microarrays of antibodies from a population of cells [ǉǎǏ]. ĉe precision of the bind-
ing curves measured for the antibodies produced by each cell is suﬃcient to organize related cells
into distinct groups using common statistical algorithms for data clustering. We also demonstrate
the ėrst example of datasets that simultaneously describe the antigenic speciėcity, isotype, and ap-
parent aﬃnity of the antibodies produced by individual primary B cells (104) generated in mice
given a series of immunizations designed to mimic a multipart vaccination. Together, these data
constitute a detailed proėle of the individual B cells contributing to the humoral immune response
with a resolution not previously possible.
Ǎ.Ǌ Results
Microengraving is a soě lithographic technique for printing proteinmicroarrayswhere each spot in
the array comprises the proteins secreted by a single cell. ĉemethod uses an array of microscopic
wells to segregate individual cells spatially into subnanoliter volumes. A typical array comprises
ǐǈ,ǈǈǈ microwells arranged over an area ofǊǈ × ǎǈmm2 on a polymeric slab; each well is ǈ.ǉ
nL in volume (Ǎǈ × Ǎǈ × Ǎǈm3). Cells seĨle by gravity from a suspension into the microwells and
weakly adhere to the boĨoms of the wells at a density ofǉ cell per well. ĉe array is then placed
in contact with a glass slide, and the antibodies secreted by each cell are captured on the surface
of the slide which is uniformly coated with a secondary antibody. ĉe arrangement of captured
antibodies on the resulting microarray matches the arrangement of cells in the microwells. ĉis
printing process can be repeated with the same set of cells to produce multiple replicate antibody
microarrays (see Figure Ǎ.ǉ Figure Ǎ.Ǌ for an illustration) [ǉǎǏ].
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(10 nM, Red)Figure Ǎ.ǉ: Experimental method for assessing the aﬃnities of antibodies produced by single cells.
Schematic illustration of the microengraving process for generating multiple replicates of microar-
rays of antibodies from one population of cells. Cells are loaded into the microwells molded into
the PDMS slab, and then used to print onto glass slides functionalizedwith capture antibodies. Af-
ter producingmicroarrays, the microwells containing cells are transferred tomedia for subsequent
enumeration by immunoĚuorescence.
We reasoned that a set of ǎ–Ǐ replicated arrays would be suﬃcient to determine the speciėcity,
isotype, and apparent aﬃnity of the captured antibodies produced by a given cell in a microwell.
One replicate provides data on the isotype of each antibody when interrogated with a collection
of diﬀerentially-labeled secondary antibodies speciėc for an isotype, or a subclass (e.g., goat-anti-
mouse IgM, IgGǉ or IgGǊa). ĉe remaining replicates can be used to assess the apparent aﬃnity
of each antibody captured on the microarrays for a particular antigen. A binding curve for the an-
tibodies produced by each cell can be constructed by ėrst applying a series of concentrations of
antigen (e.g., ǉǈ pM – ǉǈǈ nM) to a set of replicate microarrays, and then measuring the Ěuores-
cent intensities of captured antigen as a function of concentration [ǉǎǐ]. Variations in the rates of
secretion among cells or in the eﬃciency of capture among glass slides can both aﬀect the amount
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Figure Ǎ.Ǌ: Schematic illustration of the labelling scheme for assessing concentrations of captured
monoclonal antibody and antigen at a given element in the microarray. Each replicate print is ex-
posed to antigen at one concentration within a speciėed range (e.g., ǉǈ pM to ǉǈǈ nM) and a ėxed
concentration of a labelled secondary antibody (ǉǈ nM). Spots containing antibody non speciėc
for the antigen appear in one color only.
of antibody captured from each cell on each replicate. To account for the intra- and interarray vari-
ations, we also labeled the arrays with a ėxed concentration of an anti-Ig antibody to assess the
amount of antibody captured at each element. ĉe ratio of the Ěuorescence intensities measured
for bound antigen to that for the amount of antibody captured (anti-Ig) normalizes the antigen
captured at a given concentration and location on the array by the amount of antibody available at
that site. Varying the concentration of antigen applied across replicate microarrays, while holding
the concentration of the secondary antibody constant for each, yielded a series of ratios used to
construct the binding curves for that antibody. An apparent dissociation constant (KDapp) for
an antibody from a given cell can then be calculated by ėĨing these curves.
Single-cell measurements to assess the aﬃnity ofmonoclonal antibodies.
We used a monoclonal line of hybridomas producing antibodies speciėc for chicken ovalbumin to
test the feasibility of the approach described above for estimating the aﬃnities of antibodies cap-
tured from single cells. We deposited hybridomas into an array of microwells, and then produced
ėve replicate microarrays of antibodies from that array of cells. Between each print, the media in
the wells was exchanged by gently rinsing the surface of the microwells. Each microarray of anti-
bodies was then exposed to a diﬀerent concentration of Ěuorescently-labelled ovalbumin (ǉǈ pM
to ǉǈǈ nM) (see Figure Ǎ.ǋ).
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Figure Ǎ.ǋ: Measurements of the aﬃnities of antibodies produced by single cells. Representative
composite Ěuorescent images fromėve antibodymicroarrays producedbymicroengraving labelled
withĚuorescent antigen, andcorresponding regionofwells containing anti-ovalbuminhybridomas
stained with carboxyĚuorescein succinimidyl ester (CFSE). ĉe dashed white boxes indicate the
physical edges of each microwell. Scale bar is Ǎǈ μm.
ĉe data from each cell was ėĨed with a langmuir binding curve to estimate KDapp: ĉe
median value for ǋ,ǌǎǉ individual cells was ǈ.ǏǑ nM and exhibited a very narrow distribution (ǑǍƻ
bootstrap conėdence interval: ǈ.Ǐǐ, ǈ.ǐǈ nM) (²).
Although the precision of the measurement is most critical for distinguishing related cells, we also
evaluated the accuracy of themeasured value relative toELISA andSPR.ĉe apparent dissociation
constant determined by ELISA using the puriėed antibody and plate-bound antigen was ǈ.Ǎ nM
(Figure Ǎ.ǌ insert), and the aﬃnity of the antibody determined by SPR using soluble antigen and
bound antibody was ǈ.ǉǉ nM. ĉese data suggest that the measurements are reproducible for a
given clone and that the estimated aﬃ ity is a close approximation to that determined from bulk
quantities of antibody.
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Figure Ǎ.ǌ: Plot of the fractional occupancies measured for ǋ,ǌǎǉ cells as a function of the concen-
tration of ligand applied to ėve replicate microarrays. (Inset) ĉe median binding curve and the
curve measured by ELISA for the puriėed antibody are shown.
Binding curves are suﬃcient to distinguish closely-related hybridomas
ĉe high degree of precision observed for the individual binding curves measured for the anti-
ovalbumin hybridomas suggested that it should be possible to distinguish similar clones within
a mixed population by comparing the binding curves measured for their antibodies. We repeated
the experiment described aboveusing amixture of three diﬀerentmonoclonal hybridomas produc-
ing antibodies speciėc for mousemajor histocompatibility complex (MHC) class I (anti-H–ǊKb).
Speciėcally, three hybridoma cell lines were each labelled with unique cytosolic dyes, and then a
mixture of these three was deposited onto an array of microwells at a density ofǉ cell per well.
We generated seven replicate microarrays by microengraving using this set of cells, and stained
them with tetrameric complexes of class I MHC; tetrameric antigen was used to improve detec-
tion without obscuring the epitopes recognized by the antibodies, and to increase the strength of
the interaction for the low aﬃnity clone (cǉǊǏ). Aěer the ėnal print, all of the cells were stained
in situ for DNA, imaged by immunoĚuorescence, and subsequentlymatched to the corresponding
antibodies on the microarrays (Figure Ǎ.Ǎ and Figure Ǎ.ǎ).
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Figure Ǎ.Ǎ: Binding curves distinguish similar hybridomas. Representative composite Ěuorescent
images of one microarray and the corresponding cells in microwells (Yǋ, aqua; cǉǊǏ, magenta;
cǉǋǎ, purple). ĉemicroarray was imaged aěer staining with anti-mouse IgG (red) and tetrameric
MHC class I (H–ǊKb). ĉe cells were labelled with three diﬀerent cytosolic dyes before loading
the microwells, and stained for DNA content aěer printing. ĉe dashed white boxes indicate the
boundaries of each microwell. ĉe scale bar is Ǎǈ μm.
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Figure Ǎ.ǎ: A plot showing the fractional occupancy of each element in the region of themicroarray
shown inFigure Ǎ.Ǎ as a functionof the concentrationof tetramericH–ǊKb. ĉecolors of the traces
correspond with the identity of the clone determined by immunoĚuorescence.
ĉeexperiment yielded a collection of binding curvesmatched tomore than ǋ,Ǐǈǈ single cells.
ĉese data allowed us to conėrm that themeasured binding curves were consistent and distinct for
each clone. Apparent avidities were calculated and compared to the anti-ovalbumin hybridoma,
and the precision of these estimates was determined by calculating bootstrap conėdence intervals
(Figure Ǎ.Ǐ and Figure Ǎ.ǐ).
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Figure Ǎ.Ǐ: Apparent dissociation constants measured in all hybridoma clones employed. (a)
Boxplot of apparent dissociation constants obtained by langmuir ėt on the microengraving data.
Notches show the ǑǍƻ conėdence interval.
ĉemagnitude of the intervals varied for each clone, but in each case, were approximately one
to two orders of magnitude less than the calculated value, indicating the high precision of themea-
surements. To validate that the aﬃnities of the three clones were indeed diﬀerent, the aﬃnities
of each antibody for monomeric class I MHC were determined by SPR (data not shown). ĉe
measurements conėrmed that the three clones produce distinct antibodies, but the values did dif-
fer from those estimated by microengraving. ĉis result was expected since the conėguration of
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Figure Ǎ.ǐ: Table of the actual numerical values of the median apparent dissociation constant and
ǑǍƻ conėdence intervals. (c) Accuracy of themicroengravingmethod over a range of dissociation
constants. Conėdence intervals (ǑǍƻ) are ploĨed as a function of measured apparent dissociation
constant.
the assay, the diﬀerences in valency, and capture antibodies could not be matched across the two
techniques. Moreover, our technique – diﬀerently than SPR measurements – is aﬀected by the
contribution of the non-functional fraction of the secreted antibodies. In order to visualize the en-
tire dataset, it was necessary to develop a compact graphical representation corresponding to the
binding curve for each cell (Figure Ǎ.Ǒ and Figure Ǎ.ǉǈ).
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Figure Ǎ.Ǒ: Method for constructing an aﬃnity heatmap (AﬃMap). ĉree examples of measured
binding curves from the anti-H–ǊKb clones are shown: i) antigen-speciėc antibodies that exhibit
saturation of binding (triangle), ii) non-speciėc/low-aﬃnity antibodies (circle), and iii) antigen-
speciėc antibodies that do not exhibit saturation of binding (square). ĉe composite Ěuorescent
images correspond to each data point in themedian-centered curves. ĉe colored bands shown on
the plots indicate the colors used in the corresponding density plots in Figure Ǎ.ǉǈ.0.001 0.01 0.1 1 10 100 1000
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Figure Ǎ.ǉǈ: Construction of anAﬃMap for the three clones in Figure Ǎ.Ǒ. Each row represents the
binding curve measured for the antibody secreted by one cell as a density plot. Antigen-speciėc
antibodies that do not exhibit saturation show only blue coloring. Non-speciėc or low aﬃnity an-
tibodies have no coloring.
We centered each curve such that its median value was positioned at zero. ĉe data were then
converted to a density plot where points above and below themedianwere represented in contrast-
ing colors. In this form, the density plot for an antibody with a high aﬃnity for the target antigen
shows a progression of color (from red to blue) with an inversion at the median (white), while the
density plot for an antibody with a low aﬃnity is almost completely white. ĉis representation is
also convenient because stacking such lines vertically yields a concise picture of the entire dataset.
ĉe resulting image can be examined quickly to identify antibodies withmeasurable aﬃnities (col-
ored lines) and to highlight the relationships between cells with similar apparent aﬃnities for the
target antigen. We refer to these visual representations of the aﬃnity measurements collected for a
population of cells as ‘aﬃnity heatmaps’, or AﬃMaps.
ĉe diﬀerences visually evident from the binding curves measured for the three clones suggested
that statistical algorithms for data clustering should be able to classify the cells into related popula-
tions. We tested the utility of three unsupervised clustering algorithms for sorting cells into groups
of identical clones: k-means clustering, one-dimensional hierarchical clustering, and principal-
components analysis (PCA) (Figure Ǎ.ǉǉ, Figure Ǎ.ǉǊ and Figure Ǎ.ǉǋ).
ĉe data collected by cellular staining provided a reference to assess the accuracy of the as-
signments made by the computational algorithms. For both k-means and hierarchical clustering,
the average sensitivity (ratio of true positives to combined true positives and false positives) was
greater than ǐǏƻ and the average speciėcity (ratio of true negatives to combined true negatives and
false positives) was greater than Ǒǌƻ (see Table Ǎ.ǉ).
Table Ǎ.ǉ: Sensitivity and speciėcity of clustering algorithms to model data
- Clone Measure
Classiėer Yǋ cǉǋǎ cǉǊǏ Avg. sens Avg. spec. Avg. PPV Avg. NPV
Actual(stains) ǉǍǊǏ ǐǍǎ ǉǋǊǐ - - - -
K-means ǉǌǐǊ ǐǋǉ ǉǋǑǐ ǐǏ.ǈƻ Ǒǌ.ǋƻ ǐǏ.ǈƻ Ǒǌ.ǌƻ
Hierarchical ǉǎǉǏ Ǐǌǌ ǉǋǍǈ ǐǐ.ǋƻ ǑǍ.Ǌƻ ǐǑ.ǐƻ ǑǍ.ǎƻ
Multiparametric proėles of humoral immune responses in mice. ĉe ability to distinguish ac-
curately amongst three monoclonal immunoglobulins speciėc for the same antigen suggested that
it should be possible to examine the diversity in a more heterogeneous population of B cells, such
as those involved in a developing humoral immune response. Mice were immunized with chicken
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Figure Ǎ.ǉǉ: AﬃMap of anti-H–ǊKb hybridomas generated by k-means (n=ǋ) clustering (ǋ,Ǐǉǉ
cells). ĉemedian proėles for each cluster are superimposed (black).
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Figure Ǎ.ǉǊ: AﬀMap for three anti-H–ǊKb hybridomas organized by hierarchical clustering (city/
ward linkage). ĉreedominant subclusters are indicatedwith colors corresponding to the cytosolic
labels in Figure Ǎ.ǉǈ
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Figure Ǎ.ǉǋ: Principal-components analysis of aﬃnities measured for three anti-H–ǊKb hybrido-
mas. Single cells are ploĨed as a function of the ėrst two principal components. Colors indicate
the identity of the cells assigned (a) by intracellular staining and (b) by hierarchical clustering.
ĉe vectors show the two-dimensional projection of the original multidimensional basis of the
principal-component space.
ovalbumin and boosted either once or twice (see Figure Ǎ.ǉǌ).
Splenocytes isolated from these mice were stimulated ex vivo with a mitogen (lipopolysaccha-
ride, LPS) for three days to convert B cells into immunoglobulin-secreting cells. We then charac-
terized these cells by a combination of microengraving and immunoĚuorescence. ĉe complete
dataset collected for each cell comprised ǉ) DNA staining to assess the number of cells per well,
Ǌ) surface-expressed markers (IgM and BǊǊǈ) to identify B cells, ǋ) the isotype of the antibody
produced (IgM, IgGǉ, IgGǊa, or IgGǊb) by a given cell, and ǌ) the aﬃnity of that antibody for
ovalbumin (Figure Ǎ.ǉǍ).
ĉedata collected for each cellwere compiled to construct a cellular proėle of thehumoral immune
response observed for each mouse (³).
ĉe graphical representation of the data makes it possible to assess visually the diﬀerences in
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Figure Ǎ.ǉǌ: Proėles of antibody responses generated by immunized mice. (above) Immunization
schedule used for the three mice proėled. (below) Graphical proėles of the populations of single
cells characterized from each mouse. ĉe total area of each circle is proportional to the number
of cells enumerated with the phenotypes indicated. Single cells expressing either BǊǊǈ or IgM on
their surfaces were classiėed as B cells. ĉe innermost blue-green circle represents the subset of
individual secreting B cells for which a complete set of aﬃnity data was obtained. ĉe distribution
of isotypes for this subset is indicated to the leě of the colored circles for each mouse. Red circles
represent the subset of individual antibody-secreting B cells classiėed as antigen-speciėc (with a
dissociation constant, KD<ǉǈǈnM).ĉedistributionof isotypes in eachof these subsets is shown
to the right of the colored circles for eachmouse. ĉequality of themicroengravedmicroarrays can
be estimated by comparing the number of single secreting B cells which yielded a complete set of
aﬃnity data to the total number of single secreting B cells detected (i.e., relative size of the green
circlewith respect to the enclosing isotype+ circle). Here, from leě to right, ǎǐ.Ǎƻ, ǋǑƻ and Ǌǈ.Ǐƻ.
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Figure Ǎ.ǉǍ: A representative set of the raw multivariate data collected by microengraving and im-
munoĚuorescence for primary splenocytes from the immunized mice.
the numbers of antibody-secreting cells and antigen-speciėc cells. For all three mice analyzed, B
cells (BǊǊǈ+ and/or IgM+) comprised themajor fractionof the individual cells isolated inmicrow-
ells. Only Ǌǈ–ǋǈƻ of those cells, however, actively secreted antibodies that were one of the four
isotypes scored. Our analysis of which antibodies exhibited speciėcity and aﬃnity for ovalbumin
relied on this antibody-secreting population of B cells; we did not identify B cells that may have
been speciėc for ovalbumin, but that did not secrete antibodies aěer treatment with LPS. We fur-
ther restricted the analysis to those B cells for which a complete binding curve was availableãthat
is, ones where high quality spots of the secreted antibody were present across all microarrays in-
terrogated with ovalbumin. Either uneven Ěuorescent staining or a low ratio of signal-to-noise for
a given element on one or more replicates excluded some cells from further consideration. ĉese
stringent conditions reduced the total size of eachdataset, but data for aminimumof ǎǌǐ individual
antibody-secreting primary B cells from each mouse remained aěer this ėltering.
Classiėcation of antibodies generated in humoral immune responses.
ĉedata collected for the immunizedmice show, as expected, that primary immunization, followed
by administration of a booster, yielded an increase in the percentage of antigen-speciėc B cells.
To determine speciėcity for ovalbumin, we examined a plot of the binding curves that was rank-
ordered according to their apparent dissociation constants, and then set a threshold at the point
where the measured ratio failed to vary with concentration (Figure Ǎ.ǉǎ).
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Figure Ǎ.ǉǎ: AﬀMaps for the populations of B cells from immunized mice for which data from all
replicate microarrays were available (isotype and aﬃnity). Each binding curve was ėt and ordered
according to the calculated apparent dissociation constant. ĉe threshold for antigen-speciėc cells
was set where the data threshold at the point where the measured ratio failed to vary with concen-
tration.
ĉis procedure excluded any B cells secreting antibodies with values ofKDapp greater than
ǉǈǈ nM. Following a single booster, Ǌ.Ǎƻ of the Ig secreting B cells identiėed in our analysis were
antigen-speciėc (ǈ.ǎƻ of the total population of splenocytes assayed). ĉis percentage increased
to Ǐ.Ǐƻ for a mouse receiving two boosters (ǉ.ǋƻ of the total population of splenocytes assayed).
ĉe proėles for the three mice also show that aﬃnity maturation and class-switching events oc-
curredwith repeated exposure, as expected. ĉe frequency of class-switched antibodies within the
antigen-speciėc population increased with the number of immunizations (from ǋƻ IgGǉ to Ǌǐƻ).
ĉe median dissociation constant for the antigen-speciėc antibodies decreased with the number
of immunizations (Figure Ǎ.ǉǏ).
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Figure Ǎ.ǉǏ: Plot of apparent dissociation constants calculated from individual binding curves for
immunized mice. ĉe box plots show the change in the median value of the measured apparent
dissociation constants with increased immunization.
Analysis of the antigen-speciėc population of B cells by data clustering of the corresponding
AﬃMaps provided further insights to the diversity represented in those cells. To classify the rela-
tionships among the antigen-speciėc B cells identiėed in the immunized mice, we applied unsu-
pervised hierarchical clustering to group cells based on both the isotype and binding curves of the
antibodies they produced (Figure Ǎ.ǉǑ and Figure Ǎ.ǉǐ).
ĉe IgMs scored were largely indistinguishable by their apparent aﬃnities (over the range of
concentrations tested). ĉe estimated values of KDapp for the IgGǉ antibodies produced by
the mouse that received three immunizations ranged from ǉ nM to ǊǍ nM; only seven cells pro-
duced antibodies with dissociation constants below ǉǈ nM. Analysis by clustering organized these
cells into ėve populations based on the shape of their binding curves. ĉe ratio of cells produc-
ing antigen-reactive IgG to those producing IgM is smaller than one might expect based on the
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Figure Ǎ.ǉǐ: AﬃMap of antigen-speciėc cells identiėed in amouse aěer two boosters indicates the
diversity in antibody response. Both the aﬃnities and the isotypes were included in the hierarchi-
cal clustering (Euclidean/average), but separated in the ėgure for graphical clarity. ĉe colored
branches in the dendrograms indicate the cells that are most closely related. ĉe apparent dissoci-
ation constants (nM) calculated from a langmuir curve ėt for each clone are listed to the right of
the data for each cell; these numerical values were not considered in clustering.
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Figure Ǎ.ǉǑ: AﬀMap organized by hierarchical clustering (Euclidean/average) for immunized
mouse receiving one booster. Both the aﬃnities and the isotypes were included in the analysis
by clustering, but set apart graphically for clarity. ĉe colored branches in the dendrograms in-
dicate closely related cells. ĉe apparent dissociation constants (nM) calculated from a langmuir
curve ėt for each clone are listed to the right of the data for each cell; these numerical values were
not considered in the clustering.
typical compositions of antigen-reactive sera from hyperimmunized animals where the principal
component is oěen IgG [ǉǎǑ]. One rationalization for this observation is that the population of
cells taken from the spleen may include those IgM-producing B cells that are involved in a new
primary response to the recurring antigenic stimulus. ĉe short period of in vitro stimulation with
LPS can also cause someB cells to proliferatemore than others; this diﬀerential responsemay alter
the frequency of antigen-speciėc cells that secrete antibodies compared to the frequency of splenic
plasma cells present prior to stimulation ex vivo.
Ǎ.ǋ Discussion
We have developed a method to construct proėles that indicate the quality and diversity of a hu-
moral immune response with single-cell resolution using data collected by both microengraving
and immunoĚuorescence. ĉe breadth of the correlated, quantitative data collected here for indi-
vidual primaryB cells has not beenobtained, to the best of our knowledge, by any other single assay
presently available. ĉe data are equivalent to that acquired by Ěow cytometry (determination of
lineages by surface-expressed markers on cells) and immunosorbant assays (isotype, speciėcity,
and frequency), but with the advantage that these two sets of data are perfectly matched to each
other. ĉedata also include an estimate of the aﬃnity of the antibodyproducedby a singleB cell for
an antigen of interestãa measurement that previously has required puriėed antibodies collected
from expanded clonal populations of cells.
One signiėcant advantage of the technique developed here over ELISpot or ELISA for estimating
the aﬃnity of an antibody is that the relative occupancyof the antibody ismeasuredusing antigen in
solution. ĉis approach minimizes confounding multivalent interactions of antibodies with plate-
bound antigen or the relative capture of antigen on the surface in its native structure. Interactions
from polyreactive, low-aﬃnity antibodies can also induce false-positives. We do not know, how-
ever, the extent to which the format of the assaymay overestimateKDapp for isotypes with diﬀer-
ent numbers of binding sites (e.g., IgG, IgM).ĉis potential source of errormakes themethod best
suited for making relative comparisons among cells with the same isotypes. Furthermore, we have
also found that applying antigens at concentrations at or above ǈ.Ǎ–ǉ μM results in signiėcant
non-speciėc staining that interferes with the quality of the data. ĉis practical limit deėnes an up-
per bound on the values ofKDapp that can be accurately estimated. ĉe strength of the technique
presented here is similar to that of other types of microarrays used for assessing gene expression:
the method yields a diverse set of data with which to make relative comparisons among many in-
dividual events to determine paĨerns of events or unique outliers. For gene expression, measuring
the diﬀerential expression of a gene undermultiple conditions uniquely identiėes genes aﬀected in
similar ways; here the binding curves generated from multiple arrays identify related populations
of cells secreting a particular antibody. ĉe cellular proėles constructed for the mice immunized
with ovalbumin demonstrate howmicroengraving, in combinationwith immunoĚuorescence, can
highlight those B cells actively contributing to a humoral immune response. ĉe frequencies of
antigen-speciėc B cells in the mice receiving immunizations reĚect the subset of those cells that
were actively secreting antibody aěer activation with LPS. Our estimated frequencies are similar
to those determined previously by surface-staining and Ěow cytometry for mice undergoing a pri-
mary response to a hapten (nitrophenol) (ǉ–Ǌƻ of total splenocytes) [ǉǎǎ]. ĉe frequencies of
antigen-speciėc B cells, however, can vary widely with the schedule of immunizations, the anti-
gens, the genotypes of the mice, and the timing of sampling [ǉǎǍ] [ǉǎǎ] [ǉǎǎ]. We were able to
capture antibodies secreted by splenocytes taken directly from a mouse (data not shown), but the
quality of the data (signal-to-noise) was insuﬃcient for robust quantitative analysis. We anticipate
that technical reėnements tomicroengravingwill improve the sensitivity as well as the eﬃciency of
capture, andmakemitogenic stimulation unnecessary. We believe that further development of the
approach described here will enable rapid monitoring of humoral immune responses in humans
to vaccines. Such measures could facilitate the rational design of vaccines by providing insight to
the diversity andmaturation of antibody-producing clones induced by a candidate vaccine among
diﬀerent populations of patients as a function of formulation or adjuvants [ǉǏǈ]. ĉis detailed
knowledge could potentially reduce the cost of vaccine trials by improving the criteria for inclu-
sion in the study, and would complement related genomic and proteomic analyses. In addition to
vaccine development, the approach here also should improve clinical research on the pathogenesis
of both infectious and autoimmune diseases [ǉǏǉ] [ǉǏǊ] [ǉǏǋ] [ǉǏǌ] [ǉǏǍ] [ǉǏǎ] [ǉǏǏ].
Ǎ.ǌ Methods
Cell culture.
Hybridoma cell line ǈǑǑ–ǈǉ, secreting anti-OVAwas obtained fromStatens Serum Institut. ĉeYǋ
cell line, secreting anti-H–ǊKbantibodywas a kind giěofDr. PCresswell. Anti-H–ǊKbhybridoma
lines (cǉǊǏ and cǉǋǎ) were described previously (Ǒ). All hybridomas were cultured in DMEM
(Gibco) supplemented with ǉǈƻ FBS, Ǎǈ units penicillin/Ǎǈ µg streptomycin, Ǌǈ mMHEPES, Ǎǈ
µM Ǌ-mercaptoethanol, ǉ mM sodium pyruvate and ǈ.ǉ mM nonessential amino acids (Gibco).
Cells were maintained at Ǎƻ COǊ, at ǋǏ° C, and split every Ǌ–ǋ days.
Fluorescent reagents.
ĉe following reagents were purchased from Invitrogen and used as received: Ovalbumin Alexa
Fluor ǍǍǍ conjugate (O–ǋǌǏǐǊ); Alexa Fluor ǎǌǏ goat anti-mouse IgGǉ (AǊǉǊǌǈ); Alexa Fluor
ǍǑǌ goat anti-mouse IgM (AǊǉǈǌǌ); Alexa Fluor ǍǍǍ goat anti-mouse IgGǊa (AǊǉǉǋǏ); Alexa
Fluorǌǐǐgoat anti-mouse IgGǊb(AǊǉǉǌǉ); AlexaFluorǎǌǏgoat anti-mouse IgG(H+L)(AǊǉǊǋǍ),
CellTracker Blue CMAC (CǊǉǉǈ), CellTracker Red CMTPX (CǋǌǍǍǊ), CFSE (CǋǌǍǍǌ).
Labeling hybridomas for imaging.
To label hybridomas with one of the three cytosolic dyes used (CellTracker Blue, CellTracker Red,
or CFSE), cells were incubated in serum-freemedia containing one of the dyes (ǉǈ µM) for ǋǈmin
at ǋǏ ºC. ĉe cells were pelleted, and the media replaced with DMEM/ǉǈƻ FBS. ĉe cells were
incubated for ǋǈ min at ǋǏ ºC, and then used for microengraving.
Mice.
For immunizations, a hybrid mouse strain between ǉǊǑ and Balb/c was used. ĉese mice also
contain the XBP–ǉ gene Ěanked by lox-P sites, but expression of the XBP–ǉ gene is normal, as de-
termined by biochemical analysis [courtesy of Dr. Laurie Glimcher; C. A. Hu, data unpublished].
Immunizations and splenocyte stimulation.
Mice were immunized intraperitoneally with a mixture of OVA (Ǎǈ µg) and HEL (Ǎǈ µg) as an
emulsion with complete Freund’s adjuvant (Sigma), and boosted at day ǉǌ, and day ǊǏ with an
emulsion of antigen and incomplete Freund’s adjuvant. Splenocytes were harvested from themice
four days aěer their last booster. ĉe splenocytes were harvested by disaggregation of the spleen,
and the resulting suspensionsof splenocytes (ǉǉǈǎ inRPMIǉǎǌǈ)were stimulatedwith lipopolysac-
charide (LPS; Ǌǈ µg/ml) for three days.
Microengraving.
ĉemicroengraving systemwas employed as described. [ǉǎǏ]BrieĚy, a prepolymer of PDMS(Syl-
gard ǉǐǌ, DowCorning) was cast against molds of SU–ǐ posts manufactured by photolithography
on ǋ inch silicon wafers (Silicon Sense, Nashua, NH).ĉemicrowells (Ǎǈ μm Ǎǈ μm Ǎǈ μm) were
arranged in ǌǈxǌǈ blocks on a pitch of ǉǈǈ μm; the blocks were arranged in a ǌ ǉǋ grid. Aěer cur-
ing for ǉǊ–Ǌǌ h, the arrays of microwells were removed, treated in an oxygen plasma for ǎǈ s, and
placed into a solution of bovine serum albumin (ǈ.Ǎƻ w/v) for at least ǉ h at room temperature.
ĉe molds were gently rinsed three times with phosphate-buﬀered saline, and then cells were de-
posited into the wells by gravity. Typically, ǈ.Ǎ mL of a suspension of cells (ǍǉǈǍ cells/mL) were
added to the stamp for ǋ–Ǎ min; the degree of loading was observed qualitatively under a micro-
scope. Excess cells were lightly rinsed from the surface, and then excess media was aspirated from
the surface. ĉemolds were placed into contact with glass slides (Super-Epoxy Ǌ™, Telechem Intl.)
pre-coated with goat anti-mouse IgG capture antibody (Southern Biotech ǉǈǋǈ–ǈǉ) or goat anti-
mouse IgG (H+L) (ǉǈǉǈ–ǈǉ), and blocked with BSA. (Capture antibodies were deposited from
a semi-optimized coating buﬀer (Ǎǈ mM Borate, pH Ǒ, ǐǈ mM Sucrose, Ǎǈ mMNaCl) ( J. Ronan
et al., unpublished data).) ĉe stamp supported on the glass slide was placed in a hybridization
chamber (DT–ǉǈǈǉ with set of screws used for DT–ǊǈǈǊ, Die-Tech, San Jose, CA) to hold the
assembly together, and incubated for ǋǈ min at ǋǏ deg C. Aěer incubation, stamp was gently re-
moved from the glass slide, and placed immediately into a reservoir of media. ĉe glass slide was
placed in a blocking buﬀer (ǉƻBSA/ǈ.ǈǍƻTween Ǌǈ/PBS) for ǉ h at room temperature. For repli-
cate prints, the process above was repeated with the same stamp and a pre-coated slide. ĉe slides
were analyzed by incubating with Ěuorescent antibodies and/or proteins of interest as previously
described [ǉǎǏ].
Hybridoma experiments
Cells from three monoclonal hybridomas were independently labelled with cytosolic dyes (cǉǋǎ
with CellTracker Blue CMAC, cǉǊǏ with CellTracker Red CMTPX, Yǋ with CFSE) (Invitrogen),
and then deposited into microwells. Seven replicate microarrays were generated by microengrav-
ing, and probedwith anti-mouse Ig (H+L) (Alexa ǎǌǏ, ǉǈ nM, Invitrogen) and tetramericH–ǊKb-
streptavidin (Alexa ǍǋǊ, ǉ pM to Ǎǈǈ nM). Aěer engraving, the cells were labelled with a nuclear
stain (Hoescht ǋǋǋǌǊ, Invitrogen), and then imaged by epiĚuorescence on an automated, inverted
microscope.
Immune response proėling
Splenocytes were harvested from a hybrid strain of mice (between ǉǊǑ and Balb/c) at days ǈ, ǉǍ
and ǋǈ following immunization and stimulated for three days with LPS (Ǌǈ µg/ml). ĉe cells
were then deposited intomicrowells, and six replicatemicroarrays were generated bymicroengrav-
ing. Aěer engraving, the cells were ėxed with ǌƻ paraformaldehyde, labelled with a nuclear stain
(Hoescht ǋǋǋǌǊ), anti-IgM (Alexa ǎǌǏ), and anti-BǊǊǈ (rhodamine), and imaged. One microar-
ray was stained with isotype-speciėc antibodies: anti-IgM (Alexa ǍǑǌ), anti-IgGǉ (Alexa ǎǌǏ),
anti-IgGǊa (Alexa ǍǋǊ) and anti-IgGǊb (Alexa ǌǐǐ). Five replicates were probed with anti-mouse
Ig (H+L) (Alexa ǎǌǏ) (ǉǈ nM) and increasing concentrations of ovalbumin (Alexa ǍǍǍ) (ǉǈ pM
to ǉǈǈ nM).
Data analysis
Fluorescence images of the cell-loaded PDMS device were mined by custom routines in Meta-
morph soěware (MolecularDevices). Glass slides supporting theprintedmicroarrayswere imaged
on amicroarray scanner (Genepix ǌǈǈǈB, ǌǊǈǈAL) andmined byGenepix Pro soěware (Molecu-
lar Devices). Multidimensional data was correlated in MATLAB (ĉeMathWorks, Inc). All sub-
sequent data ėltering, analysis and clusteringwere performed by custom codewriĨen inMATLAB
(available upon request). Additional methods. Additional details for all experimental methods are
available in the Supplementary Material Descriptions, including cell culture, Ěuorescent reagents,
mice and immunization methods.
ImmunoĚuorescence.
For analysis of cells in the wells of the PDMS grid, cells were ėxed in ǌƻ paraformaldehyde for ǉǍ
min at room temperature, then rinsed, and stained using Alexa Fluor Ǎǎǐ-labeled goat anti-mouse
IgM(µchain) antibody,AlexaFluorǌǐǐ-labeledanti-mouseCDǌǍR/BǊǊǈantibody(cloneĆǋ–ǎBǊ),
and Hoechst ǋǋǋǌǊ (ǉ µg/ml). Arrays of microwells were covered with a thin layer of PBS and
placed face downonto the surface of a clean glass slide. All imageswere acquired on an inverted epi-
Ěuorescence microscope (Nikon Eclipse TEǊǈǈǈ-E) equipped with a Hamamatsu Orca AG cam-
era, and an automated x-y translation stage (Prior Instruments). Overlapping imageswere acquired
for the entire array using the Scan Slidemodule in theMetaMorph soěware package (vǏ.ǉ, Molec-
ular Devices, Sunnyvale, CA). Images of complete blocks of microwells (ǌǈ ǌǈ wells ǍǊ blocks per
array) were assembled using the Scan Slidemodule inMetaMorph for each data channel acquired.
Semi-automated tabulation of the number of cells found in each well, and their expressed surface
markers, was generated using custommacros wriĨen inMetaMorph (available upon request).
Microarray imaging.
For analysis of slides probed with Ěuorescent dye reagents, we usedmicroarray scanners (Genepix
ǌǈǈǈB and ǌǊǈǈAL) to collect the images of the microarrays in either two (aﬃnity slides) or four
channels (isotype slides). ĉe accompanying soěware (Genepix Pro,MolecularDevices)was used
to extract features and Ěuorescent data. Raw numerical data was then exported toMATLAB® (ĉe
MathWorks, Natick, MA) for multidimensional correlation, ėltering and statistical analysis.
Data correlation and analysis.
Raw numeric data obtained from isotype and aﬃnity slides were imported into MATLAB®. Fur-
ther processing was performed by customMATLAB® scripts and open source subroutines (avail-
able upon request). Scanned spots with poor signal quality (high spot covariance, low signal to
noise ratio and/or high saturation levels) were ėltered from the dataset. Remaining good quality
spots were then ranked as Ig+, by seĨing a threshold on the background corrected median inten-
sity, total intensity and signal to noise ratio in the corresponding channel. ĉe isotype slides were
taken as the reference measure of the Ig-secreting cells in a given array. ĉe ėrst print generated
with each set of microwells was used to evaluate isotypes, and these prints consistently were of
higher quality (higher signal to noise ratio, more positive spots) than the scans obtained for the
aﬃnity slides. Filtered information from a) isotype slides, b) aﬃnity slides and c) cellular stains
(imaged by epiĚuorescence microscopy) was correlated on the basis of relative spatial coordinates
(column, row, block number). Once the full multidimensional dataset was assembled, a subset
of wells was selected that contained single cells and yielded Ig+ elements in all slides (ǉ isotype
plus Ǎ aﬃnity for the mouse dataset; Ǐ aﬃnity and no isotype for the anti-Kb dataset). Unsuper-
vised clustering, either by hierarchical or partitioning methods, was performed in MATLAB® to
resolve distinct classes of clones. Cophenet distances and coeﬃcients were computed to assess the
quality of diﬀerent hierarchical methods. Only hierarchical clusteringmethods yielding an average
cophenet coeﬃcient> Ǒǈƻwere employed. SilhoueĨe and gap statistics were similarly employed
to determine the adequate number of clusters used in partitioning methods (i.e. k-means). Princi-
pal components analysis was used routinely tomonitor the distribution of the selected dataset and
to control the quality of the clustering results.
Determination of antigen-speciėc clones in themouse dataset.
Each vector of data corresponding to a single cell was ėt with a Langmuir binding isotherm by non
linear least squares (ǑǍƻ conėdence interval). ĉe aﬃnity curves obtained were sorted in ascend-
ing order, based on the ėĨed apparent dissociation constant Kdapp. A threshold was determined
following visual inspection of the data to facilitate the identiėcation of clones with measurable
Kdapp (< ǉǈǈ nM). ĉe frequency of antigen-speciėc clones was calculated with respect to the
total number of wells shown to be consistently secreting in the isotype slide. Isotype information
was obtained for each antigen-speciėc clone.
Evaluation of accuracy of clustering applied tomodel hybridoma data.
ĉe identity of each cell was determined by analysis of the immunoĚuorescence data collected for
the cells with cytosolic stains in the microwells (Figure Ǎ.ǉǈ). Each unsupervised method (hier-
archical or k-means) was compared to the cell marker count (assumed as representing the true
classiėcation) and a value for the sensitivity (true positives over combined true positives and false
negatives), speciėcity (true negatives over combined true negatives and false positives), positive
predictive value (PPV) and negative predictive value (NPV) were obtained for each of the three
clonal classiėcations. ĉe average across the three clones is included in Table Ǎ.ǉ.
Part IV
Discussion
ǉǍǏ
In the previous chapters I have described a series of tools for the high-throughput and high
resolution characterization of both the immune system and the humanmicrobiome. In chapter Ǎ I
present uEn, a technique to proėle the antibody-mediated cell response and shown its application
toward the study of vaccinations. In chapter ǌ, I introduce the use of microfabrication to perform
“pulse-chase” experiments on single lymphocytes with physiologically relevant ligand doses. ĉe
remaining work Part II, introduces the use of supervised learning in the analysis of newly available
microbiome data and demonstrates its applicability toward diﬀerentiating healthy and diseased
pediatric IBD patients on the basis of their stool microbiome.
ĉe integration of these and other [ǉǏǐ] systems-level tools will allow us to deėne the rela-
tionship between host immune system and microbiome and hopefully elucidate the molecular
mechanisms responsible for this delicate and vital balance. What factors trigger changes in gut
inĚammation? Are these factors microbial, environmental or host-derived? What predisposes and
precipitates the pathogenic behaviour of pathobionts?
By investigating immune system status as awholewith rapid analysis of shiěs in themicrobiota,
one can begin to answer some of these questions. ĉe resultingmultidimensional datawill identify
key associations and improve the resolution of longitudinal observations. Discovering signiėcant
correlations and dynamic shiěs in either microbiota or immune system will, in turn, direct further
biochemical investigations aimed at deėning the underlying biological mechanisms. Before each
of the methods presented in this work can be eﬀectively integrated with the others, speciėc devel-
opments and technical improvements are necessary.
Microengraving for instance, though a relatively simple experimental procedure, still requires
some amount of training and suﬀers from poor automation. I’ve participated in early eﬀorts to-
wards the optimization and standardization of the technique, conducted in collaboration with
[ǉǏǑ, J.Ronan] and [ǉǐǈ, A.Oguniunny]. Since then substantial technological development has
taken place [ǉǐǉ] [ǉǐǊ] [ǉǐǋ] and has been directed toward i) further standardization of the mi-
croengraving protocol, ii) the creation of speciėc devices and engineering solutions that simplify
the current process and iii) the streamlining of data mining instrumentation and algorithms.
ĉe establishment of standard protocols and a set of appropriate tools [ǉǐǈ] has improved the
quality and repeatability of themicroengraving process. Staining of glass slides is done bymeans of
commercially available automation to ensure uniform signal. Chip fabrication is standardizedwith
the use of an injection mold to increase the speed of production. Lastly, the placement of the chip
in contact with the glass slide is performed by means of an appropriate mechanical device instead
of relying onmanual placement. Datamining has also been streamlined: improvement on chip de-
sign allows automatic alignment of images and identiėcation of wells; the use of dedicated imaging
instrument signiėcantly increases the speed of data acquisition; and the development of custom
soěware for image analysis and data correlation removed the largest boĨleneck in the pipeline.
ĉese eﬀorts have already enabled the routine collection of data by microengraving [ǉǐǌ],
adding the ability to select relevant antibody producing cells and proėling the status of humoral
immune responses to the panel of techniques at the disposal of the immunologist. ĉus it is now
possible to determine the impact diﬀerent microbial communities will have on the dynamic and
the secretions of lymphocyte populations, by applying microbial factors or entire microbial pop-
ulations to the microengraving chip (or extracting mucosal lymphocytes at diﬀerent stages of gut
colonization). Changes in secretory paĨerns undetectable by traditionalmethodsmay be diagnos-
tic of disease initiation or, at least, informative about its progression.
For this speciėc reason, other secreted factors will be of interest when proėling the dynamics
of immune responses, including cytokines, chemokines, ROS as well as pathogen derived secre-
tions, just to name a few. Cytokines in particular mediate lymphocyte activity and homeostasis,
as well as the regulation of dendritic cells and antigen presenting cells in general. By engineering
improvements in the signal-to-noise ratio for the printed protein microarrays and by expressing
cytokine-speciėc capture antibodies, uEn has been expanded by [ǉǐǋ] to include the analysis of
cytokine release.
Cytokine measurements, in turn, allow for the detection and proėling of other fundamental
players of the immune response in the gut mucosa, such as T lymphocytes (Tregs andĉǉǏ) and
dendritic cells. Since it is well known that the equilibrium between Tregs andĉǉǏ cells in the gut
determines inĚammatory state, it may be possible to develop an assay for inĚammation or, beĨer,
individuate the factors responsible for the initiation of the inĚammatory process.
Technological developments have also permiĨed routine recovery of the single cells interro-
gated [ǉǐǉ], permiĨing the study and characterization of rare lymphocytes [ǉǐǍ]. ĉis ability
will be of paramount importance when tools will be applied to the study of mucosal immunity,
since lymphocyte populations in the mucosa are less abundant and harder to isolate than those
routinely extracted from peripheral blood. It will be possible to recover individual lymphocytes
demonstrating activity upon interaction with microbial factors and thus further characterize them
molecularly and genetically.
Lastly, no quantitative models exist to describe the reaction of the immune system to micro-
biota. Further technological advances in microengraving will allow the acquisition of a greater
number of signals, thus increasing the number of variables measurable at each stage of the process.
In turn, this will enable the formation of more detailed theoretical models, potentially capable of
predicting the course of autoimmune disease and infection.
Exposure of single immune cells to physiologically appropriate quantities of microbial factors
can be useful for deėningmolecular details of the interaction between single immune cells and the
microbiota. ĉe tool demonstrated for themapping of surface dynamics of single lymphocytes
can easily be adapted to this task, by either employing microbial factors as ligands or by enabling
contact between microbes and single antigen-presenting cells.
Development and redesign of the method shown in this work will however be necessary to
surmount its principal limitation: low throughput. ĉe construction of parallel array (or chamber
microchips) is a practical improvement and has already been demonstrated for diﬀerent applica-
tions. [ǉǐǎ] [ǉǐǏ] [ǉǐǐ]Technological advances in Ěuorescencemicroscopy are also needed in or-
der to image largerėeldsof viewwith the same level of resolution shown in thiswork. [ǉǐǑ] [ǉǑǈ] [ǉǑǉ]
ĉe validity of this approach, however, has been amply demonstrated. Similar types of high-
resolution single cells experimentshavebeendevised throughmicrofabricationandhigh-resolution
microscopy. [ǉǑǊ]Tolar et al [ǉǍǈ] and Sohn et al. [ǉǌǑ] have observed the changes occurring dur-
ing the initiation of B cell signalling and the microclustering requirements on the surface of B cells
bymeans of Ěuorescence energy transfermeasurements. Mapping of the response of immune cells
to chemotactic stimuli similar to the ones found in vivo has also been conducted with the aid of
microfabricated chips. [ǉǍǍ] [ǉǑǋ]
ĉe biological insight granted by these high-resolution techniques promises to elucidate many
details regarding the intracellular pathways and surface interactions of single immune cells with
their microenvironment and at the immunological synapse. [ǉǑǌ] ĉe application of these tech-
nologies to antigen presenting cells and lymphocytes in the gutmucosa, will allow us to interrogate
the molecular pathways responsible for microbial recognition and processing.
Development of high throughput methods to interrogate immunity by deėnition requires so-
phisticated analysis algorithms to evaluate the resulting data output. Computational tools devel-
oped for the analysis of microbiome composition will be highly relevant in the characterization
of mucosal immunity, both in the gut and elsewhere in the body. Machine learning tools reduce
the complexity of monitoring large bacterial communities and are sensitive to subtle shiěs in mi-
crobial composition. Changes in the parameters measured for the immune system can then be
correlated with these shiěs with the aim of determining causative factors, or at least key biomark-
ers. Information about the host immune system can also be integrated by performing classiėcation
of taxonomical data against any of the parameters measured while characterizing the immune re-
sponse. Machine learning models will then identify the signiėcant changes in the microbiota that
accompany variation in immune parameters.
Future work will include the evaluation of other existing machine learning algorithms and fea-
ture selection strategies. Although a limited number of models have been discussed herein and
ensemble methods such as RandomForest proved optimal, novel algorithms are actively being de-
veloped in the machine learning research community. In particular, eﬀorts are focusing on dealing
with larger datasets in parallel and the adaptation of ensemblemodels to data with large number of
features [ǉǑǍ]. ĉese are two kind of advances that would greatly beneėt classiėcation ofmicrobial
sequencing data.
One potential method for the unbiased evaluation of algorithms is the organization of a ma-
chine learning competition onmicrobiome data [ǉǋǊ]. ĉe hope is to stimulate the development
of new algorithms to classify microbial community data, by providing an anonymized dataset of
patient sequences and metadata on an open-access platform. It will also be important to assess
whether the inclusion of phylogenetic information (or ecological information) would positively
aﬀect the accuracy of supervised learning and whether it can provide further insight in the com-
munity structure at a speciėc site. Even though classic machine learning algorithms could be ap-
plied directly to rawmicrobiome data, it is arguable that beĨer performance in classiėcation would
be achieved by incorporating microbiological and evolutionary knowledge in a classiėcation algo-
rithm. Correct preprocessing and representation of the input data generally improves the perfor-
mance of machine learning algorithms, oěen requiring less input data to achieve the same clas-
siėcation accuracy. Previous knowledge about the input data or its underlying structure can be
integrated into classiėcation algorithms, and varying input representation can highlight diﬀerent
paĨerns in the data. In the case of microbiome data, it will be necessary to evaluate whether the in-
clusion of phylogenetic information can improve accuracy and relax training dataset requirements.
Any improvement in accuracy can improve the rate and the quality at which associations between
microbial composition and disease are found.
ĉe integration of machine learning algorithms into sequencing processing pipelines is also
a future direction for the work illustrated here. Supervised learning methods can prove to be a
powerful tool in evaluating the relative importance of various sequencing parameters (sequencing
platform, sequencing depth, read length, variation between centers,etc.). ĉe rapid comparison of
sequencing results coming from control experiments can be a direct and straightforward applica-
tion for approaches based on learning.
Perhaps most importantly, it will be crucial to apply and adapt the tools presented here to the
analysis of longitudinal studies. Key to the advance of our understanding of host-microbiota in-
teraction will be the collection of longitudinal data on microbial composition and immune status.
Only byobserving the transition fromnormal physiology to inĚammatory state and its sequela, will
it be possible to infer the correct trigger and the order of each step in the cascade leading to dis-
ease. Soěware and machine learning algorithms will have to be adapted to deal with time-varying
data, by allowing for the real-time updating of training sets. It will also be necessary to develop an
appropriate structure for the input data that takes into account time as an independent variable so
that it can be parsed bymachine learning algorithms. As the algorithmswould be dealingwith time
series data, itmay bemore appropriate to buildmodels for the trend of parameters rather than their
discrete values.
Finally, a focus of future work will be the integration of ecological theory in the study ofmicro-
bial populations living in association with the human host. Understanding the biology of the mi-
crobiome and how it interacts with the host immune systemwill require a development of ecolog-
ical theory beyond the current levels. Created to describe ecology and evolution of animal species,
current ecological theory does not suﬃce to describe and predict the ecology of microbial species.
A clear deėnition of species in microorganisms is lacking. Mobile genetic elements make this def-
inition even more challenging. Moreover, despite the recent improvements brought about by ǉǎS
sequencing,MLST, and pyrosequencing, measuring the richness and spatial distribution ofmicro-
bial species remains an imprecise quantitative exercise. ĉese are challenges that will have to be
surmounted to analyze and predict the impact of microbes on their host, as well as their spatio-
temporal dynamics. [ǉǑǎ] Formal construction of theoretical hypotheses is arguably the best way
to tackle these challenges and advance the ėeld of microbiome biology. ĉeoretical formulations
will be able to generate predictions, which then can be experimentally validated by the set of new
tools being created.
ĉe type of analysis described will allow us to ėnd more quickly and consistently important
paĨerns in microbiome data, a desirable outcome in a ėeld where data is currently being accumu-
lated at an impressive rate and where there exists clear clinical correlations of immediate impact.
Ultimately, the various tools developed as part of this work will be integrated to provide a uni-
ėed view of the host immune system and the microbiota. ĉe resulting picture will hopefully
deepen our knowledge of the complex and deeply interesting interaction humans maintain with
the microbes around us.
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